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Abstract: 
Magnesidin is a magnesium chelate of the 3-hexanoyl and 3-octanoyl tetramic acid 
derivatives isolated from Psuedomonas magensiorubra. Its activity against gram-
positive bacteria was found to be a specific target for Gingivitis, a dental plaque. 
Although the synthesis of magnesidin has been reported earlier, it was not reproducible. 
The highly polar nature and it’s ability to exhibit tautomerization makes their chemical 
behavior complex and difficult to predict its structure. A variety of reactions and an in 
depth understanding of the chemical structure is necessary to attain the synthesis of 
these compounds.  
This dissertation focuses on addressing the attempts towards the synthesis of 
Magnesidin by identifying the important intermediates necessary for the synthesis as β-
keto esters, α,β-unsaturated amino esters. The focus of the work has been addressed 
by developing a TAG molecule approach, which is similar to the concept of solid phase 
synthesis except for the fact that the TAG molecule can be identified under UV and also 
can be detected using various spectroscopic techniques. Microwave synthesis has been 
explored and applied in to the synthesis of benzyl mono and di bromination, 1,3- 
benzodioxoles have been established. The benzyl mono bromination is applied to 
synthesize the TAG molecule, which is then applied in developing a method of 
synthesis for β-keto esters.  The azide approach was used to synthesize the α,β-
unsaturated amides, which are another essential class of compounds in the synthesis of 
magnesidin.  
Key Words: Magnesidin, tetramic acids, gingivitis, β-keto acids, α,β-unsaturated amino 
esters, 1,3-benzodioxoles, tautomerization, microwave synthesis and bromination. 
Chapter I 
Introduction 
1.1 Tetramic Acids: 
The tetramic acids has were known ever since its simple derivatives were prepared in 
the early 1940’s, but its key importance was realized only in 1960’s when they were 
identified as important structural unit in many natural products. The biological activity of 
tetramic acids extends from potent antibiotic, antiviral and anti-ulcerative properties, 
cytotoxicity and mycotoxicity, the inhibition of tumors (in mice and humans) as well as 
fungicidal action while some Tetramic acids are responsible for pigmentation of certain 
molds and sponges1-7. This attracted the interest of not only natural products chemists, 
but also of chemical ecologists, medicinal and synthetic chemists. The most common 
tetramic acids exist as a 3-acyl derivative, and a very few exists as a 4-O-alkyl ether 
derivative. This makes the synthesis of these compounds very challenging and would 
be a great contribution to synthetic and medicinal chemistry. These target compounds 
have a very complex chemical behavior and the architectural framework includes not 
only stereo centers but also many other synthetically challenging substrates8,9. For 
these reasons, there are either no or only few synthetic methodologies available for 
many classes of these compounds. Some of the synthetic equivalents of tetramic acids 
were also subjected to clinical investigations and are in the process of drug 
development 10. 
Although the basic structural unit of the tetramic acid does not look very complex, the 
various reactive sites on the tetramic acid make it more complex to be synthesized. The 
primary reactions of the tetramic acid ring can be summarized as follows:   
 2	  
• Attack by electrophiles like aldehydes, bromine, nitrating agents on C-3. 
• Attack by nucleophilic species like hydrazine on C-2 and C-4.  
• Acylation on position N-1, C-3 and O-4. 
• With organometallic bases or metallation at C-3. 
• Substitution at C-5. 
 
Figure 1.1. The reactive skeleton of tetramic acid 1. 
 
1.1.1 Structure and acidity of tetramic acid:  
Tetronic acid, which is very close in structure to tetramic acid, is more explored in 
comparison to tetramic acids. It is known much earlier and was first prepared11 in 1896 
and its pKa is about 3.76, making it a strong acid in aqueous solution12. The solid state 
IR spectrum proves that it exists in enolic form 2 which showed absorptions at 1690 cm-l 
for the carbonyl and 1635 cm-l for the alkenyl (C=C) stretching13. It was further 
supported by UV absorptions with λmax at 223 and 248 nm in aqueous ethanol. Whether 
it exists in the enol 2 or enolate 3 forms in fig 2 is dependent on the pH of the solution14.  
4
5
N
H
1
2
3O
O
Nucleophiles
Electrophiles,Metallation
Acylation
Acylation
Tetramic Acid 1
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Figure 1.2. Enol and enolic forms of tetronic acid and 2-imino tetronic acid. 
 
As tetramic acid is a nitrogen analogue of tetronic acid, and was assumed to exist in the 
enol form 5, however exits in keto form 1 and was first synthesized15 in 1972. There 
were few publications that reported tetramic acid prior to then16,17 but it was later proven 
that the synthesized compound was 2-iminotetronic acid18,19 4 and not tetramic acid 1. 
The tetramic acid 1 is much weaker acid15 with pKa 6.4 in aqueous solution as 
compared to its oxygen analogue 2.  The solid state infrared spectrum of 1 shows 
absorptions at 3230 cm-1 (N-H stretch), 1696 cm-1 (C=O), 1670 cm-1 (N-H bend) and 
1782 cm-1 (C=O) from the second carbonyl at C-4 unlike 2 or 3, which is further 
supported by the negative ferric chloride test with 1. With the fact that a solid-state 
existence involves in H bonding, the spectrum was also recorded on a solution phase 
and C4 band was still observed. The UV spectrum however shows a single absorption 
(λmax 260 nm) due to the corresponding enolate species 6 with the intensity being 
strongly dependent on the pH of the solution. To conclude, in aqueous solution, the 
ionic form 6 exists predominantly in equilibrium with the 2,4-diketo form 5 while the enol 
form 4 is absent. 
O
HO
O O
O
O
2 3
O
HO
NH
4
Enol form Enolic Form 2-Imino tetronic acid
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Figure 1.3. Keto, enol and enolate forms of tetramic acid: 
 
The acidity of tetramic acids with a substituent on the 3rd position is comparable to 
tetronic acids. For example, the pKa of the tetramic acid with acyl substituent 7 on 3rd 
position is in the range of 3.0-3.520,21 and that of the tetramic acid with alkoxy 
substituent 8 is about 2.3-2.512. 
 
Figure 1.4. Pka comparison of tetronic and tetramic acids substituted at 3. 
 
1.1.2 Tautomerization in Tetramic Acid:  
 The enolization of the tetramic acid was observed in Proton NMR, however the spectra 
is complicated due to the presence of other tautomeric forms. The UV absorption 
spectra for 3-acyltetramic acids and analogues20 shows an absorption of red light 
indicating the conversion of enol forms with λmax 220 and 277 nm to enolate forms with 
N
H
HO
ON
H
O
O
51
N
H
O
O
6
Keto form Enol form Enolate form
N
H
O
O
O
N
H
O
O
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O
O
HO
O
2
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λmax 240 and 279 nm. The 3-acyl tetramic acids 7 exist in two sets of rapidly 
interchanging internal tautomers 9,10 and 11,12. The tautomers 9 and 10 just like 11 
and 12 are obtained by mutual proton transfer and the two sets 9,10 and 11,12 are 
inter-converted quite fast amongst themselves. However the tautomerization between 
sets of 9,10 and 11,12 is slow and detectable on NMR time scale.  
 
Figure. 1.5. Tautomeric forms of acyl tetramic acid. 
 
The ratios of these tautomers for some specific 3-acyltetramic acids like 13, 14, and 15 
were reported by Steyn and Wessels 22,23.  The ratio of tautomers 9:10:11:12 proposed 
for these tetramic acids was 5:15:0:80. They were however in contradiction to 
Yamaguchi’s calculations which were based on electron density values24. Steyn’s 
calculations were based on the observed chemical shifts and NMR (proton and carbon). 
The study of ratio of tautomers concluded that the 3-acyl tetramic acid exists 
predominantly in exo-enolic form analogous to 12. Semi empirical methods like SCF-
N
H
HO
O
O
N
H
O
O
HO
N
H
O
O
OH
N
H
O
OH
O
Fast
Fast
Slow
9 10
11 12
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MO, ΔHf calculations, also predict exo-enolic form as major tautomer. The results have 
become more obvious with the X-ray crystallographic structural determination of the 
tetramic acid 13, which existed in the exo-enolic form23.  
 
Figure. 1.6. 3-Acyl tetramic acids tested for tautomer ratio. 
 
The idea that the exo-enolic form is the principal tautomer was confirmed from the 
conclusions of X-ray crystal structures25,26 of the antibiotic Triandamycin A 16 and that 
of α-Cyclopiazonic acid 17. The above-mentioned ratios are good only for simple 3-
acyltetramic acids, with further more substitution; the ratio and existence of tautomers 
would differ. In case of N-Acyl tetramic acids27, tautomer analogous to 9 would be major 
one, as the possibility of H-bonding with the C-4 carbonyl increases, with the lone pair 
on nitrogen being no longer able to increase the proton acceptor ability of C-2 carbonyl. 
 
 
Figure 1.7. Structures of triandamycin A 16 and α-cyclopiazonic acid 17. 
HN
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O
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O
O
HO
14 15
O
O
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1.2 Naturally Occurring Tetramic Acids: 
The tetramic acids that exist in nature can be classified on the basis of their structure. 
The structural differences are commonly attributed to the substituents on the ring. The 
discussion in this part focuses on variation of tetramic acids based on their substitution 
at various centers on the ring. The substitution at C-3 is a key aspect for the biological 
activity of a tetramic acid and the variation at this position is greatly exhibited by these 
natural products. Positions 2 and 4 are carbonyls and there are very rare and few 
compounds with an ethereal linkage at 4 position and hence this classification is ignored 
for this part of the discussion. The classification of the tetramic acids can be listed as 
follows: 
• 3-Acyl teramic acids. 
• Dienoyl tetramic acids. 
• Polyenoyl tetramic acids.  
• Decalinoyl tetramic acids 
• Macrocyclic tetramic acids 
• N-Acyl tetramic acids. 
 
1.2.1. 3-Acyl Tetramic Acids: 
Tetramic acids with an acyl substitution on the third position (C-3) are most commonly 
found tetramic acids in nature. Tenuazonic acid 18 is one of the simplest 3-acyltetramic 
acids with a chiral center at C-5.  It was originally isolated from the culture filtrate of 
Alternaria tenuis auct28. A great interest has been attributed to this compound because 
of its extreme biological activity29-31. It doesn’t exhibit great deal of antibacterial activity 
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32 but has an inhibitory effect33 on several viruses when induced at a high dosage 
including poliovirus MEF-l, ECHO-9, parainfluenza-3, vaccinia, and herpes simplex 
(HF). It also involves in the inhibition of amino acid incorporation into microsomal protein 
of humans, there by inhibiting the growth of human adenocarcinoma in the embryonated 
egg. Although it does exhibit a wide range of biological activity, its value has been 
limited due to its extreme toxicity. When the microbes have been fed with L-valine, 
leucine34 or L-norvaline28, they produce isopropyl 19, isobutyl 20, or n-propyl 21 
tenuazonic acid analogues. These were found to have biological activity similar to, 
though less potent than, 18 itself. 
 
Figure. 1.8 Structures of tenuazonic acid and its variation at C-5 substitution. 
 
Reutericyclin is another tetramic acid that is acylated at C-3 and at position 1(on N) and 
is isolated35,36 from Lactobacillus rueteri.  It is active towards many gram positive 
bacteria like sourdough lactic acid bacteria, Staphylococcus aureus, Listerica innocua, 
and some pathogens like Enterococcus faecium the gram-negative bacteria are 
resistant to Reutericyclin. It not only exhibits various biological functions but is also used 
as a preservative in food industry. Pachydermin is an unusual oxalylated tetramic acid 
that was isolated37 from the New Zealand basidiomycete Chamonixia pachydermis. It 
exhibits mild antibiotic conditions but is believed to show the activity after it undergoes 
HN
O
O
HO
H
18
HN
O
O
HO
19
HN
O
O
HO
20
HN
O
O
HO
21
 9	  
degradation in acidic conditions. α-Cyclopiazonic acid, a mycotoxic tetramic acid was 
isolated by Holzapafel and workers from the fungus Penicillium cyclopium Westling38. 
They studied the acid’s structure and relative stereochemistry with the help of proton 
NMR spectroscopy of 17 and its degradation products. Investigation of the biosynthetic 
route39-42 of 17 gave an idea of the building blocks, which are L-tryptophan, mavalonic 
acid and acetate. However the assembly of these intermediates produced β- 
cyclopiazonic acid 22, which upon further undergoes ring closure by syn addition43 to 
give α- cyclopiazonic acid 17. The imino derivative of the acid 23 has also been 
obtained by following a similar culture. However, the source of ammonia is not clear, if it 
is from fungus or by natural chemical reaction, aminolysis of 17. α-Cyclopiazonic acid 
acts as an antioxidant and is a potent inhibitor of calcium uptake44-46 and Ca2+ATP-ase 
activity in sarco and endoplamic reticulum.  
 
Figure 1.9. Structures of ruetericyclin, pachydermin, α,β-cyclopiazonic acid and 
malonomycin. 
 
Malonomycin 26 is also a tetramic acid that belongs to similar family and is isolated 
from Streptomyces rimosus var. paromomycinus, which is antiprotozoal and is 
specifically potent against typanosomes47. The unique structure of Malonomycin has 
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been deduced by van der Baan and coworkers48, 49. Aminomalonic acid is the key 
component responsible for biological activity, because Mono-decarboxylation of this 
functional group by refluxing in water, led to complete loss of biological activity49.  
 
1.2.2 Dienoyltetramic acids: 
Dienoyltetramic acids are tetramic acids with 1-oxo-pentadienyl substituent at C-3 
position in the ring. The first one of its kind streptolydigin 27 was isolated in 1956 from 
the Streptomyces lydicus50. It is responsible for inhibition of terminal DNA tranferase 
and RNA polymerase enzymes and is also effective towards gram-positive bacteria. 
The structure activity relation studies concluded that the 3-dienoyl substituent is 
crucial51. Oxidative degradation52,53 of streptolydigin gives streptolic acid 28 and ydiginic 
acid 29 which were characterized by NMR, mass and UV spectroscopy. 
 
Figure. 1.10. Oxidative degradation of streptolydigin. 
 
Another tetarmic acid that fallsin this class and is very close in structure and behavior to 
27 is Tirandamycin A 16, isolated54 form the culture of Streptomyces tirandis. Its 
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biological activity is also quite comparable55,56 to Streptolydigin 27 except that its inbition 
of DNA transferase is that prominent51. Tirandamycin B 30 isolated57 from  also 
behaves as Streptomyces flaveolus is analogous to 16 in structure but also in biological 
properties. A structural hybrid of 16 and 30  was isolated58 from the fermented beers of 
Streptomyces sp.AB-1006A-9 and was called Tirandalydigin, showed an antimicrobial 
spectrum not very different form these other compounds59. 
 
Figure. 1.11. Structural analogues of streptolydigin 27. 
 
Another class of compounds that act as metabolites and have similar structure is 
Nocamycin derivatives. Bu-2313A 32 and Bu-2313B 33 (known as Nocamycin I) were 
isolated60,61 from an unidentified oligospotic actionomycete strain. These two 
compounds have a great range of biological activity and are good for both gram positive 
and negative bacteria. Moreover they were effective against aerobic and anaerobic 
bacteria like Streptococci, with 33 being twice as effective as 32.  Later in 1977, another 
tetramic acid Nocamycin II 34 has been added to this family. However the biological 
activity62 of 34 is surprisingly not the same as 32 and 33, although a common 
biosynthetic path way has been postulated for all these compounds. 
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Figure. 1.12. Structures of nocamycin related tetramic acids. 
 
1.2.3 Decalinoyl Tetramic Acids: 
This is a special class of tetramic acids because the total synthesis of many of these 
compounds is still not reported. Equisetin is the first tetramic acid of this kind to be 
isolated63 from Fusarium equiseti in 1974. It has varied biological activity and exhibits 
antibiotic function, HIV inhibition, cytotoxicity and even DNA binding in Mammals64-66. 
Trichosetin is the nearest tetramic acid in structure to equisetin and was isolated67 from 
dual culture of Trichloro derma harzianum and Bacillus subtillis. Trichosetin is a N-
desmethyl homologue of equisetin and coniosetin68, altersetin69 and paeciloestin70 are 
structurally close to equisetin. Trichosetin was found to be phytotoxic and it was 
observed in seeding growth assays.  It also was found to show damaging effect on the 
mitochondria. Considering these factors, although Trichosetin is active biologically, its 
extreme biological toxicity has minimized its importance. Coinsetin, altersetin and 
paeciloestin are all active against gram-positive but are inactive towards gram-negative 
bacteria.  However these compounds also exhibited an extent of toxicity with coinsetin 
being twice as toxic as the other two. 
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Figure. 1.13. Structures of decalinoyl tetramic acids. 
 
1.2.4 Polyenoyl tetramic acids:  
As the name suggests polyenoyl tetramic acids are the tetramic acids with polyenoyl 
substitution on the tetramic acid at position 3. Erythroskyrine 35 was one of the first 
tetramic acids identified as the important pigment of penicillium islandicum Sopp. It has 
a strong antibiotic action against Staphylococcus species71. Fuligorubin A 36, another 
tetramic acid of this class has been isolated form Fuligo Septica which led to a series of 
compounds 40-42 derived from tyrosine, isolated72 from Leocarpus Fragilis. However 
the importance of these compounds as biologically active compounds is not very clear 
and is limited to use as chelating agents and colorants. The polyenoyl tetramic acid with 
antibiotic activity has not been identified before the isolation73 of Oleficin 40 from a 
strain of streptomyces parvulus. A little later α-Lipomycin 41 and β-Lipomycin 42 were 
isolated74, which differ from 40 only in the chain length of the olefin connected on the C-
3 of the tetramic acid. Both 41 and 42 are highly active against gram-positive bacteria 
but are in effective towards fungi. Oleficin 40 also plays an important role as ionophore 
especially for Mg2+ and Ca2+ ions in isolated rat liver mitochondria75. 
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Figure. 1.14. Structures of polyenoyl tetramic acids. 
 
1.2.5 Macrocyclic tetramic acids:  
Ikarugamycin is a macro cyclic acid, isolated76 from the culture broth of Streptomyces 
phaeochromogenes var. ikaruganensis Sakai. Other than antibiotic activity it showed in 
vitro antiamoebic, antiulcer77 activity and a strong specific antiprotozoal behavior. 
Ikarugamycin is a 16-membered macro cyclic lactam and the trans, anti, cis-decahydro-
as-indacene skeleton. Another antifungal compound isolated78,79 from a Streptomyces 
strain is capsimycin 25 also called as antibiotic N-461. Heat-stable antifungal factor 
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(HSAF) is a secondary metabolite produced80 by the bacterium Lysobacter 
enzymogenes. It is highly active against a variety of fungi. Discodermide is another 
macro cyclic tetramic acid close in structure to the above compounds and is isolated81 
from a deep-sea sponge of Caribbean called Discoderma dissoluta. A macrocyclic 
tetramic acid with cytotoxic activity against melanoma cells is Cylidramide, isolated82 
from marine sponge Haliochondria cylindrata Tanita. Macrocidin A and B are a unique 
set of macrocyclic tetramic acids, isolated83 from Phoma macrostoma and act as weak 
plant pathogens.  
 
 
Figure. 1.15. Structures of macrocyclic tetramic acids. 
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1.2.6 N-Acyl tetramic acids 
N-acyl tetramic acids are tetramic acids substituted by acyl derivatives at N-1 of the 
ring. Dysidin 43 was the first N-acyl tetramic acid to be isolated84 from the indo Pacific 
sponge Dysidea hebacea. It was also the first chlorine containing tetramic acid and 
exists with ethereal linkage on C-4. Malingamide A 44, is a little more complex chlorine 
containing compound, but is not biologically active85 like 43 and was isolated from the 
marine cyanophyte Lyngbya majuscula. Magnesidin, another N-acyl tetramic acid with a 
spectrum of biological activity was isolated86 as a magnesium salt from Psuedomonas 
magnesiorubra. 
 
Figure. 1.16. Structures of dysidin, malingamide A and magnesidin. 
 
The blue green algae from which Malingalide A was isolated also contained many other 
tetramic acids but lacked the long chain fatty acid and the chlorine substitution on it. A 
series of seven compounds were isolated87,88 and named Pukeleimide A-G (44-50). The 
X-ray structure has determined that the structure is planar with the hydroxy and hydroxy 
methyl groups being out of plane. 
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Figure. 1.17.  Structures of pukeleimides (A-G). 
  
Althiomycin 51 is another compound of this class, isolated89 from Streptomyces 
althioticus and exhibited antibacterial activity. However it has become a very important 
compound due to its extremely low toxicity and activity against both gram positive and 
negative micro organisms90. Dolastain is another N-acyl tetramic acid that was 
isolated91 from shell-less Western Indian Ocean mollusk Dolabella auricularia. It was 
observed to be a potent cytostatic agent against leukemia cells. 
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Fig. 1.18. Structures of althiomycin and dolastain. 
 
1.3 Magnesidin: 
Of all these tetramic acids, Magnesidin 56 is of a special interest of the dissertation and 
is the target molecule of the research. Magnesidin is an inseparable 1:1 mixture of the 
magnesium chelates of the 3-hexanoyl and 3-octanoyl tetramic acid derivatives86,92,93. It 
is a unique magnesium-containing compound and was the first reported example of a 
naturally occurring tetramic acid as a magnesium salt. It was isolated from a new 
Pseudomonas species called Psuedomonas. magnesiorubra, obtained from the surface 
washings of the marine green alga Caulerpa peltata. 
 
1.3.1 Extraction and physical properties of magnesidin: Magnesidin 56 
was extracted93 from Psuedomonas. Magnesiorubra by following a step of procedures. 
Fermentations were carried out under immersed culture conditions for 30 hrs at 280 c, in 
a medium containing 2% glucose, 1.5% peptone, 0.5% yeast extract, 0.5% soluble 
starch, 3% NaCl, and 0.1% MgSO4.7H2O with the pH being 7.494. At the end of the 
fermentation, the cells that would contain the antibiotic were centrifuged and extracted 
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repeatedly with hot acetone until it becomes colorless. The orange extract was 
decolorized with activated charcoal and the filtrate was evaporated. The powdered 
Magnesidin thus obtained was purified and crystallized from methanol as colorless 
needles. It is soluble in ether, ethyl acetate, chloroform, acetic acid, methanol, ethanol, 
butanol and pyridine but insoluble in water. It is stable up to 1210 c and over a range of 
pH between 2 and 8. 
 
1.3.2 Tautomers of magnesidin: 
Magnesidin exhibits all the four tautomers and they were studied using 2D NMR. The 
NOSEY spectrum revealed the cross peaks in this compound and the tautomers exist 
as shown in the fig. The ratio of external tautomers based on the NMR calculations was 
found to be 89:1193,94 while the internal tautomers were inter-converted so fast that they 
are not recordable on an NMR time scale. The major tautomer mixture was found to be 
a and b while the minor was c and d. 
 
Figure. 1.19. Tautomers of magnesidin. 
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1.3.3 Antibacterial activity of magnesidin: 
Magnesidin inhibits95 gram-positive bacteria (MIC 2-7 g/mol), particularly spore bearers, 
and also prevents the decay of foodstuff caused by spore germinating organisms. Table 
1 explains in detail the activity of Magnesidin against various gram-positive bacteria.  
Table 1.1: Antibiotic properties of magnesidin. 
S.No Test Oraganism Minimal Inhibitory Concentration (MIC) 
1 Bacillus subtilis ATTC 6633 3 
2 Bacillus megatherium 2 
3 Bacillus anthracis 2 
4 Staphylococcus aureus FDA 209P 3 
5 Staphylococcus albus 4 
6 Sarcina lutea 2 
7 Gaffkya tetagena 5 
8 Streptococcus faecalis 7 
9 Escherichia coli >100 
10 Salmonella typhimurium >100 
11 Proteus vulgaris >100 
 
Along with its activity, it has been found mildly toxic, and so cannot be absorbed orally. 
There are several other tetramic acids that are active against gram-positive bacteria but 
the specific use of Magnesidin is prevention of gingivitis and reducing dental plaque. Its 
use as food preservative has also been reported but it has not much been explored. 
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1.4 Probable application of magnesidin for gingivitis: 
Gingivitis is characterized by gingival inflammation and/or bleeding and is caused by 
plaque at and under the gingival margins. Epidemiological surveys indicate that an 
average of 50% of the adult population of the United States have gingivitis. Most people 
brush their teeth however; toothbrushes cannot effectively remove plaque at or under 
the gum line.  
Floss is effective at removing plaque in locations, difficult to reach; however only about 
20% of the US population use floss. Inconvenience is a commonly cited reason for not 
flossing. Since gingivitis is caused by plaque and plaque is composed of various kinds 
of bacteria, in theory anti-microbial agents should be effective against gingivitis.  
There are a number of anti-microbial agents formulated in toothpaste or rinses on the 
market.  The most effective of these agents is chlorhexidine digluconate (CHG). CHG 
reduced gingivitis by 50-80% in clinical trials. However, CHG is available in the US by 
prescription only and is generally used on a short-term basis (2-4 weeks only). Patient 
compliance is generally poor due to the unpleasant side effects associated with the use 
of CHG, which include staining of the teeth, interference with taste function, and 
enhanced calculus formation96. Two products available on over-the-counter (OTC) 
market have shown marginal effectiveness in clinical trials, called Total® and 
Listerine®. Total, a toothpaste containing triclosan, reduced gingivitis by 20-25% in 
clinical trials. Listerine reduced gingivitis by 20-35% in clinical trials. Neither triclosan 
nor Listerine are substantive agents, thus the anti-microbial effect is lost quickly97.  The 
remaining anti-microbial agents available in OTC products have failed to show 
effectiveness in clinical trials. Thus, there is currently no truly efficacious anti-gingivitis 
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product that is both convenient to use and appealing to the consumer. It appears that 
the only chemicals that have been shown to have potent anti-plaque and anti-cavity 
activity are fluoride and chlorhexidine, both of which are halogenated65,98.  
Other commonly used compounds including the phenolics are not as effective as plaque 
and cavity-control agents99. Considering the importance of healthy teeth and gums in 
general human health, and the lack of availability of a proper remedy, it is very 
important to develop an industrially viable synthetic approach for Magnesidin. In 
addition the synthetic method should be a method that can be used to produce in an 
industrial scale and apply it to other tetramic acids of medicinal significance. 
 
1.5 Synthesis and complications in mimicking the biosynthesis: 
There are two literature reports outlining preparation of Magnesidin which were reported 
three decades ago95, however the reported methods have too many disadvantages, 
including low reaction yields, difficulty to reproduce and isolate the intermediates.  In 
many literature reported attempts to reproduce this procedure, intermediates were lost 
during purification. The key steps in these preparations are the acylation of 5-ethylidene 
pyrrolidine-2,4-dione with an appropriate acid chloride in the presence of boron 
trifloride-ethereate. Jones and coworkers investigated5 the viability of this strategy and 
they reported that the product was being lost during the basic workup required for the 
lewis acid-mediated acylation. These problems explain why there is no manufacturing 
procedure for the preparation of such an important antibiotic.  It is even more important 
that there are no reliable synthetic procedures for many other tetramic acid derivatives, 
considering that tetramic acids show a remarkable diversity in terms of biogenetic 
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descent as well as structural variations and biological activity.  The high polarity of these 
compounds and the fact that they can exist in various tautomeric forms (2,4-diketo form 
prevails in solution) renders them difficult to handle and their spectra difficult to interpret. 
In designing a successful preparation route for Magnesidin, it is wise to explore the way 
that nature assembles tetramic acid.  Biosynthesis of the tetramic acid more often 
originates from the respective a-amino acid precursors (N1-C5-C4 fragment) [13].  The 
source of the C2-C3 segment of the tetramic acid, as well as of potential 3-alkanoyl side 
chains has been found for most cases to be acetate (Scheme 1).  In case of Magnesidin 
the α-amino acid should be substitutes by α-β unsaturated amino acid and the acetate 
to be substituted by malonate. 
 
Figure. 1.21. Structure of magnesidin and biosynthetic assembly of the tetramic acid. 
 
However, there are a few relatively old synthetic procedures that have already emulated 
biosynthesis for tetramic acids in general, although not necessarily with the same order 
of individual steps, starting from Meldrum’s acid and α-amino acids under neutral pH 
that preserve the C-5 chirality. For instance Lacey’s classical sequence100 starts from α-
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amino ester that condenses with a β-keto acid or with diketene followed by the basic 
Dieckmann condensation (C3-C4 bond formation) 101.  The mildest and most versatile of 
all is Jouin’s synthesis102. The synthesis involves use of meldrums acid in synthesizing 
the teramic acid and the figure 1.22 explains the reaction sequence. Condensation 
between the methylene carbon in meldrum’s acid and the amino acid is initiated with 
dicyclohehyl carbodiimide (DCC) and dimethyl aminopyridine (DMAP) as the catalyst 
and heating the intermediate γ-amino-β-keto ester leads to the corresponding tetramic 
acid.   
 
Scheme 1.1. The Lacey-Dieckmann and the Jouin tetramic acid ring cyclization. 
 
Perhaps the major contribution toward tetramic acid synthesis comes from introducing 
ketenylidene-triphenyl phosphorane (Ph3P=C=C=O) as a C2-C3 tetramic acid building 
block (Scheme 3)102. This approach is best demonstrated in preparation of the antibiotic 
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acylation and sodium hexamethyl disilazanide catalyzed N1 acylation (Scheme 3).  The 
antibiotic is prepared in four steps without racemization at the C5 position. 
 
 
Scheme 1.2. Utilization of Ph3P=C=O as a tetramic acid building block. 
Although the presented synthetic procedure substantially shortens the preparation of 
the antibiotic, these acylation procedures are very difficult to perform, which seems to 
be a general problem in the preparation of tetramic acid derivatives. The success of the 
downstream 3-acylation depends on the system being acylated. C5- or N1-
unsubstituted tetramic acids are particularly difficult to react. Another problem is the 
introduction of long-chain acyl residues, and these shortcomings are present in each 
and every known tetramic acid preparation procedure. For instance, the Jones 
acylation104 using acyl halides and a boron trifluoride-ether complex does not work well 
with 5-usubstituted tetramic acid and is unsuitable for the introduction of Lewis acid 
sensitive highly unsaturated tetramic acid moieties. Yoshi’s protocol105 initially involved 
4-O-acylation in the presence of dicyclohexyl carbodiimide and a catalytic amount of 4-
dimethylaminopyridine and acyl-migration, which was promoted by adding Et3N, and 
this method had low reproducibility mostly in the 4-O to 3C acyl shift. Boeckman’s 
approach via 2-b-phosphonylacetyltetramic acid compromises stereochemistry in C5 
position106. Given these described synthetic problems, it is easy to see that there is a 
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need for a general synthetic procedure that would allow the introduction of a diverse 
number of substituents in any of the tetramic acid positions.   
 
1.6 Aim of dissertation: 
From the literature reports, it is understood that in designing a successful synthesis of 
Magnesidin, reproducibility, product yield and reaction conditions are few of many 
important considerations. Most importantly, it is acknowledged that new synthetic 
approaches should substantially differ from currently available ones.  The thesis will 
focus on the following goals and each goal would be addressed further in the following 
chapters.  
• Tag(s) should be introduced in early stage of preparation that will facilitate easier 
isolation, purification and analysis synthetic intermediates.   
• Starting materials should be simple and their synthetic procedures should be 
available for all the intermediates. 
• Overall Synthetic procedure for tetramic acid should be applicable to large-scale 
tetramic acid manufacturing. 
• To develop a general synthetic procedure to prepare any derivative of tetramic 
acid focusing on the synthesis of Magnesidin. 
 
Each Chapter of the dissertation addresses one of the above set goals for the project. 
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Chapter II 
 Synthesis of TAG Molecule: 
2.1 Abstract:  
The synthesis of magnesidin involves very complex reactions and complicated 
purification methods. A tag molecule is assumed to solve the problems associated with 
the synthesis and the chapter discusses the synthesis of the tag molecule in an 
environmentally friendly reaction conditions. 
2.2 Introduction to TAG molecule: 
The syntheses reported earlier for Magnesidin when attempted to reproduce by other 
researchers indicated that the intermediates would evaporate or decompose either 
during the reaction or work up2. The purification of tetramic acids and their 
intermediates would be tough due to the physical properties of the compounds (like low 
volatility), tautomerization, and high polarity. Also in many earlier attempts it was 
reported that the intermediates were tough to be handled during work up and 
purification because of their chemical behavior. For example if we consider the case of 
β–keto acids which are essential intermediates in the synthesis of tetramic acids, there 
isn’t a reliable synthetic procedure3, which can be applied in general to prepare any type 
of β–keto acids available due to afore mentioned reasons. The main problem 
associated with the synthesis of these compounds is that they undergo β–
decarboxylation even at slightly elevated temperatures and often involve complicated 
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purification methods. Preparation and purification of b-keto esters is complicated 
because the majority of them are oils and so it is hard to monitor the reaction 
processes. If these oils can be transformed in to solids, it would not only be easy to 
monitor the reaction but also simple to purify. Simple crystallization techniques can be 
employed for purification, and hence better yields can be obtained. Considering these 
facts, a tag molecule, application of which can change the physical properties of the 
intermediates there by providing easy purification and handling, is necessary for a 
successful synthesis of magnesidin and the intermediates required for.  
2.3 Results and Discussion:  
After a careful consideration of various important synthetic facts, structural studies and 
chemical behavior, a set of phthtalic and naphthalic compounds have been identified to 
have the potency to serve as tag molecules as shown in figure 2.1.’ 
 
Figure.2.1. The tag molecules designed for synthesis. 
While designing the synthesis of the tag molecule, there are several aspects to be 
considered. The procedure should be simple, economical and reproducible on industrial 
scale and should not involve too many steps, keeping in mind the possible low yield at 
the end. The strategy in scheme 2.1 was the preliminarily designed for synthesizing the 
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tag molecule A, with an intention to follow up the same procedures for tag molecules B 
and C. 
 
Scheme 2.1. Proposed synthesis of the tag Molecule A. 
However in the proposed synthesis the step in which acid 1 has to be converted to acid 
chloride 2 and acid chloride 2 to alcohol 3a, the acid and acid chloride were not very 
well dissolved in spite of trying various solvents and their mixtures. As a result, the yield 
of the acid chlorides produced are very low and even the small amount of acid chloride 
produced could not be reduced to the corresponding alcohol 3a. The reduction could 
not be accomplished even after trying a range of reducing agents and is summarized in 
in scheme 2.2. When lithium aluminium hydride (LiAlH4) was used, it led to over 
reduction on the carbonyl of the acid leading to the product 4 and over reduction of the 
carbonyl of amide leading to the product 5. Sodium borohydride on the other hand was 
not very effective in reducing the acid chloride. It only produced 30% of the desired 
alcohol 3a and the main product of this reaction is the corresponding aldehyde.  
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Scheme 2.2. Attempts in synthesizing the tag molecule A. 
 
Since solubility was one of the main problems faced during the reduction of above-
mentioned acids, the acid was transformed into the corresponding ethyl ester 6 of the 
acid 1 to increase the solubility. A strong acid like sulphuric acid was used as catalyst 
for the esterification reaction to produce 70% of the ester and the reaction results are 
presented in scheme 2.3. 
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Scheme 2.3 Synthesis of the ester to be reduced. 
Once the ester has been synthesized, with an improved solubility it was anticipated that 
the reduction reaction would be favored to produce the corresponding alcohol but even 
in this case various attempts to reduce the ester 6 remained unsuccessful. And in case 
of the ester the over reduction has led to different products 4a, 5, and 7 other than 3a as 
shown in scheme 2.4. 
 
Scheme 2.4 Attempts towards reducing the ester to alcohol. 
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As there wasn’t any success with reducing the acid, acid chloride or ester in to 
corresponding alcohols, the order of the steps is slightly modified and it was first 
attempted to synthesize p-amino benzyl alcohol 12 which can further be coupled with 
phthalic anhydride to obtain the tag molecule 3a. Not only the acid 8 but the acid 
chloride 9 and both the methyl and ethyl esters 10 and 11 have been subjected for 
reduction as shown in scheme 2.5. The results were not very encouraging even for p-
amino benzyl alcohol, the molecule being very polar. It was tough to isolate the 
compound even if some product is formed. NaBH4 and LiAlH4 were both unsuccessful in 
producing the desired compound in desired yields. That could be one of the reasons 
why this compound is not commercially available on all catalogues for sale and if 
available is very expensive.  
 
Scheme 2.5. Attempts to reduce p-amino benzoic acid and its esters. 
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After a series of changes in methodology and unsuccessful attempts, it was understood 
that the tag molecule itself needs a good method of preparation and the previous 
scheme would not be successful. A new strategy has been proposed aiming the 
synthesis of tag molecule compromising on no of steps in the reaction, as shown in 
scheme 2.6. 
 
Scheme.2.6  Altered procedure to synthesize Tag Molecule A. 
The attempts to synthesize the Tag molecule A, following the scheme 2.6 were not very 
impressive as few of these reaction conditions had to be developed and stabilized. Like 
the first step of the reaction to produce 4 has a moderately good yield but its completion 
takes as long as 16 hrs. And upon investigation, it was identified that the general 
procedures available for the cyclic imides involve long reaction times and also poor 
yields. The reaction time has to be cut short along with improving the yields. In the step 
2 of the scheme, where benzyl bromination occurs to produce 5a, it was obtained only 
in a 57% yield with the rest being the di-bromo product 5b4. The mono and di-bromo 
products are so close in Rf that the separation of these compounds is very tedious, time 
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taking and also results in reducing the yield. Also it involves use of CCl4 as solvent, 
which is very toxic and is banned in some of the countries. Since Microwave is a good 
media to increase selectivity, reduce reaction times, and also environmentally friendly, a 
general method of synthesis using the microwave is established for both these classes 
of compounds-cyclic imides (which need shorter reaction times and better yields) and 
benzyl mono, di-bromo products (which require selectivity, thereby better yielding and 
also environmentally friendly). 
 
2.3.1 Microwave Synthesis of phthalimides and naphthalimides:  
Phthalimides have been widely used, as amino acid protection groups5 and also have 
been widely used in the field of medicinal chemistry6. However an efficient high yielding, 
inexpensive synthetic procedure for these compounds is unavailable. Long reaction 
time is also another major problem associated with these types of compounds. The use 
of microwave irradiation to accelerate chemical reactions has become increasingly 
popular7. The most recent observations suggest that the high energy heating is 
responsible for the acceleration of chemical reactions8. In a typical cyclization reaction 
producing imides, anhydride is condensed with the corresponding amine at elevated 
temperatures. The reaction involves dehydration too and dehydration reactions are 
facilitated in a microwave, it was hypothesized that microwave synthesis of phthalimide 
and naphthalimide derivatives would be ideal. But a common problem associated with 
microwave synthesis is over heating of the reaction mixture. Solvent-free procedure 
using TaCl5-silica gel as a catalyst is an example described for the preparation of imides 
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under microwave irradiation9. Sandhu et al. advocated the use of a more ecofriendly 
solvent-free system, involving the reaction of equal amounts of anhydride and amines or 
amino acids in the absence of solvent in a domestic oven without any catalyst10. All 
these cases being solvent free conditions and the reaction temperatures being not 
reported10, decomposition of the products is possible with a slight change in 
temperature or power.  
To circumvent this, as well as several other problems associated with the use of a 
domestic microwave, it has been modified and several reactions were performed to 
outline the efficiency of the same. The use of our modified microwave reactor offers a 
number of advantages over traditional household ones1. For instance, the temperature 
inside the reaction vessel can be constantly monitored and the radiation power can be 
adjusted.  Subsequently, a condenser has been fixed, which allows the reaction mixture 
to the solvent’s boiling point without any loss of the solvent. Additionally, the set up 
allows the use of magnetic stirrer, making the reaction mixture homogenous and 
minimizing the overheating on a particular side of the reaction vessel. On the whole 
microwave-assisted reactions can be conducted with or without solvent and also in the 
environmentally friendly solvents such as ionic liquids11. 
Considering that microwave absorption is stronger for polar molecules, given a reaction 
mixture, all the components may not be heated equally, refluxing the mixture using a 
magnetic stirrer allows formation of fewer byproducts. With the mentioned advantages, 
controlled microwave assisted reactions would be superior to conventional heating in 
regards to isolated yield. To test these anticipated advantages, microwave-assisted 
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reactions were employed for the preparation of cyclic imides. The reaction time is 
however dependent on the size of the ring and conjugation in the cyclic imides from the 
corresponding cyclic anhydride and amine. 
As the precursor of tag molecule A can be prepared from phthalic anhydride or 
naphthalic anhydride and p-toluidene, the first set of reactions were focused on 
phthalimides and corresponding amines in DMF and then extended to naphthalic 
derivatives. The reaction mixture was refluxed at a particular magnetron of the 
microwave, depending on the reaction composition and polarity. Once the reaction is 
complete, product was isolated by ice-water precipitation from the still hot reaction 
mixture. The reaction time and yields are presented in Table 1. Preparation of aromatic 
and aliphatic phthalimides under conventional heating from the corresponding amines 
usually requires prolonged time in solvents such as toluene, acidic acid, and etc12. 
There are also reports of solvent free microwave assisted synthesis13. However, solvent 
free approach can be successful only if one of the reactants absorbs microwave 
irradiation and has relatively low melting point. On the other hand, this procedure is 
applicable to broad range of amines regardless of their physical state or microwave 
radiation absorption because solvent (DMF) is an excellent microwave reaction media, 
as it was demonstrated on the examples of aromatic amines (4a-4d) and aliphatic 
amines (4e and 4f, Table 2.1). 
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Table 2.1: Preparation of derivatives of phthalimides. 
Microwave Conventional Entry Product 
Time (hr) Yield (%) Time (hr) Yield (%) 
4a 
 
 
1 
 
94P1 
 
16 
 
85 
4b 
 
 
1 
 
95 P1 
 
16 
 
65 
4c 
 
 
0.5 
 
97 P1 
 
12 
 
65 
4d 
 
 
1 
 
85 P2 
 
16 
 
60 
4e 
 
 
0.75 
 
95 P2 
 
16 
 
60 
4f 
 
 
0.75 
 
90 P2 
 
16 
 
63 
 
P1=300 Watts and P2= 450 Watts in microwave. 
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In general, five-membered cyclic anhydrides are more reactive than six-membered 
cyclic anhydrides. Therefore, it is not surprising that microwave assisted reaction 
conditions used for the preparation of cyclic imides with 1,8-naphthalic anhydride were 
longer than that of phthalic anhydride. The reaction time is more than quadrupled. 
However replacing the DMF with pyridine as solvent, the isolated yield was higher and 
the reaction time was shortened (Table 2.2). The isolation of the product requires 
quenching the reaction mixture with water or with aqueous hydrochloric acid followed by 
crystallization of the product. 
 
Table 2.2 Preparation of derivatives of 1,8- naphthalimides. 
Microwave Conventional Entry Product 
Time (hr) Yield (%) Time (hr) Yield (%) 
4g 
 
 
2 
 
90P1 
 
20 
 
70 
4h 
 
 
2 
 
95 P1 
 
24 
 
75 
4i 
 
 
1 
 
93 P1 
 
24 
 
50 
P1=450 Watts in microwave 
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As the desired imides 4a and 4h are prepared; the next step of the reaction is benzyl 
bromination. The reported procedures available resulted in very low yields due to 
possible di bromination and hence complicated purification methods, so a better 
preparation of benzyl bromination needs to be developed. 
 
2.3.2 Microwave synthesis of mono and di-bromo benzyl derivatives: 
The majority of benzyl radical bromination reactions have been performed using 
elemental bromine14-16 or N-bromoimides17,18 and chlorinated organic solvents, such as 
the highly toxic carbon tetrachloride (CCl4) as reaction media. More recently, however, 
bromine has been mostly replaced by other sources due to its corrosive behavior. CCl4 
is the most effective solvent for performing these reactions but its ozone-depleting 
capability and increasing restrictions to its use due to environmental impacts 
necessitates synthetic teams to find a more applicable system for free radical 
bromination with less impact on the environment.  In spite of the above listed restrictions 
and hazards, use of CCl4 as a common organic solvent has been reported even as 
recently as in this decade19-21.  This is largely due to the fact that even today, as we 
develop a firm understanding of the impact of performing chemical synthesis using 
green chemistry22, the quest for greener solvents has provided chemists with few 
alternatives for CCl4. Chloroform and methylene chloride were used as less toxic 
alternatives to CCl4, but the real advancement towards the realization of 
environmentally friendly reactions has been in the possibility to perform radical reactions 
in non-chlorinated solvents, such as methyl acetate, benzene, and carbon disulfide23. 
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More attempts toward replacing chlorinated solvents with environmentally friendly 
reaction media were recognized when an attempt of benzyl bromination was performed 
with bromine in water media24. Even so, in this process, depending on the nature of the 
substrate, a substantial amount of the aromatic ring bromination was also observed. 
Also in the search of safer bromination reagents, a bromine complex of the styrene vinyl 
pyridine co-polymer25, bromotrichloroethane26,27 and copper (II) bromide28 have been 
reported to be effective for benzylic bromination as environmentally safe alternatives. 
However, these bromination reagents are expensive and are not recyclable for multiple 
uses in reaction mixtures. 
Water is an ideal reaction media from the environmental standpoint, and remains the 
gold standard for solvents for green chemistry.  Although water has already been used 
as a green solvent (HBr/H2O2 reaction media)29-31 and visible-light-promoted solvent-
free NBS benzyl bromination32, these approaches have several drawbacks.  The 
selectivity of the reaction is low and even result in lower isolated yields of benzyl 
bromides.  In addition, the reaction requires longer times (20-30 hrs). These drawbacks 
stress the need for a more selective, environmentally friendly procedure for preparation 
of benzyl bromides with good yields. Goswami and coworkers went a step ahead in this 
aspect and reported microwave-assisted benzyl bromination without solvents and a 
radical initiatior33. The reaction was performed in a few minutes with microwave 
magnetron power of 450W. However, the isolated yields following column 
chromatography were still low (around 40%), even though the reaction time was 
substantially reduced (~15 minutes), and therefore a more efficient and environmentally 
friendly benzyl bromination method was still sought after. 
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Herein a new benzyl bromination approach that requires short reaction times, has been 
developed in environmentally friendly solvents, and produces high to excellent isolated 
yields for both mono- and di- benzyl bromination. Ethyl acetate and diethyl carbonate 
were the two environmentally friendly solvents chosen34. While a few radical 
bromination reactions in ethyl acetate were explored previously20, the reported ratio of 
mono to di bromination is 1:2, and to the best of our knowledge there are no reported 
radical benzyl bromination reactions using diethyl carbonate as reaction media. Both of 
these solvents are environmentally friendly, and recyclable. To shorten the reaction time 
benzyl bromination was performed under microwave-assisted conditions as shown in 
scheme 2.7. The conditions mentioned apply for both mono and di-bromination of N-
protected toluidenes. 
 
Scheme. 2.7 Microwave-assisted radical benzyl bromination of N-protected toluidines. 
 
The reaction conditions were optimized for these compounds using microwave and 
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carbon tetrachloride, (b) diethyl carbonate, and (c) diethyl carbonate with microwave 
heating is presented in Figure 2.2.  
As demonstrated numerous times in the literature, carbon tetrachloride is an 
exceptionally powerful benzyl bromination solvent35. In the case of preparation of 13a 
(Figure 2.2), the reaction is complete after refluxing for one hour with isolated yield 
higher than 90%. If carbon tetrachloride is substituted with ethyl acetate as the reaction 
media, then the reaction progress is much slower. For instance, ~65% benzyl mono-
bromination was obtained together with benzyl di-bromination after twenty-four hours of 
the reaction mixture refluxing. With diethyl carbonate as the solvent, the reaction 
mixture was refluxed for only six hours before completion (Figure 2.2).  
 
 
Figure 2.2.  Comparison of various reaction conditions for benzyl mono-bromination 
  
As mentioned above, and in one of the previous research reports, microwave heating is 
superior to conventional heating in radical reactions36. This procedure was applied to 
the reactions described in this report, and found that the required reaction time was 
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significantly shortened from 360 minutes to 30 minutes (Figure 2.2), when diethyl 
carbonate was used as the reaction media. The diethyl carbonate microwave benzyl 
bromination can be considered both environmentally friendly and superior to 
conventional benzyl bromination in carbon tetrachloride. 
These optimized reaction conditions for microwave-assisted benzyl bromination in both 
ethyl acetate and diethyl carbonate as reaction media were used for preparation of a 
number of other compounds (Table 2.3). The isolated yields and reaction conditions are 
similar to those presented in Table 1. Microwave-assisted reactions are, in general, 
superior to conventional reactions37. In the case of radical bromination, microwave-
assisted reactions require shorter reaction times, higher reaction selectivity and 
ultimately better-isolated yields when compared to conventional bromination reactions38 
and is even more effective for polar molecules such as amides38. The time difference 
between conventional and microwave-assisted bromination of these compounds is quite 
large. For instance, in the case of 13a (Table 2.3) in the conventional preparation of this 
compound, took twenty-four hours for completion with the ratio of mono- to di-bromo 
product was 3:1, and the isolated yield of mono-bromo product 13a was only 55%.  
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Table 2.3. Time and yields of benzyl monobromination of protected toluidenes 
 
Entry Product Time 
(min) a 
Yield 
(%)a 
Time 
(min) b 
Yield 
(%)b 
13a 
 
30 90 30 95 
13b 
 
60 85 30 90 
13c 
 
40 90 30 90 
13d 
 
60 95 40 95 
13e 
 
40 5 40 85 
a: Ethyl Acetate (400 W), b: Diethyl carbonate (450W) 
Once successful results were obtained for N-protected p-amino toluidenes, the method 
has been generalized for various other toluidenes and the reaction conditions for 
microwave-assisted mono benzyl bromination are presented in Scheme 2.8. 
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Scheme 2.8 Microwave-assisted radical benzyl bromination of substituted toluenes 
The reaction conditions remained same even for simple aromatic compounds; and the 
optimized reaction time and isolated yields for mono benzyl bromination in 
environmentally friendly solvents are presented in Table 2.4. The reaction times were 
shortened from a few hours (conventional solvent refluxing) to around 0.5 h under 
microwave conditions. With ethyl acetate as a solvent, the reaction can be conducted 
with microwave power of 400 W.  The power for diethyl carbonate is slightly higher, 450 
W, resulting in shorter (by 5 to 10 minutes) reaction times and marginally better isolated 
yields (Table 2.4). 
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Table 2.4. Time and isolated yields of benzyl monobromination of substituted toluenes. 
 
Entry Product Time (Min) a Yield (%)a Time (Min) b Yield (%)b 
13f 
 
30 92 20 95 
13g 
 
30 85 20 85 
13h 
 
30 90 20 95 
13i 
 
40 80 30 80 
13j 
 
20 98 15 98 
13k 
 
30 90 20 98 
Solvent used a: Ethyl acetate, 400W b: Diethyl carbonate, 450W. 
2.3.3 Benzyl di bromination of toluidenes: 
Considering that the introduction of the second bromine in the benzyl position by radical 
bromination is much more difficult, the reaction conditions for di bromination have also 
been explored. Although the di bromination product is almost always present in radical 
benzyl bromination reactions as it is demonstrated in Figure 2.2, the common problem 
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associated with these reactions is complete conversion of benzyl bromides into benzal 
bromides (radical di bromination)39. The reaction usually requires aggressive reagents 
and longer reaction times. In this case, microwave-assisted di bromination is superior to 
conventional heating procedures for the preparation of these compounds.  
 
Figure 2.3.  NMR reaction following of comparative benzyl di-bromination 
To further optimize the reaction conditions on molecules of our interest comparative 
radical benzyl di-bromination was performed (Figure 2.3). In carbon tetrachloride, the 
reaction is complete after three hours. In ethyl acetate, the reaction was not completed 
even after refluxing for twenty-four hours. Diethyl carbonate was a better solvent than 
ethyl acetate, but still required eleven hours of refluxing for completion (Figure 2.3). 
With conventional heating, carbon tetrachloride was superior to diethyl carbonate as the 
benzyl di-bromination solvent. However, diethyl carbonate, as the reaction media in a 
microwave was superior to conventional heating with carbon tetrachloride as the 
reaction media. This reaction was complete in half an hour as in comparison to three 
hours in carbon tetrachloride. There is yet another advantage of using diethyl 
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carbonate. After cooling the reaction mixture to 15˚C almost all succinimide crystallizes 
from the reaction mixture and can be recycled into NBS. The solvent was distilled off 
under reduced pressure and used in new bromination reactions. 
Table 2.5. Time and isolated yields of benzyl dibromination of protected p-toluidine 
Entry Product Time 
(min) 
Yield (%) Time 
(min) 
Yield (%) 
15a 
 
80 70 30 85 
15b 
 
100 60 30 80 
15c 
 
90 65 30 85 
15d 
 
90 75 40 90 
 
These optimized reaction conditions were used to perform benzyl di bromination on 
several cyclic amides (Table 2.5). These compounds (p-amino benzaldehydes and p-
amino benzal bromides) are precursors for preparation of tagged monosaccharide used 
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in preparation of diverse oligosaccharide library published elsewhere35,40,  Microwave-
assisted benzyl di-bromination in both ethyl acetate and diethyl carbonate proceeded 
smoothly. However diethyl carbonate is the superior solvent regarding both reaction 
times and isolated yields (Table 2.5). The reactions were completed in less than 40 min 
with a microwave magnetron power of 600 W. 
 
Table 2.6. Time and isolated yields of benzyl di-bromination of substituted toluene 
Entry Product Time 
(Min) a 
Yield 
(%)a 
Time 
(Min) b 
Yield 
(%)b 
15e 
 
90 70 60 85 
15f 
 
90 75 75 85 
15g 
 
90 70 60 90 
15h 
 
120 60 90 85 
15i 
 
60 75 40 95 
 
As for imides, simple toluidenes also showed better results using diethyl carbonate 
instead of ethyl acetate. Switching the solvents, gave selectivity and hence better-
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isolated yields with less reaction times for di-bromo products and all the reactions were 
complete in less than 90 min (Table 2.6).   
2.3.4 Synthesis of the tag molecule: 
The methodologies developed have been applied to the synthesis of the tag molecule 
as proposed above. After the bromo derivative was prepared, the corresponding ester 
was synthesized using sodium acetate which was then hydrolyzed using sodium 
hydroxide to obtain the desired tag molecule A in 74% overall yield. 
 
Scheme.2.9. The synthesis of the tag Molecule A (3a). 
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2.4 Conclusion: 
In conclusion, the effect of microwave irradiation on the preparation of cyclic imides, 
benzyl and benzal bromides have been explored and reported. With the possibility to 
control the power of microwave radiation, it was easy to achieve selectivity, better yields 
and less reaction time. This approach is superior to conventional synthetic approach in 
both isolated yield of the product and required reaction time for preparation of cyclic 
imides and bromides. Also benzyl mono- and di-bromination procedure not only gave 
good results but is also environmentally friendly and superior to same reaction in carbon 
tetrachloride as a solvent. These reactions are conducted under microwave radiation 
and in diethyl carbonate as the reaction media with NBS as a source of bromine. Upon 
completion of the reaction, the formed succinimide was separated by filtration and the 
solvent distilled off. With an easy, environmentally friendly preparation of NBS from 
succinimide, both the reagent and the solvent are also recyclable. Diethyl carbonate is 
our solvent of choice with microwave heating for both benzyl mono- and di-bromination. 
Isolation of products and recycling the reagents and the solvent is a simple process. 
Successfully establishing the methods of preparation of afore mentioned compounds, 
the tag molecule synthesis was made possible. 
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2.5 Experimental and spectral data: 
Phthalimide synthesis in Microwave, General procedure A: To a suspension of 
phthalic anhydride (1.48 gm, 10 m.mol) in N, N-dimethyl formamide was added the 
corresponding amine (10m.mol, 1 eq). The reaction mixture was put in the microwave 
reactor equipped with condenser and magnetic stirrer and stirred under mild solvent 
refluxing (magnetron power between 300 and 450 W). After reaction was completed 
reaction mixture was poured onto crushed ice (~200 g). Formed white precipitate was 
separated by filtration, washed with water and dried under reduced pressure. According 
to the NMR spectra compounds are more than 96% pure.  
Preparation of 2-p-tolylisoindoline-1,3-dione (4a): Titled compound was produced 
following the general procedure A from phthalic anhydride (1.48g, 10m.mol) and p-
toluidine (1.07g, 10 m.mol). The product was obtained in (2.2g) 94% yield. 1H NMR (400 
MHz, CDCl3) δ 7.93 (dd, J = 5.5, 3.0 Hz, 2H), 7.77 (dd, J = 5.5, 3.0 Hz, 2H), 7.31 (s, 
4H), 2.41 (s, 3H) ppm. 13C NMR (400 MHz, CDCl3) δ 167.6, 138.4, 134.6, 132, 130.2, 
130, 129.9, 129.2, 126.9, 126.7, 126.6, 123.9, 21.4 ppm. 
Preparation of 2-p-phenylisoindoline-1,3-dione (4b): Titled compound was produced 
following the general procedure A from phthalic anhydride (1.48g, 10m.mol) and aniline 
(0.93g, 10m.mol). The product was obtained in (2.1g) 95% yield. 1H NMR (400 MHz, 
CDCl3) δ 7.96 (dd, J = 5.5, 3.0 Hz, 2H), 7.79 (dd, J = 5.5, 3.0 Hz, 2H), 7.50 (t, J = 7.3 
Hz, 2H), 7.44 (d, J = 7.3 Hz, 1H), 7.40 (dt, J = 2.7, 1.6 Hz, 1H) ppm. 13C NMR (400 
MHz, CDCl3) δ 167.5, 134.6, 131.9, 131.9, 129.3, 128.3, 126.8, 123.9 ppm. 
Preparation of 2-(3-bromophenyl) isoindoline-1,3-dione (4c):Titled compound was 
produced following the general procedure A from phthalic anhydride (1.48g, 10m.mol) 
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and m-bromo aniline (1.07g, 10m.mol). The product was obtained in (2.9g) 97% yield. 
1H NMR (400 MHz, CDCl3) δ 7.96 (dd, J = 5.5, 3.0 Hz, 1H), 7.79 (dd, J = 5.5, 3.0 Hz, 
1H), 7.62(s, 1H), 7.48(d, J = 7.8 Hz, 2H), 7.39 (t, J = 7.8 Hz, 1H). 13C NMR (400 MHz, 
CDCl3) δ 167.6, 139.4, 134.6, 132.0, 131.7, 129.3, 129.2, 127.5, 124, 123.9, 21.6 ppm. 
Preparation of 2-(biphenyl-2-yl) isoindoline-1,3-dione (4d): Titled compound was 
produced following the general procedure A from phthalic anhydride (1.48g, 10m.mol) 
and biphenyl-2-amine (1.69g, 10m.mol). The product was obtained in (2.5g) 85% yield. 
1H NMR (400 MHz, CDCl3) δ 7.96 (dd, J = 5.5, 3.0 Hz, 1H), 7.79 (dd, J = 5.5, 3.0 Hz, 
1H), 7.62(s, 1H), 7.48(d, J = 7.8 Hz, 2H), 7.39 (t, J = 7.8 Hz, 1H). 13C NMR (400 MHz, 
CDCl3) δ 167.6, 139.4, 134.6, 132, 131.7, 129.3, 129.2, 127.5, 124, 123.9, 21.6 ppm. 
Preparation of 2-hexylisoindoline-1,3-dione (4e): Titled compound was produced 
following the general procedure A from phthalic anhydride (1.48g, 10m.mol) and hexyl 
amine (1g, 10m.mol). The product was obtained in (2.2g) 95% yield. 1H NMR (400 MHz, 
CDCl3) δ 7.96 (dd, J = 5.5, 3.0 Hz, 2H), 7.79 (dd, J = 5.5, 3.0 Hz, 2H), 3.62 (t, J = 7.2 
Hz, 2H), 1.82 (m, 2H), 1.3(m, 6H), 0.83 (t, J = 7.6 Hz, 3H). 13C NMR (400 MHz, CDCl3) 
δ 169.1, 134.2, 132.2, 123.8, 38, 31.8, 28.5, 26.7, 22.5,13.8 ppm. 
Preparation of 2-heptadecylisoindoline-1,3-dione (4f): Titled compound was 
produced following the general procedure A from phthalic anhydride (1.48g, 10m.mol) 
and heptadecyl amine (2.6g, 10m.mol). The product was obtained in (3.5g) 90% yield. 
1H NMR (400 MHz, CDCl3) δ 7.96 (dd, J = 5.5, 3.0 Hz, 2H), 7.79 (dd, J = 5.5, 3.0 Hz, 
2H), 3.62 (t, J = 7.2 Hz, 2H), 1.82 (m, 2H), 1.3(m, 28H), 0.83 (t, J = 7.6 Hz, 3H). 13C 
NMR (400 MHz, CDCl3) δ 169.3, 134.2, 132.2, 123.8, 38.6, 30.7, 29.8, 29.8, 29.6, 29.3, 
29.2, 27.5, 22.5, 22.5, 14.3 ppm. 
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Phthalimides by conventional heating, General procedure B: To a suspension of 
phthalic anhydride (1.48g, 10m.mol) in 20 ml of toluene, was added the corresponding 
amine (10m.mol, 1 eq) and 1ml of triethyl amine. The suspension was refluxed at 70°c 
for about 12-24 hrs, until the completion of the reaction as monitored by TLC and the 
excess solvent was distilled and collected into a collector by increasing the reflux 
temperature. The pure compound was obtained as colorless needles upon cooling the 
remaining solution. Compounds 1a-1f were synthesized using the general procedure B. 
Naphthalimide synthesis in Microwave, General procedure C: Pyridine (100 ml) 
solution of 1,8-Naphthyl anhydride (1.98g, 10 m.mol) and corresponding amine (10 
m.mol, 1eq) was refluxed at microwave magnetron power of 450W. After cooling to 
room temperature, reaction mixture was poured onto ice. Formed white solid was 
separated by filtration, washed with water, and dissolved in dichloromethane (100 ml). 
Dichloromethane solution was washed with 10% hydrochloric acid (3x50 ml), water 
(3x50 ml), dried over anhydrous sodium sulfate and evaporation of the solvent under 
vacuum gave pure product.  
2-phenyl-1H-benzo[de]isoquinoline-1,3(2H)-dione (4g1): Titled compound was 
prepared according to the general procedure C described above using naphthyl 
anhydride(1.98g, 10m.mol), aniline(0.93g, 10m.mol) and 15ml of DMF. The product was 
obtained in 70% yield (1.91g). 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J = 7.3 Hz, 2H), 
8.27 (d, J = 8.3 Hz, 2H), 7.79 (t, J = 8.0 Hz, 2H), 7.56 (t, J = 7.5 Hz, 2H), 7.49 (t, J = 7.4 
Hz, 1H), 7.32 (d, J = 7.2 Hz, 2H). 13C NMR (400 MHz, CDCl3) δ 164.6, 135.7, 134.5, 
132, 131.8, 129.6, 128.9, 128.8, 128.7, 127.3, 123.1 ppm. 
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2-phenyl-1H-benzo[de]isoquinoline-1,3(2H)-dione (4g2): Titled compound was 
prepared according to the general procedure C described above using naphthyl 
anhydride(1.98g, 10m.mol), aniline(0.93g, 10m.mol) and 15ml of pyridine. The product 
was obtained in 90% yield (2.45g). 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J = 7.3 Hz, 
2H), 8.27 (d, J = 8.3 Hz, 2H), 7.79 (t, J = 8.0 Hz, 2H), 7.56 (t, J = 7.5 Hz, 2H), 7.49 (t, J 
= 7.4 Hz, 1H), 7.32 (d, J = 7.2 Hz, 2H). 13C NMR (400 MHz, CDCl3) δ 164.6, 135.7, 
134.5, 131.9, 131.8, 129.6, 128.9, 128.8, 128.7, 127.3, 123.1 ppm. 
2-p-tolyl-1H-benzo[de]isoquinoline-1,3(2H)-dione (4h1): Titled compound was 
prepared according to general method C described above using naphthyl anhydride 
(1.98g, 10m.mol), p-bromo toluene (0.93g, 10m.mol) and 15ml of DMF. The product 
was obtained in 65% yield (1.98g). 1H NMR (400 MHz, CDCl3) δ 8.65 (d, J = 7.3 Hz, 
2H), 8.27 (d, J = 8.3 Hz, 2H), 7.79 (t, J = 7.8 Hz, 2H), 7.36 (d, J = 8.1 Hz, 2H), 7.21 (d, J 
= 8.1 Hz, 2H), 2.45 (s, 3H). 13C NMR (400MHz, CDCl3) δ 164.6, 139.6, 135.6, 134.5, 
131.9, 131.7, 129.8, 129.5, 129.4, 128.7, 127.3, 125.8, 123.1, 21.7 ppm. 
2-p-tolyl-1H-benzo[de]isoquinoline-1,3(2H)-dione (4h2): Titled compound was 
prepared according to general method C described above using naphthyl anhydride 
(1.98g, 10m.mol), p-bromo toluene (0.93g, 10m.mol) and 15ml of pyridine. The product 
was obtained in 95% yield (2.89g). 1H NMR (400 MHz, CDCl3) δ 8.65 (d, J = 7.3 Hz, 
2H), 8.27 (d, J = 8.3 Hz, 2H), 7.79 (t, J = 7.8 Hz, 2H), 7.36 (d, J = 8.1 Hz, 2H), 7.21 (d, J 
= 8.1 Hz, 2H), 2.45 (s, 3H). 13C NMR (400MHz, CDCl3) δ 164.6, 139.6, 135.6, 134.5, 
131.9, 131.8, 129.8, 129.5, 129.4, 128.7, 127.3, 125.8, 123.1, 21.7 ppm. 
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2,7-dip-tolylbenzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone (4i2): 
Titled compound was prepared according to general method C described above using 
naphthyl anhydride (1.98g, 10m.mol), p-bromo toluene (1.86g, 20m.mol) and 20ml of 
pyridine. The product was obtained in 93% yield (4.14g). 1H NMR (400 MHz, CDCl3) δ 
8.84 (s, 4H), 7.42 (d, J = 7.8 Hz, 4H), 7.24 (d, J = 7.8 Hz, 4H), 2.45 (s, 6H) ppm. 13C 
NMR (400MHz, CDCl3) δ 163.6, 139.7, 132.3, 131.9, 130.6, 128.2, 126.9, 21.7 ppm. 
Naphthalimides by Conventional Heating, General Procedure D:  
A suspension of 1,8-Naphthyl anhydride (1.98g, 10m.mol) and corresponding amine 
(10m.mol, 1eq) in 20 ml of pyridine was refluxed at 70°c for about 20 hrs and the excess 
solvent was distilled off by increasing the reflux temperature and setting up a collector to 
collect the solvent. The compound was obtained upon cooling the solution. Compounds 
2a1,2 , 2b1,2 and 2c2 have been prepared using this procedure and were obtained in 
yields from 50-75%. 
Monobromination, General Procedure E (the product is insoluble in reaction media at 
room temperature). To an ethyl acetate (15 ml) or diethyl carbonate (10 ml) solution of 
substituted toluenes (10 m.mol, 1eq) was added benzoyl peroxide (5 mg; 0.02 mmol, 
0.34 mol %) and N-bromo succinimide (18 m.mol, 1.8 equivalents). The reaction mixture 
was refluxed (for respective times as in tables 1 and 2 for ethyl acetate and diethyl 
carbonate) under microwave heating (magnetron power of 400W for ethyl acetate and 
450W diethyl carbonate). Clear reaction mixture was cooled down to room temperature. 
Formed white crystalline product was separated by filtration, washed with ice-cold 
solvent and dried at room temperature. The yield is 1.2 g (90%) for ethyl acetate as 
solvent and 1.26 g (95%) for diethyl carbonate as reaction media. Filtrate was left at 5˚C 
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overnight. Formed white precipitate was separated by filtration and dried to give 925 mg 
(88%) for ethyl acetate and 967 mg (93%) for diethyl carbonate of succinimide. 
2-(4-(bromomethyl)phenyl)isoindoline-1,3-dione (13a):  
Titled compound is prepared according to the general procedure E from 2-p-
tolylisoindoline-1,3-dione (2.37g, 10m.mol), N-bromo succinimide(3.2g,1.8m.mol) and 
benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 25 ml of ethyl acetate or 20 ml of 
diethyl carbonate. The product was obtained in 90% yield (2.83g) in ethyl acetate and 
95% yield (2.99g) in diethyl carbonate. 1H NMR δ 7.94-7.97 (m, 2H), 7.78-7.81 (m, 2H), 
7.53 (d, J = 8.42 Hz, 2H), 7.45 (d, J = 8.42 Hz, 2H), 4.52 (s, 2H) ppm. 13C NMR δ 167.4, 
137.7, 134.8, 131.9, 130.7, 126.9, 124.1 and 32.8 ppm. 
2-(2-(bromomethyl)phenyl)isoindoline-1,3-dione (13b):  
Titled compound is prepared according to the general procedure E from 2-m-tolyl 
isoindoline-1,3-dione (2.37g, 10m.mol), N-bromo succinimide(3.2g,1.8m.mol) and 
benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 25 ml of ethyl acetate or 20 ml of 
diethyl carbonate. The product was obtained in 75% yield (2.36g) in ethyl acetate and 
85% yield (2.68g) in diethyl carbonate. 1H NMR δ 7.94-7.97 (m, 2H), 7.78-7.81 (m, 2H), 
7.58 (t, J = 8.42 Hz, 1H), 7.44 (d, J = 8.42 Hz, 2H), 7.24 (d, J = 7.6Hz, 1H), 4.52 (s, 2H) 
ppm. 13C NMR δ 167.4, 137.7, 134.8, 131.9, 130.1, 126.9, 124.1 and 32.8 ppm. 
2-(4-(bromomethyl)phenyl)-1H-benzo[de] isoquinoline-1,3 (2H)-dione (13c):  
Titled compound is prepared according to the general procedure E from 2-p-tolyl-1H-
benzo[de]isoquinoline-1,3(2H)-dione (2.87g, 10m.mol), N-bromo succinimide (3.2g, 
1.8m.mol) and benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 25 ml of ethyl 
acetate or 20 ml of diethyl carbonate. The product was obtained in 90% yield (2.39g) in 
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ethyl acetate and 90% yield (2.39g) in diethyl carbonate. 1H NMR δ 8.65 (d, J = 7.2Hz, 
2H), 8.28 (d, J = 7.2Hz, 2H), 7.80 (t, J = 7.8Hz 2H), 7.58 (d, J=8.2 Hz 2H), 7.28 (d, J = 
8.2 Hz, 2H), 4.57 (s, 2H) ppm. 13C NMR δ 167.4, 137.7, 134.8, 131.9, 130.1, 126.9, 
124.1, 32.8 ppm.          
1-(4-(bromomethyl)phenyl)pyrrolidine-2,5-dione (13d):  
Titled compound is prepared according to the general procedure E from 1-p-
tolylpyrrolidine-2,5-dione (1.89g, 10m.mol), N-bromo succinimide(3.2g,1.8m.mol) and 
benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 25 ml of ethyl acetate or 20 ml of 
diethyl carbonate. The product was obtained in 85% yield (2.28g) in ethyl acetate and 
90% yield (2.41g) in diethyl carbonate. 1H NMR δ 7.68 (d, J = 6.42 Hz 2H), 7.34(d, J = 
6.42 Hz 2H), 4.63(s, 2H), 2.92 (s, 4H) ppm. 13C NMR δ 176.26, 138.4, 132.1, 130.1, 
126.9, 126.5, 32.6, and 28.6 ppm.   
1-(4-(bromomethyl)phenyl)-1H-pyrrole-2,5-dione (13e):  
Titled compound is prepared according to the general procedure E from 1-p-tolyl-1H-
pyrrole-2,5-dione (1.87g, 10m.mol), N-bromo succinimide (3.2g,1.8m.mol) and benzoyl 
peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 25 ml of ethyl acetate or 20 ml of diethyl 
carbonate. The product was obtained in 90% yield (2.39g) in ethyl acetate and 90% 
yield (2.39g) in diethyl carbonate. 1H NMR δ 7.50 (d, J = 6.82 Hz, 2H), 7.34 (d, J = 6.82 
Hz, 2H), 7.04 (s, 2H), 4.51(s, 2H) ppm. 13C NMR δ 164.3, 138.8, 132.2, 130.2, 126.4, 
32.5 ppm. 
1-(bromomethyl)-4-nitrobenzene (13i): Titled compound is prepared according to the 
general procedure F from 4-nitro toluene (1.37g, 10m.mol), N-bromo succinimide (3.2g, 
18m.mol) and benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 25 ml of ethyl acetate 
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or 20 ml of diethyl carbonate and was obtained in 80% yield (1.73g) in both ethyl 
acetate and diethyl carbonate. 1H NMR (400MHz, CDCl3) δ 8.16 (d, J=7.8 Hz, 2H), 7.54 
(d, J=7.8 Hz, 2H), 4.51 (s, 2H) ppm. 13C NMR (400MHz, CDCl3) δ 147.9, 145.1, 130.2, 
124.2, 37.9 ppm. 
Monobromination, General Procedure F: (For products soluble at room temperature 
in the reaction media). To an ethyl acetate (15 ml) or diethyl carbonate (10 ml) solution 
of substituted toluenes (10 m.mol, 1eq) was added benzoyl peroxide (5 mg; 0.02 mmol, 
0.34 mol %) and N-bromo succinimide (18 m.mol, 1.8 equivalents). The reaction mixture 
was refluxed (for respective times as in tables 1 and 2 for ethyl acetate and diethyl 
carbonate) under microwave heating (magnetron power of 400W for ethyl acetate and 
450W diethyl carbonate). Clear reaction mixture was cooled at 5˚C for 4-5 hours. 
Formed white precipitate was separated by filtration and dried to give 990 mg (94%) for 
ethyl acetate and 1.0 g (95 %) for diethyl carbonate of succinimide. The filtrate was then 
evaporated under vacuum, to obtain a powdery material, which was purified by silica gel 
column chromatography with hexane-ethyl acetate (1:4) as an eluent. The isolated yield 
of 1-bromo-4-bromomethylbenzene is 1.33 g (90%) for ethyl acetate and 1.40g (95%) 
for diethyl carbonate as reaction media.  
1-(bromomethyl)-4-fluorobenzene (13f): Titled compound is prepared according to 
the general procedure F from 4-flouro toluene (1.1g, 10m.mol), N-bromo succinimide 
(3.2g, 18m.mol) and benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 25 ml of ethyl 
acetate or 20 ml of diethyl carbonate and was obtained in 92% yield (1.7g) in ethyl 
acetate and 95% yield (1.8g) in diethyl carbonate. 1HNMR (400MHz, CDCl3) δ 7.37 (d, J 
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=7.2 Hz, 2H), 7.04 (d, J =7.2 Hz, 2H), 4.48 (s, 2H) ppm; 13CNMR (400MHz, CDCl3) δ 
164.1, 161.6, 134.1, 131.2, 131.4, 116.1, 115.9, 32.9 ppm. 
1-(chloromethyl)-4-fluorobenzene (13g): Titled compound is prepared according to 
the general procedure F from 4-chloro toluene (1.3g, 10m.mol), N-bromo succinimide 
(3.2g, 1.8m.mol) and benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 25 ml of ethyl 
acetate or 20 ml of diethyl carbonate. The product was obtained in 85% yield (1.73g) in 
both ethyl acetate and diethyl carbonate. 1HNMR (400MHz, CDCl3) δ 7.32 (4H, s), 4.45 
(2H,s) ppm; 13C NMR (400MHz, CDCl3) δ 164.06, 161.6, 134.1, 131.2, 131.4, 116.1, 
32.9 ppm.  
1-bromo-4-(bromomethyl)benzene (13h): Titled compound is prepared according to 
the general procedure F from 4-bromo toluene (1.7g, 10m.mol), N-bromo succinimide 
(3.2g, 18m.mol) and benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 25 ml of ethyl 
acetate or 20 ml of diethyl carbonate. The product was obtained in 90% yield (2.3g) in 
ethyl acetate and 95% yield (2.4g) in diethyl carbonate. 1H NMR (400MHz, CDCl3) δ 
7.47 (d, J = 8.4 Hz, 2H), 7.26 (d, J = 8.4 Hz, 2H), 4.44 (s, 2H) ppm; 13C NMR (400MHz, 
CDCl3) δ 137.1, 132.2, 130.9, 122.7, 32.7 ppm.  
1-(bromomethyl)-4-methoxy benzene (13j): Titled compound is prepared according to 
the general procedure F from 4-methoxy toluene (1.2g, 10m.mol), N-bromo succinimide 
(3.2g, 18m.mol) and benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 25 ml of ethyl 
acetate or 20 ml of diethyl carbonate. The product was obtained in 98% yield (1.9g) in 
both ethyl acetate and diethyl carbonate. 1H NMR (400MHz, CDCl3) 7.36 (d, J= 6.2 Hz, 
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2H), 7.94 (d, J= 6.2 Hz, 2H), 4.61 (s, 2H), 3.82 (s, 3H) ppm; 13C NMR (400MHz, CDCl3) 
δ160.05, 130.44, 130.1, 114.5, 55.5, 37.9 ppm.               
9-bromo-9H-fluorene (13k): Titled compound is prepared according to the general 
procedure F from fluorene (1.7g, 10m.mol), N-bromo succinimide (3.2g, 1.8m.mol) and 
benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 25 ml of ethyl acetate or 20 ml of 
diethyl carbonate. The product was obtained in 90% yield (2.2g) in ethyl acetate and 
98% yield (2.4g) in diethyl carbonate 1 HNMR (400MHz,CDCl3) δ ppm; 13C NMR (400 
MHz, CDCl3) δ 144.39, 140.01, 129.44, 128.31, 126.59, 120.49, 46.24 ppm. 
Dibromination General Procedure G (product insoluble in reaction media at room 
temperature). Ethyl acetate (15 ml) or diethyl carbonate (10 ml) suspension of 
substituted toluenes (4.2 mmol, 1 eq), benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %), 
and N-bromo succinimide (12.6 mmol, 3equivalents) was refluxed for 80 minutes (ethyl 
acetate) or 30 minutes (diethyl carbonate) and under microwave heating (magnetron 
power of 500W for ethyl acetate and 600W for diethyl carbonate). Clear reaction mixture 
was cooled down to room temperature. Formed white crystalline product was separated 
by filtration, washed with ice-cold solvent and dried at room temperature. According to 
the HPLC the product is ~97% pure. The isolated yield of 3g was 1.2 g (70%) for ethyl 
acetate and 1.32 g (85%) for diethyl carbonate as reaction media. Filtrate was left at 
5˚C overnight. Formed white precipitate was separated by filtration and dried to give 1.5 
g (86%) for ethyl acetate and 1.6 g (92%) for diethyl carbonate of succinimide. 
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2-(4-(dibromomethyl)phenyl)isoindoline-1,3-dione (15a):  
Titled compound is prepared according to the general procedure G from 2-p-
tolylisoindoline-1,3-dione(2.37g, 10m.mol), N-bromo succinimide(5.4g, 30m.mol) and 
benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 50 ml of ethyl acetate or 40 ml of 
diethyl carbonate. The product was obtained in 85% yield (2.3g) in ethyl acetate and 
90% yield (2.4g) in diethyl carbonate. 1H NMR (400MHz, CDCl3) δ 7.96-7.98 (m, 2H), 
7.81-7.83 (m, 2H), 7.5-7.7 (d, J = 8.42 Hz, 2H), 7.49-7.52 (d, J = 8.42 Hz, 2H), 6.68 (s, 
1H) ppm. 13C NMR (400MHz, CDCl3) δ 167.2, 141.5, 134.8, 133.1, 131.8, 127.6, 124.2, 
40.1 ppm.  
1-(4-(dibromomethyl)phenyl)pyrrolidine-2,5-dione (15b):  
Titled compound is prepared according to the general procedure G from 1-p-
tolylpyrrolidine-2,5-dione (1.89g,10m.mol), N-bromo succinimide(5.37g,1.8m.mol) and 
benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 50 ml of ethyl acetate or 40 ml of 
diethyl carbonate. The product was obtained in 60% yield (2.1g) in ethyl acetate and 
80% yield (2.8g) in diethyl carbonate. 1H NMR (400MHz, CDCl3) δ 7.67 (d, J=6.8 Hz, 
2H), 7.27 (d, J=6.8 Hz, 2H), 6.64(s, 1H), 2.92(s, 4H) ppm. 13C NMR (400MHz, CDCl3) δ 
176.3, 138.4, 132.1, 130.1, 126.9, 32.6, and 28.6 ppm.   
1-(4-(dibromomethyl)phenyl)-1H-pyrrole-2,5-dione (15c):  
Titled compound is prepared according to the general procedure G from 1-p-tolyl-1H-
pyrrole-2,5-dione (1.87g,10m.mol), N-bromo succinimide(5.37g,1.8m.mol) and benzoyl 
peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 50 ml of ethyl acetate or 40 ml of diethyl 
carbonate. The product was obtained in 65% yield (2.2g) in ethyl acetate and 85% yield 
(2.9g) in diethyl carbonate. 1H NMR (400MHz, CDCl3) δ 7.68 (d, J = 6.42 Hz 2H), 7.34 
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(d, J = 6.42 Hz 2H), 7.03(s, 1H), 6.68 (s, 1H) ppm. 13C NMR (400MHz, CDCl3)  δ 164.3, 
138.1, 135.3, 134.4, 131.7, 130.1, 129.1, 128.5, 127.1, 122.7, 32.6 ppm. 
2-(4-(dibromomethyl)phenyl)-1H-benzo[de] isoquinoline-1,3 (2H)-dione (15d):  
Titled compound is prepared according to the general procedure G from 2-p-tolyl-1H-
benzo[de]isoquinoline-1,3(2H)-dione (2.87 g,10 m.mol), N-bromo succinimide (5.37g, 18 
m.mol) and benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 50 ml of ethyl acetate or 
40 ml of diethyl carbonate. The product was obtained in 75% yield (3.3g) in ethyl 
acetate and 90% yield (4g) in diethyl carbonate. 1H NMR δ 8.65 (d, J = 7.2Hz, 2H), 8.28 
(d, J = 7.2Hz, 2H), 7.80 (t, J = 7.8Hz 2H), 7.58 (d, J=8.2 Hz 2H), 7.28 (d, J = 8.2 Hz, 
2H), 6.89 (s, 1H) ppm.  13C NMR (400MHz, CDCl3) δ 167.4, 137.7, 134.8, 131.9, 130.1, 
126.9, 124.1, 40.1 ppm.         
1-(dibromomethyl)-4-nitrobenzene (15e):  
Titled compound is prepared according to the general procedure G from 4-nitro toluene 
(1.37g, 10 m.mol), N-bromo succinimide (5.37g, 30 m.mol) and benzoyl peroxide (5 mg; 
0.02 mmol, 0.34 mol %) in 50 ml of ethyl acetate or 40 ml of diethyl carbonate and was 
obtained in 60% yield (1.8 g) in ethyl acetate and 85% yield (2.5 g) in diethyl carbonate. 
1HNMR(400MHz, CDCl3) δ 8.16(d, J=5.6 Hz, 2H), 7.54(d, J=5.6 Hz, 2H), 6.64(s, 1H) 
ppm. 13C NMR (400MHz, CDCl3) δ 147.9, 145.1, 130.2, 124.2, and 37.9 ppm. 
Dibromination, General Procedure H (product soluble in reaction media).  The ethyl 
acetate (15 ml) or diethyl carbonate (10 ml) suspension of substituted toluenes (10 
m.mol, 1 eq), benzoyl peroxide (5 mg; 0.02 mmol; 0.34 mol %) and N-bromo 
succinimide (30 m.mol, 3 equivalents) was refluxed (30 minutes for ethyl acetate and 20 
minutes for diethyl carbonate) under microwave heating (microwave magnetron power 
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of 500W for ethyl acetate and 600W for diethyl carbonate). Clear reaction mixture was 
cooled at 5˚C for 4-5 hours. Formed white precipitate was separated by filtration and 
dried to give 82-96% of succinimide for ethyl acetate and 88-97% for diethyl carbonate. 
The filtrate was then evaporated under reduced pressure to a powdery material, which 
was subjected to column chromatography with 25% hexane, ethyl acetate to obtain pure 
product. 
1-(dibromomethyl)-4-fluorobenzene (15e): Titled compound is prepared according to 
the general procedure H from 4-flouro toluene (1.1g, 10m.mol), N-bromo succinimide 
(5.37g, 30m.mol) and benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 50 ml of ethyl 
acetate or 40 ml of diethyl carbonate and was obtained in 70% yield (1.9g) in ethyl 
acetate and 85% yield (2.3g) in diethyl carbonate. 1H NMR (400MHz, CDCl3) δ 7.37 (d, J 
=7.2 Hz, 2H), 7.04 (d, J =7.2 Hz, 2H), 6.64 (s, 1H) ppm; 13C NMR (400MHz, CDCl3) δ 
164.1, 162.1, 134.2, 131.2, 131.1, 116.1, 115.9, 40.7 ppm                                   
1-(chloromethyl)-4-fluorobenzene (15f): Titled compound is prepared according to the 
general procedure H from 4-chloro toluene (1.3g, 10 m.mol), N-bromo succinimide 
(5.37g, 18 m.mol) and benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 50 ml of ethyl 
acetate or 40 ml of diethyl carbonate. The product was obtained in 75% yield (2.1g) in 
ethyl acetate and 85% yield (2.4g) in diethyl carbonate. 1H NMR (400MHz, CDCl3) δ 
7.32 (4H, s), 6.64 (1H, s) ppm; 13C NMR (400MHz, CDCl3) δ 136.6, 134.5, 130.6, 129.3, 
40.1 ppm.  
1-bromo-4-(bromomethyl)benzene (15g): Titled compound is prepared according to 
the general procedure H from 4-bromo toluene (1.7g, 10m.mol), N-bromo succinimide 
(5.37g, 1.8m.mol) and benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 50 ml of ethyl 
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acetate or 40 ml of diethyl carbonate and was obtained in 70% yield (2.3g) in ethyl 
acetate and 90% yield (3g) in diethyl carbonate. 1H NMR (400MHz, CDCl3) δ 7.47 (2H, 
d, J=8.4 Hz), 7.26 (2H, d, J=8.4 Hz), 6.44 (s,1H). 13C NMR (400MHz, CDCl3) δ 137.1, 
132.2, 130.9, 122.7, 40.1 ppm.  
1-(bromomethyl)-4-methoxybenzene (15i): Titled compound is prepared according to 
the general procedure H from 4-methoxy toluene (1.2g, 10m.mol), N-bromo succinimide 
(5.37g, 1.8m.mol) and benzoyl peroxide (5 mg; 0.02 mmol, 0.34 mol %) in 50 ml of ethyl 
acetate or 40 ml of diethyl carbonate. The product was obtained in 75% yield (2.1g) in 
ethyl acetate and 95% yield (2.7g) in diethyl carbonate. 1H NMR (400MHz, CDCl3) δ 
7.36 (d, J=6.2 Hz, 2H), 7.94 (d, J=6.2 Hz, 2H), 6.14 (s, 1H), 3.82 (s, 3H) ppm; 13C NMR 
(400MHz, CDCl3) δ 160.1,130.4, 130.1, 114.5, 55.5, 40.1 ppm.                                                
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Chapter III 
Synthesis of β-keto acids: 
3.1. Abstract: β-Keto acids are one of the important biological components from 
nature and their synthesis involves complex procedures. The chapter focuses on 
development of the tag molecule as a protection for acid group, its deprotection and 
application in the synthesis of β-Keto Acids. 
3.2 Introduction  
3.2.1 β-Keto acids: 
 β-Keto acids are very important and are essential starting materials and/or 
intermediates in many organic syntheses like preparations of ketones1 and many natural 
products2-4. For example in all the biosyntheses of 3-acyl tetramic acid, it was reported 
that the β-Keto acids are one of the primary intermediates and also play a key role in 
synthesis of substituted cyclopenteno phenathrenes5. They are very important 
intermediates in synthesizing biologically active compounds6,7 like SR141716, 
phloroglucinols, and 5-dezaminopterin. These acids, also known as 3-oxaoalkanoic 
acids are used extensively for biochemical investigations, especially for studies of the 
mechanisms of enzyme-induced decarboxylations8. There are many methods reported 
for synthesis of these compounds but none of these are general and applicable to all 
compounds of this class and often very low yielding and involve tedious purification 
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methods. One common way that these compounds are synthesized is from 1,3 
dicarbonyl compounds9-14. Acylation of the active carbon of these dicarbonyl 
compounds followed hydrolysis and decarboxylation gives β-Keto acids. However these 
methods require use of strong bases such as EtONa15, EtMgBr16, n-BuLi17 or powerful 
metals like Na18 which are not very suitable if the substrates are very sensitive. Another 
known method of preparation is conversion aldehydes to β-Keto acids by addition of 
ethyl diazoacetate in various thermal conditions19 and also in presence of tin (II) 
chloride20. There are several other reports that used aldehydes for preparing the β-Keto 
acids but none of these were reliable in terms of yields and purification methods. And 
another major concern regarding the use of these procedures is that the method is 
generalized and is applicable to only a specific group of compounds. The reports 
themselves indicate formation of different intermediates during the reaction of some of 
the substrates. The article by Gutsche et al. reported formation of dioxolane from n-
heptanal but not the corresponding β-Keto acid21. So a good method that can be applied 
in general to prepare any type of a β-Keto acid, good yielding, simple to purify and also 
applicable to industry is on demand. The chapter describes the efforts towards 
developing a methodology for β-Keto acids that satisfies all the above-mentioned 
advantages and reports a successful preparation of the compounds. 
3.2.2: Protection groups and their role in synthesis: 
If a chemical reaction has to be carried out selectively at one reactive site in a 
compound with many functional groups, the other reactive sites need to be blocked 
temporarily. Those compounds that are used to block the reactive sites are called 
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Protection Groups22. It is very difficult to envision the synthesis of some organic 
compounds and natural products without the use of protection groups and with the 
increasing complexity in molecules and hence their syntheses, the chemists needed 
and developed more new protection groups with specific tasks to be performed. 
However there are some minimum requirements that are looked for in a new protection 
group. 
1. It must react selectively in good yield to give a protective substrate that is stable 
to projected reactions. 
2. Should have minimum additional functionality to avoid further sites of reaction. 
3. It should be selectively removed in good yield by readily available, preferably non 
toxic reagents 
4. The protective group should form a crystalline derivative without generating any 
new stereogenic centers and can be easily separated from side products 
Since only a few protection groups can satisfy all these criteria for elaborate substrates, 
a large number of mutually complementary protective groups are needed and are 
available too.  
 
 
Figure 3.1. The tag molecules to be used for synthesis. 
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Three tag molecules, PG1, PG2 and PG3 as in fig.1 were designed, which satisfied the 
first two conditions from the studies done in chapter II but the conditions 3 and 4 ought 
to be tested out and is done in the following results and discussion. Along with 
designing the protection groups, the protection and deprotection methods should be 
established and these conditions also have to come over a set of requirements to be 
proven as able protection groups.  
Phthalic anhydride and its derivatives are known to be used for protection of amines 
and acids23-28. The protection and deprotection of amines and acids with these 
protection groups is well studied and is performed in a variety of conditions. While there 
are many protection groups for acids, more are being invented and used because of 
their specific use in a particular synthesis. In this chapter the tag molecule phthalimido 
benzyl group, its derivatives and naphthalimido benzyl groups are identified as a 
protection group for acids and its protection-deprotection chemistry is studied. The 
assumption that it can be deprotected under variety of conditions was made with the 
idea that they can be hydrogenated and also hydrolyzed in presence of a base and an 
acid. And so its orthogonality in deprotection can be taken advantage of, especially in 
preparation of peptides from amino acids. Depending on the type of protection on amine 
group, the deprotection of ester can be altered. When benzyloxy carbonyl protected 
amine is used the ester can be deprotected under acidic conditions for selective acid 
deprotection and catalytic hydrogenation or simple NaOH hydrolysis can be used for 
butoxy carbonyl protected amino esters. And in acids other than amino acids, the 
deprotection can be altered depending on whether the substrate has acid or base labile 
groups. On the whole the tag molecules as shown in fig.1 as protection groups seemed 
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to have promising application in protection deprotection of acids, amines and sulfides. 
Moreover their broad range of applications as protection groups and tag molecules 
envisions potency in synthesizing the β-Keto acids. 
3.3 Results and Discussion:  
3.3.1: The Tag molecule in the synthesis of β-keto acids:  
Of all these methods using 1,3 dicarbonyls and especially malonate esters is the 
commonly used method but still has many disadvantages. Diethyl malonate was the first 
used of its kind for the synthesis of these acids. But the problem associated with the use 
of diethyl malonate was that the two ethyl esters compete against each other for 
hydrolysis in spite of using one equivalent of the base (NaOH, LiOH or KOH), there by 
reducing the yield of the reaction at this stage greatly. Also the diethyl malonate esters 
are liquids and remain liquids after c- acylation. The Rf values of these compounds 
being very close they are tough to be isolated using column chromatography and hence 
have to be distilled to obtain pure compounds. But being very sensitive to heat (as they 
undergo decarboxylation at elevated temperature), distilling these liquids often results in 
loss of some of the product, which decomposes to the corresponding ketone. To over 
come this problem one of the ethyl esters was replaced by tert-butyl ester and the same 
synthetic sequence has been studied for preparation of some β-Keto acids29. This 
method has improved the handling of the reaction but the yields were still very low. 
Later trimethyl silyl esters were used instead of the ethyl esters but the yield and 
purification methods did not make any substantial improvements even in this method30. 
 82	  
However all these esters, diethyl, mono ethyl tert-butyl and di silyl esters of malonate 
are all liquids and hence purification of these compounds would still remain complicated 
with them being liquids. It will ultimately result in low yields and tedious purification 
procedures. This was the starting point of the current synthesis towards β-Keto acids 
where the benzyl esters substituted the above-mentioned esters. Initial attempts were 
towards the making of dibenzyl malonate with an assumption that the di benzyl ester 
would be a solid and so can be easily handled. The proposed synthesis of β-Keto acids 
is as shown in fig.2 and the proposal was based on the idea that benzyl ester would be 
a solid as compared to ethyl ester and so purification methods would be easier as 
compared to the other esters previously reported. But during the synthesis of mono 
benzyl ethyl malonate it was realized that it is a liquids too and the purification and 
handling of this compound is as tough and tedious as handling the ethyl ad silyl esters. 
In process of obtaining the product 3 there was decomposition of 2 observed due to the 
vigorous reactivity of Mg in ether. The scheme was later altered by switching mono 
benzyl ethyl malonate to di benzyl malonate and was not successful in spite of the 
change. 
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Scheme 3.1. Proposed synthesis of β-Keto acids using mono benzyl ester. 
 So a more stable ester than mono benzyl ethyl malonate, dibenzyl malonate was 
necessary to obtain a successful synthesis and in this context the proposed tag 
molecules from previous chapters were introduced in to the synthesis. The idea behind 
using these tag molecules is that they are of a much higher molecular weight as 
compared to benzyl esters and so the physical properties of these compounds would be 
much different and better than them. The tag molecule PG 1 was chosen for its 
simplicity, to start with amongst the three and based on the above assumption the 
synthesis of β-Keto acids was proposed is as shown in scheme 3.2.  
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Scheme 3.2 Synthesis of β-Keto acids using the tag molecule. 
The scheme was successful in preparation of compound 6a and the idea of 
transforming them into solids was successful and 6a was also recrystallized from 
dichloromethane. However the attempts to synthesize 7 remained unsuccessful as the 
tag molecule would hydrolyze in the process. The Grignard conditions which were 
proposed earlier as were too harsh for these types of compounds, the alternatives to 
this method were explored and the MgCl2, NEt3 conditions suited best. 8 was 
successfully synthesized using MgCl2 conditions. But the next step which involves the 
removal of tag molecule by hydrogenation gave only a satisfactory yield. In order to 
improve the yield of this reaction and to explore the alternatives it was felt that the tag 
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molecule should be investigated for protection-deprotection sequences. Since the 
protection in the above sequence is acid protection as an ester, it was first explored for 
ester protection and deprotection. 
3.3.2 Tag molecule as protection group for acids: 
The tag molecules were prepared using microwave synthesis as reported in chapter II 
and since the high molecular weight of the protection group can change the physical 
properties of some liquids and oily substances with a low molecular weight, by making 
them solids and hence making purification easier by recrystallization or a simple wash 
with non polar solvents. The advantages of the using the tag molecules as protection 
groups PG 1, PG 2 or PG 3 are as follows: 
 They are prepared from inexpensive starting materials in few steps  
 The protection groups can be easily deprotected and recycled in most cases. 
 The protection groups are organic equivalents of resin, due to high molecular 
weight and hence simple solvent wash can purify the products. 
 The imidic bond in the molecules give crystalline properties to the products there 
by making purification easier by recrystallization. 
 Their UV activity solves the characterization problems usually associated with 
resins. 
 Dry conditions are not required to monitor the reactions. 
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As the protection group has been designed and synthesized in a good yield, it has been 
applied to the protection of the acid and the protection group can be incorporated on to 
the acids in three different ways as shown in fig.3.2. 
 
 
Figure 3.2 Protection of Acids with PG1, PG2 and PG3. 
 
N
Br
O
O
N
O
O
O
O
R1
R1 O-Na+
O
R1 OH
O
Method A or B
Method C
R R
R= H, for different R1 6a-6j and R=OMe different R1 6k-6t
R1 O-Na+
O
R1 OH
O
Method A or B
Method C
N
O
O
Br
N
O
O
O
O
R1
6u-6w
 87	  
The protection group can be incorporate onto the acid by reacting it with the acid in 
three ways. 
1) The salt of corresponding acid. 
2) The acid in presence of cyclohexyl amine. 
3) The acid in presence of NaHCO3. 
All the protection groups PG 1, PG 2 and PG 3 were studied for protection deprotection 
sequences. In the first method the salt of an acid is used and the tag molecule is mixed 
with the salt of an acid in solvents like DMF or DMSO and sonicated for few hours to 
obtain the esters. Three acid salts, sodium acetate, sodium benzoate and potassium 
salt of mono ethyl malonate have been transformed into their corresponding esters 
using this method. However it would not be practically possible to produce the salt of 
every acid. As alternatives, the other two methods involve use of acids directly with the 
protection groups in presence of two bases NaHCO3 and cyclohexyl amine. When 
DMSO was used as solvent, the benzyl bromides would react with cyclohexyl amine to 
produce about 5% of the corresponding secondary amine. However switching the 
solvent from DMSO to DMF has solved the problem and hence increased the yield of 
the desired product. All three methods involve very simple reaction conditions. The 
mixture is sonicated for few hours and precipitation of product would occur with ice. The 
first two protection groups PG1 and PG 2 were successful in synthesizing the esters 
(6a-6t) using all the three methods. All methods yielded good to excellent yields as 
shown in table 3.1. The structures of the acids are shown in figure 3.3.  
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Figure 3.3 Structures of protected esters using protection groups with PG1 and PG2. 
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Table 3.1.  Protection of acids as corresponding esters with PG1 and PG2. 
 
 
 
Isolated Yield (%) Esters 
Method A Method B Method C 
6a NA NA 90 
6b 76 79 93 
6c 89 92 NA 
6d 87 91 NA 
6e 84 95 96 
6f 87 90 NA 
6g 84 91 NA 
6h 88 94 NA 
6i 78 81 NA 
6j 91 94 NA 
6k NA NA 93 
6l 75 77 91 
6m 86 90 NA 
6n 87 93 NA 
6o 86 93 NA 
6p 81 91 NA 
6q 79 87 NA 
6r 88 95 96 
6s 84 88 NA 
6t 93 96 NA 
 
NA- Not Applicable, NP - No Product 
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However, the third protection group PG 3 was not successful except for the salt of acids 
method. In presence of the bases, the protection group PG 3 was hydrolyzed and hence 
did not produce desired esters. The products (6u-6w) are shown in figure 3.4 and their 
yields using the protection group PG 3 are reported in table 3.2. 
 
 
Fig 3.4 Esters produced using the protection group PG 3. 
 
 
Table 3.2. Protection of acids as corresponding esters with PG 3. 
 
 
Isolated Yield (%)        Ester  
Method A Method B Method C 
6u NA NA 79 
6v NA NA 84 
6w NA NA 92 
6x NP NP NP 
6y NP NP NP 
 
NA - Not Applicable, NP - No Product (Hydrolysis of PG3) 
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3.3.3. Deprotection with Palladium (neutral conditions): 
While exploring the deprotection methods for the esters various factors were 
considered. The deprotection conditions should mild and simple and should not affect 
any of the substrates in the process. They should also be good yielding as the yield loss 
in this step greatly affects the yield of overall other reactions in the sequence. The idea 
behind designing the protection group was to make its applicability vast and general for 
most of the substrates. The orthogonality of deprotection is one of the main factors that 
decides the applicability of the protection groups and hence having different 
deprotection methods that not only vary in their behavior but also can be altered as per 
the substrate requirements is desired. All the esters 6a-6t were deprotected with this 
method and yielded about 78-96% yield.  For those substrates, which are sensitive to 
hydrogenation, it was observed that the product underwent complete hydrogenation. In 
those reactions where a parallel deprotection needs to be employed, with these 
protection groups, both deprotections can be obtained in single step. For example in 
case of 6g and 6q Cbz-protected glycine ester produced glycine as end product 
deprotecting both PG 1/PG 2 and Cbz at the same time. As an added advantage the 
precursor of the protection group corresponding toluene was obtained as by product in 
deprotection, which can further be brominated in the benzyl position to obtain the 
desired protection group. So this method also helps recycle the protection group and re 
use of the same was tested out form one of the deprotection. The recycle and re-use 
was successful not just on small scale but was acceptable up to a scale of 10g 
produced in our lab. The scheme and results for deprotecion9 using Pd/C/H2/MeOH are 
as shown in fig.5 and table 4: 
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Scheme 3.3. Deprotection of PG1 and PG 2 with Pd/C/H2 
 
 
Table 3.3: Deprotection using Pd/C/H2 in MeOH. 
 
 
Ester Isolated Acid  Yield 
(%) 
9a/9b(%) 
6a Monoethlyl malonate 87 86 
6b Acetic acid 82 85 
6c Octanoic acid 84 81 
6d Dodecanoic acid 82 84 
6e 2-Phenyl butanoic acid 93 88 
6f Boc-Glycine 84 87 
6g Glycine 79 81 
6h Benzoic acid 96 89 
6i Picolinic acid 84 87 
6j 
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6k Mono ethyl malonate 86 85 
6l Acetic acid 79 89 
6m Octanoic acid 83 88 
6n Dodecanoic acid 87 83 
6o 2-Phenyl butanoic acid 91 88 
6p Boc-Glycine 83 84 
6q Glycine 81 79 
6r Benzoic acid 94 91 
6s Picolinic acid 85 88 
6t 
 
92 90 
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Although hydrogenation using Pd/C is one of the most common methods, it might not be 
practically possible to use in all scales and is not convenient to use a balloon of 
hydrogen or par shaker at all times. And since palladium has been extensively studied 
and various other sources of H2 have been reported, Pd/C/HCOONH4 was tried as 
second method of deprotection for the esters. The method is comparable to the results 
from previous method to most of the esters. It was most effective for aromatic esters 
and in case of aliphatic esters; the yields of the obtained acids were a little lower than 
aromatic esters. Even in this method, the protection group ca be reproduced from a 
recycled compound upon benzyl bromination. Table 5 explains the isolated yields of the 
acids and the precursor of the protection group produced in the reaction. In both cases 
the results were in comparison to the previous method and so the choice of method 
would depend on convenience and availability of raw materials and the equipment in the 
lab. In case of malonic ester 6a and 6k however this method was not very successful 
because it involves heating the reaction mixture and malonic esters being sensitive to 
heat, decomposed during the reaction. 
 
 
 
Scheme 3.4. Deprotection using Pd/C/HCOONH4/MeOH10. 
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Table 3.4: Deprotection using Pd/C/HCOONH4/MeOH 
 
 
Ester Isolated Acid  Yield 
(%) 
9a/9b(%) 
6a No reaction NA 86 
6b Acetic acid 82 85 
6c Octanoic acid 84 81 
6d Dodecanoic acid 82 84 
6e 2-Phenyl butanoic acid 93 88 
6f Boc-Glycine 84 87 
6g Glycine 79 81 
6h Benzoic acid 96 89 
6i Picolinic acid 84 87 
6j 
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6k No reaction NA 85 
6l Acetic acid 79 89 
6m Octanoic acid 83 88 
6n Dodecanoic acid 87 83 
6o 2-Phenyl butanoic acid 91 88 
6p Boc-Glycine 83 84 
6q Glycine 81 79 
6r Benzoic acid 94 91 
6s Picolinic acid 85 88 
6t 
 
92 90 
 
3.3.4 Deprotection in acidic conditions. 
If there would any palladium labile groups on the substrate the hydrogenation conditions 
would not suit and so an alternative deprotection is desirable. The ester deprotection in 
general can be done in both acidic and basic conditions. The acidic conditions were first 
explored and various acids were tested out for deprotection. One of the first acids to try 
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was, trifloro acetic acid, however this acid was not strong enough to hydrolyze the ester. 
All the esters 6a-6j were resistant to TFA. It was initially postulated that the methoxy 
group on esters 6k-6t would make the ester more labile than that of esters 6a-6j but the 
results obtained proved that an acid stronger than TFA is required to hydrolyze the 
esters. HCl, SO2Cl2 and (COCl)2 were then used as sources of acid. Using HCl as acid 
with methanol as solvent at zero degrees, most of the esters were hydrolyzed10 and in 
those esters with acid labile groups or other acid labile protection groups like BOC both 
the protection groups were deprotected. In esters 6f and 6p glycine esters protected 
with BOC are completely hydrolyzed and glycine was the end product obtained. Oxalyl 
chloride was more reactive than thionyl chloride under same conditions towards same 
esters. 
 
 
Scheme 3.5. Deprotection using SOCl2/MeOH. 
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to the loss of products during work up. The scheme in fig and the table below explain 
the reaction conditions and results of the deprotection of various esters. 
 
Table 3.5: Deprotection under acidic conditions using SOCl2. 
 
 
Ester Isolated Acid  Yield 
(%) 
9a/9b(%) 
6a No reaction NA 86 
6b Acetic acid 82 85 
6c Octanoic acid 84 81 
6d Dodecanoic acid 82 84 
6e 2-Phenyl butanoic acid 93 88 
6f Glycine 84 87 
6g Cbz-Glycine 79 81 
6h Benzoic acid 96 89 
6i Picolinic acid 84 87 
6j 
 
92 86 
6k No reaction NA 85 
6l Acetic acid 79 89 
6m Octanoic acid 83 88 
6n Dodecanoic acid 87 83 
6o 2-Phenyl butanoic acid 91 88 
6p Boc-Glycine 83 84 
6q Cbz-Glycine 81 79 
6r Benzoic acid 94 91 
6s Picolinic acid 85 88 
6t 
 
92 90 
 
  
As thionyl chloride conditions resulted too low yields, another method of acidic 
deprotection, which is a little stronger than thionyl chloride is tried and was successful, 
is to use HCl. The results were comparable to the thionyl chloride method with improved 
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Scheme 3.6. Deprotection using HCl/MeOH. 
Table 3.6. Deprotection of esters using HCl/MeOH: 
Ester Isolated Acid  Yield 
(%) 
9a/9b(%) 
6a Monoethlyl malonate 87 86 
6b Acetic acid 82 85 
6c Octanoic acid 84 81 
6d Dodecanoic acid 82 84 
6e 2-Phenyl butanoic acid 93 88 
6f Glycine 84 87 
6g Cbz-Glycine 79 81 
6h Benzoic acid 96 89 
6i Picolinic acid 84 87 
6j 
 
92 86 
6k Mono ethyl malonate 86 85 
6l Acetic acid 79 89 
6m Octanoic acid 83 88 
6n Dodecanoic acid 87 83 
6o 2-Phenyl butanoic acid 91 88 
6p Glycine 83 84 
6q Cbz-Glycine 81 79 
6r Benzoic acid 94 91 
6s Picolinic acid 85 88 
6t 
 
92 90 
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yields in comparison. The figure 8 below explains the reaction conditions with the table 
7 showing the acids obtained. In both these methods, using thionyl chloride or HCl, the 
byproducts 9c and 9d are produced in good yields which themselves can be used as 
protection groups or undergo exchange of bromides to produce the tag molecule. 
 
 
3.3.5 Deprotection in basic conditions. 
As the acidic conditions showed good results the conditions were then extended to 
basic conditions and the hydrolysis with NaOH was one of the common base hydrolyses 
used in general, so the same conditions were first explored. The hydrolysis of esters in 
presence of NaOH was successful for almost all of the esters and also was a reliable 
synthetic procedure. The yields of the acids were good and it also produced a by 
products 9e and 9f which is the protection group with hydroxy substituent instead of the 
bromo derivative. The by products 9e and 9f can directly be used as protection groups 
for esters directly as alcohols and so recycling of the tag molecule is still a possibility in 
this deprotection method also. The isolation of 9e and 9f was not difficult too because it 
precipitates, as the reaction proceeds to completion and hence can be filtered off to 
obtain in 100% purity. The only exceptions in this case are esters 6a and 6k, both of 
these esters have two centers of hydrolysis, an ethyl ester and benzyl ester, both 
hydrolysable under these conditions. The hydrolysis was not selective even with 1 
equivalent of NaOH or by using milder conditions like LiOH. All the acids were produced 
in excellent yields as shown in table 8 and the byproduct was easily isolated from the 
reaction mixture for a reuse. The figure 9 explains the reaction condition for 
deprotecting with NaOH. 
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Scheme 3.7. Deprotection using NaOH/DCM: MeOH (1:1). 
Table 3.8. Deprotection using NaOH/DCM: MeOH (1:1). 
 
 
Ester Isolated Acid  Yield 
(%) 
9e/9f(%) 
6a Monoethlyl malonate 87 86 
6b Acetic acid 82 85 
6c Octanoic acid 84 81 
6d Dodecanoic acid 82 84 
6e 2-Phenyl butanoic acid 93 88 
6f Boc-Glycine 84 87 
6g Cbz-Glycine 79 81 
6h Benzoic acid 96 89 
6i Picolinic acid 84 87 
6j 
 
92 86 
6k Mono ethyl malonate 86 85 
6l Acetic acid 79 89 
6m Octanoic acid 83 88 
6n Dodecanoic acid 87 83 
6o 2-Phenyl butanoic acid 91 88 
6p Boc-Glycine 83 84 
6q Cbz-Glycine 81 79 
6r Benzoic acid 94 91 
6s Picolinic acid 85 88 
6t 
 
92 90 
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Use of hydrazine hydrate as deprotecting reagent for phthalimide protection has been 
reported before several years and since the protection groups PG1 and PG2 are 
structurally related to phthalimide, hydrazine was tested out for these protection groups 
too. However the deprotection of esters under these conditions were different for 
different types of ester. The aliphatic esters had different results form the aromatic ones. 
For example, protected malonate ester 6a lead to a group of strange byproducts in 
different yield % as shown in fig 3.8.  
 
Scheme 3.8. Deprotection of protected mono ethyl malonate in Hydrazine. 
 
And in case of the other aliphatic esters 6b - 6g and 6l - 6q there would be only two 
products unlike 6a due to the fact that the centers of hydrolysis is less in those esters as 
in comparison with 6a. But even in this case the deprotection was not successful, as 
desired reactions did not occur. The figure 12 explains the products obtained in the 
deprotection of these aliphatic esters. The site of aliphatic ester was more reactive to 
hydrazine than on the phthalimide. 
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Scheme 3.9 Deprotection of protected aliphatic esters in Hydrazine. 
 
In case of aromatic esters however the deprotection was successful but had to be done 
in two steps. The aromatic esters when reacted with hydrazine, another protected ester 
9g or 9h was produced but did not completely deprotect it. However 9g or 9h upon 
further treatment with TFA hydrolyzed the ester completely to give the unprotected acid. 
The scheme in fig 13 explains the two-step deprotection procedure for aromatic esters 
using hydrazine hydrate followed by trifloro acetic acid. Although the ester deprotection 
is done in two steps, the purification is easy and not complicated because the hydrazide 
of phallic acid precipitates in DCM and filtering the precipitate leaves the ester solution 
of 9g or 9h in DCM when treated with TFA and a HCl wash gives the desired acid. All 
the aromatic esters were produced in good yields and the table below summarizes the 
byproducts formed with various substrates.  
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Scheme 3.10 Deprotection of protected aromatic esters in Hydrazine. 
 
 
Table 3.9: Deprotection using NH2NH2.H2O/MeOH and TFA/DCM 
 
 
Ester Isolated Acid  Yield 
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6h Benzoic acid 96 
6i Picolinic acid 84 
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3.4 Application of the protection group in synthesizing β-keto esters: 
After various deprotection methods are explored for the various esters, they were 
incorporated into the synthesis of β-keto esters. The base hydrolysis with NaOH was 
not a good method for hydrolysis to β-keto esters as discussed earlier and the 
hydrazine hydrate hydrolysis was good only for aromatic esters and the β-keto esters 
are aliphatic and so base hydrolysis can be eliminated from deprotection methods. The 
acid hydrolysis is however useful in deprotection to obtain the β-keto esters. The ethyl 
ester was stable to the acid hydrolysis and the protection group was successfully 
deprotected during the synthesis of β-keto esters. The hydrogenation conditions were 
successful with palladium, carbon but the palladium; ammonium formate conditions 
were not suitable as the reaction conditions involve heating the mixture and the β-keto 
esters were not stable at these temperatures. The β-keto esters would decompose in 
these reaction conditions. Effectively, not all conditions were successful but the acidic 
hydrolysis and hydrogenation conditions were suitable in producing the β-keto esters 
and the scheme explains the synthesis of β-keto esters. 
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Scheme.3.11  Synthesis of β-keto esters. 
 
 Using the above mentioned deprotection methods the β-keto esters shown in the table 
13 were produced in good to excellent yields. The substituent R on the esters was 
substituted by various aliphatic and substituted aromatic esters to explore the possibility 
of synthesis with various substrates. All the reactions in the scheme resulted in good 
yields there by enhancing the overall yield of the final product. 
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Table 3.9. The β-keto esters produced using the protection group. 
S.No β-Keto ester Deprotection 
Method 
Yield (%) 
4a 
 
Pd/C/H2 96 
4b 
 
Pd/C/H2 94 
4c 
 
Pd/C/H2 93 
4d 
 
Pd/C/H2 87 
4e 
 
Pd/C/H2 84 
4f 
 
Pd/C/H2 86 
4g 
 
Pd/C/H2 88 
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3.5 Conclusion:                                                                                                             
The protection group was tested for protecting the acids and various deprotection 
methods were developed. The protection of acids to esters has been done in three 
different ways and the deprotection groups were classified as acidic, basic and neutral 
conditions. They can be employed depending on the substrates, substrates with acidic 
labile moieties can use basic conditions and those with base labile moieties use acidic 
conditions. And so different deprotection conditions can be used, especially in those 
cases where parallel deprotections necessary. All the protection and deprotection 
methods yielded good to excellent results. And also in most cases the protection groups 
were recycled and can be re used. And these results were then applied to the synthesis 
of the β-keto esters. Although all deprotection conditions were used in synthesizing the 
β-keto esters, only acidic conditions and the palladium with carbon conditions were 
successful in application of their synthesis. Using these deprotection methods, a variety 
of β-keto esters were produced in very good yields. This method of synthesis was 
proven to be better than the existing ones and hence is a good contribution to synthetic 
chemistry. To conclude the protection group was not only successful in acid protection 
and deprotection but also was successful in synthesizing the β-keto esters in excellent 
yields. 
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3.6 Experimental and spectral data: 
General Method of Preparation of Esters: 
Method A: To a suspension PG 1, PG 2 or PG 3 (10 m.mol, 1 eq) and corresponding 
acid (10 m.mol, 1 eq) in 10ml of dimethylsulfoxide, was added 1 ml of dicyclohexyl 
amine*. The clear solution thus obtained was sonicated for about 4 hrs and the solution 
was poured on to ice to form a white precipitate. The precipitate was then filtered and 
washed with water 2-3 times. The product is crystallized from the precipitate in 
methanol, alternatively can be subjected to column chromatography and is isolated in 
3% Methanol, Chloroform.  
Method B: To A suspension of PG 1, PG 2 or PG 3 (10 m.mol, 1 eq) and corresponding 
acid (10 m.mol, 1 eq) in 10ml of dimethylsulfoxide, was added NaHCO3 (12 m.mol, 1.2 
eq). The reaction mixture was then sonicated for 4-5 hrs. The hot clear solution thus 
obtained, indicating the completion of reaction was poured on to ice to form a white 
precipitate. The precipitate was then filtered and washed with water 2-3 times. The 
product is crystallized from the precipitate in methanol, alternatively can be subjected to 
column chromatography and is isolated in 3% Methanol, Chloroform. 
Method C:  A suspension of PG 1, PG 2 or PG 3 (10 m.mol, 1 eq) and corresponding 
salt of the acid (10 m.mol, 1 eq) in 10ml of dimethylsulfoxide or dimethyl formamide was 
sonicated for about 4 hrs and the solution was poured on to ice to form a white 
precipitate. The precipitate was then filtered and washed with water 2-3 times. The 
product was crystallized from the precipitate in methanol, alternatively can be purified by 
column chromatography and is isolated in 3% Methanol, Chloroform. 
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4-(1, 3-dioxoisoindolin-2-yl) benzyl ethyl malonate (6a):  
The titled compound was prepared according to the general method C from 2-(4-
(bromomethyl)phenyl)isoindoline-1,3-dione PG1 (3.16 g, 10 m.mol) and potassium 
mono ethyl malonate (1.7 g, 10 m.mol) to yield 2.86 g (90%). 1H NMR (400 MHz, 
CDCl3); δ 7.95-7.98 (m, 2H), 7.78-7.82 (m, 2H), 7.48-7.51  (d, J=8.42, 2H), 7.43-7.47 
(d, J=8.42, 2H), 5.22(s, 2H), 4.15-4.24 (q, J=6.9, 2H), 3.42(s, 2H), 1.20-1.28(t, J =6.9, 
3H).13C NMR (400 MHz, CDCl3); δ 12.1, 39.6, 59.7, 64.5, 121.8, 124.7, 127.1, 129.7, 
129.8, 132.6, 133.2, 164.4, 165.2.  
4-(1, 3-dioxoisoindolin-2-yl) benzyl acetate (6b): 
The titled compound was prepared according to the general method C from 2-(4-
(bromomethyl)phenyl)isoindoline-1,3-dione PG1 (3.16 g, 10 m.mol) and sodium acetate 
(0.8 g, 10 m.mol) to yield 2.24 g (86%). 1H NMR (400 MHz, CDCl3); δ 7.95-7.98 (m, 
2H), 7.78-7.81 (m, 2H), 7.48-7.51(d, J=8.42, 2H), 7.43-7.47(d, J=8.42, 2H), 5.16 (s, 2H), 
2.11(s, 3H). 13C NMR (400 MHz, CDCl3); δ 21.2, 65.8, 124.1, 126.8, 129.2, 131.8, 
131.9, 134.7, 136.1, 167.4, 171.1. 
4-(1,3-dioxoisoindolin-2-yl)benzyl Octanoate (6c): 
The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl)phenyl)isoindoline-1,3-dione PG1 (3.16 g, 10 m.mol) and octanoic acid 
(1.44 g, 10 m.mol) to yield 3.4 g (89%) and 3.6 g (92%) respectively. 1H NMR (400 
MHz, CDCl3); δ 7.95-7.98 (m, 2H), 7.78-7.81 (m, 2H), 7.48-7.512 (d, J=8.42, 2H), 7.43-
7.47(d, J=8.42, 2H), 5.16(s, 2H), 2.35-2.4(t, J=7.61, 2H), 1.6-1.7(m, 2H), 1.2-139( m, 
8H), 0.9-1.1(t, J=6.59, 3H). 13C NMR (400 MHz, CDCl3); δ 14.3, 22.8, 25.1, 29.1, 29.3, 
31.9, 34.5, 65.6, 124.1, 126.8, 129.1, 131.7, 131.9, 134.7, 136.3, 167.4, 173.8 ppm.  
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4-(1,3-dioxoisoindolin-2-yl)benzyl tetradecanoate (6d): 
The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl)phenyl)isoindoline-1,3-dione PG1 (3.16 g, 10 m.mol) and decanoic 
acid (1.72 g, 10 m.mol) to yield 4 g (87%) and 4.2 g (91%) respectively. 1H NMR (400 
MHz, CDCl3); δ 7.95-7.98 (m, 2H), 7.78-7.81 (m, 2H), 7.48-7.51  (d, J=8.42, 2H), 7.43-
7.47 (d, J=8.42, 2H), 5.16 (s, 2H), 2.35-2.4(t, J=7.62, 2H), 1.6-1.7(m,  2H), 1.2-1.3 ( m, 
20H), 0.8-0.9(t, J=7.69, 3H). 13C NMR (400 MHz, CDCl3); δ 14.4, 22.9, 25.2, 29.4, 29.5, 
29.6, 29.7, 29.8, 29.8, 29.9, 32.2, 34.5, 65.6, 124.1, 126.8, 129.1, 131.6, 131.9, 134.7, 
136.3, 167.4, 173.8 ppm  
4-(1,3-dioxoisoindolin-2-yl) benzyl 2-phenylbutanoate (6e): 
The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl)phenyl)isoindoline-1,3-dione PG1 (3.16 g, 10 m.mol) and 2-phenyl 
butanoic acid (1.64 g, 10 m.mol) to yield 3.35 g (84%) and 3.79 g (88%) respectively. 1H 
NMR (400 MHz, CDCl3); δ 7.95-7.98 (m, 2H), 7.78-7.82 (m, 2H), 7.48-7.51 (d, J=8.42, 
2H), 7.43-7.47 (d, J=8.42, 2H), 7.24-7.35(m, 5H),5.1-5.22(q, J=12.8, 2H), 3.48-3.59(t, 
J=7.69,1H), 2.06-2.2(m,1H), 1.79-1.89(m,1H), 0.87-0.98(t, J = 7.33,3H).13C NMR (400 
MHz, CDCl3); δ 12.4, 26.8, 53.7, 65.9, 124.1, 126.7, 127.5, 128.3, 128.8, 128.8, 131.6, 
131.9, 134.7, 136.2, 139.1, 167.4, 174.1 ppm. 
4-(1,3-dioxoisoindolin-2-yl)benzyl 2-(tert-butoxycarbonylamino)acetate (6f): 
The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl)phenyl)isoindoline-1,3-dione PG1 (3.16 g, 10 m.mol) and BOC-Glycine 
(1.75 g, 10 m.mol) to yield 3.56 g (87%) and 3.69 g (90%) respectively. 1H NMR (400 
MHz, CDCl3); δ 7.95-7.98 (m, 2H), 7.78-7.82 (m, 2H), 7.48-7.51 (d, J=8.42, 2H), 7.43-
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7.47 (d, J=8.42, 2H), 5.21(s, 2H), 5.1(s, br, 1H), 4.02-4.06 (d, J=5.4, 2H), 1.3-1.5(d, J=, 
9H). 13C NMR (400 MHz, CDCl3); δ 28.54(3C), 42.7, 66.6, 80.3, 124.1, 126.8, 129.3, 
131.8, 131.9, 134.8, 135.4, 155.9, 167.4, 170.5.  
4-(1,3-dioxoisoindolin-2-yl)benzyl 2-(benzyloxycarbonylamino)acetate(6g): 
The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl)phenyl)isoindoline-1,3-dione PG1 (3.16 g, 10 m.mol) and Z-glycine 
(2.1 g, 10 m.mol) to yield 3.72 g (84%) and 4.04 g (91%) respectively. 1H NMR (400 
MHz, CDCl3); δ 7.95-7.98 (m, 2H), 7.78-7.82 (m, 2H), 7.48-7.51  (d, J=8.42, 2H), 7.43-
7.47 (d, J=8.42, 2H), 7.3-7.38(m, 5H), 5.25 (s,br,1H), 5.22(s,2H), 5.14 (s,2H), 4.02-4.06 
(d, J=5.4, 2H).13C NMR (400 MHz, CDCl3); δ 43.1, 66.6, 67.4, 124.1, 126.9, 128.4, 
128.5, 128.8, 129.4, 131.9, 132.1, 134.8, 135.3, 136.5, 156.5, 167.3, 170.1 ppm.  
4-(1,3-dioxoisoindolin-2-yl)benzyl benzoate (6h):  
The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl)phenyl)isoindoline-1,3-dione PG1 (3.16 g, 10 m.mol) and sodium 
benzoate (1.44 g, 10 m.mol) to yield 3.14 g (88%) and 3.35 g (94%) respectively. 1H 
NMR (400 MHz, CDCl3); δ 8.08-8.14(dd, J1=8.4, J2=1.46, 2H), 7.95-7.98 (m, 2H), 7.78-
7.81 (m, 2H), 7.58-7.65(d,J=8.4,2H), 7.55-7.58  (td, J1=7.42 J2=1.46, 1H), 7.47-
7.51(d,J=8.4,2H), 7.43-7.47 (dd, J1=7.42, J2=1.12, 2H),  5.41 (s,2H). 13C NMR (400 
MHz, CDCl3); δ 65.9, 123.7, 126.5, 128.3, 128.8, 129.6, 129.8, 131.5, 131.6, 133.1, 
134.4, 135.8, 166.3, 167.1 ppm.  
4-(1, 3-dioxoisoindolin-2-yl) benzyl picolinate (6i):  
The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl)phenyl)isoindoline-1,3-dione PG1 (3.16 g, 10 m.mol) and picolinic acid 
 111	  
(1.23 g, 10 m.mol) to yield 2.79 g (78%) and 2.89 g (84%) respectively. 1H NMR (400 
MHz, CDCl3);  δ 8.75-8.78 (d, J=4.61, 1H), 8.11-8.19 (d,J=7.69,1H), 7.95-7.98 (m, 2H), 
7.82-7.86(t, J=8.4, 1H), 7.78-7.81 (m, 2H), 7.60-7.65(d, J=, 2H), 7.44-7.50 (m,3H),  5.49 
(s,2H).13C NMR (400 MHz, CDCl3); δ 67.11, 124.1, 125.6, 126.9, 127.3, 129.6, 131.9, 
131.9, 134.7, 135.7, 137.3, 148.1, 150.2, 165.2, 167.4 ppm.  
4-(1,3-dioxoisoindolin-2-yl)benzyl 4-(1,3-dioxoisoindolin-2-yl)benzoate (6j): 
The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl)phenyl)isoindoline-1,3-dione PG1 (3.16 g, 10 m.mol) and 4-(1,3-
dioxoisoindolin-2-yl)benzoic acid (2.67 g, 10 m.mol) to yield 4.56 g (91%) and 4.71 g 
(94%) respectively. 1H NMR (400 MHz, CDCl3); δ 8.22-8.26(d, J=8.4, 2H), 7.94-8.0(m, 
4H), 7.78-7.86(m, 4H), 7.62-7.64(d, J=4.8, 2H), 7.58-7.61 (d, J=4.8, 2H), 7.48-7.52 (d, J 
=0.84, 2H), 5.44 (s, 2H). 13C NMR (400 MHz, CDCl3); δ  66.5, 124.1, 124.2, 126.21(2C), 
126.9, 129.1, 129.3, 130.8, 131.7, 131.8, 131.9, 134.7, 134.92(2C), 136.01, 136.3, 
165.8, 167.1, 167.4 ppm. 
4-(1,3-dioxoisoindolin-2-yl)-3-methoxybenzyl ethyl malonate (6k):  
The titled compound was prepared according to the general method C from 2-(4-
(bromomethyl)3-methoxyphenyl)isoindoline-1,3-dione PG2 (3.46 g, 10 m.mol) and 
potassium mono ethyl malonate (1.7 g, 10 m.mol) to yield 3.13 g (91%). 1H NMR (400 
MHz, CDCl3); δ 7.85-7.89 (m, 2H), 7.68-7.71 (m, 2H), 7.58 (d, J=7.2, 2H), 7.23(s, 1H), 
6.98 (d, J=7.2, 2H), 5.22(s, 2H), 4.15-4.24 (q, J=6.9, 2H), 3.42(s, 2H), 1.20-1.28(t, J 
=6.9, 3H).13C NMR (400 MHz, CDCl3); δ 12.1, 39.6, 59.6, 64.5, 121.8, 124.6, 127.1, 
129.7, 129.8, 132.5, 133.2, 164.4, 165.2 ppm.  
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4-(1, 3-dioxoisoindolin-2-yl)-3-methoxybenzyl acetate (6l): 
The titled compound was prepared according to the general methods B and C from 2-
(4-(bromomethyl)3-methoxyphenyl)isoindoline-1,3-dione PG2 (3.46 g, 10 m.mol) and 
sodium acetate (0.8 g, 10 m.mol) to yield 2.95 g (88%). 1H NMR (400 MHz, CDCl3); δ 
7.85-7.89 (m, 2H), 7.68-7.71 (m, 2H), 7.58 (d, J=7.2, 2H), 7.23(s, 1H), 6.98 (d, J=7.2, 
2H), 5.22(s, 2H), 2.11(s, 3H). 13C NMR (400 MHz, CDCl3); δ 21.2, 65.8, 124.1, 126.8, 
129.2, 131.8, 131.9, 134.7, 136.1, 167.4, 171.1 ppm. 
4-(1,3-dioxoisoindolin-2-yl)-3-methoxybenzyl Octanoate (6m): 
The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl) 3-methoxy phenyl)isoindoline-1,3-dione PG2 (3.46 g, 10 m.mol) and 
octanoic acid (1.44 g, 10 m.mol) to yield 3.63 g (86%) and 3.8 g (90%) respectively. 1H 
NMR (400 MHz, CDCl3); δ δ 7.85-7.89 (m, 2H), 7.68-7.71 (m, 2H), 7.58 (d, J=7.2, 2H), 
7.23(s, 1H), 6.98 (d, J=7.2, 2H), 5.16(s, 2H), 2.35-2.4(t, J=7.61, 2H), 1.6-1.7(m, 2H), 
1.2-139( m, 8H), 0.9-1.1(t, J=6.59, 3H). 13C NMR (400 MHz, CDCl3); δ 14.3, 22.8, 25.1, 
29.1, 29.3, 31.8, 34.5, 65.6, 124.1, 126.8, 129.1, 131.7, 131.9, 134.7, 136.3, 167.4, 
173.8 ppm.  
4-(1,3-dioxoisoindolin-2-yl)-3-methoxybenzyl tetradecanoate (6n): 
The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl) 3-methoxy phenyl)isoindoline-1,3-dione PG2 (3.46 g, 10 m.mol) and 
decanoic acid (1.72 g, 10 m.mol) to yield 4.28 g (87%) and 4.58 g (93%) respectively. 
1H NMR (400 MHz, CDCl3); δ δ 7.85-7.89 (m, 2H), 7.68-7.71 (m, 2H), 7.58 (d, J=7.2, 
2H), 7.23(s, 1H), 6.98 (d, J=7.2, 2H), 5.16 (s, 2H), 2.35-2.4(t, J=7.62, 2H), 1.6-1.7(m,  
2H), 1.2-1.3 ( m, 20H), 0.8-0.9(t, J=7.69, 3H). 13C NMR (400 MHz, CDCl3); δ 14.4, 22.9, 
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25.2, 29.4, 29.5, 29.6, 29.6, 29.8, 29.8, 29.9, 32.2, 34.5, 65.6, 124.1, 126.8, 129.1, 
131.6, 131.9, 134.7, 136.3, 167.4, 173.8 ppm.  
4-(1,3-dioxoisoindolin-2-yl)-3-methoxybenzyl 2-phenylbutanoate (6o): 
The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl) 3-methoxy phenyl)isoindoline-1,3-dione PG2 (3.46 g, 10 m.mol) and 
2-phenyl butanoic acid (1.64 g, 10 m.mol) to yield 3.68 g (81%) and 3.98 g (91%) 
respectively. 1H NMR (400 MHz, CDCl3); δ δ 7.85-7.89 (m, 2H), 7.68-7.71 (m, 2H), 7.58 
(d, J=7.2, 2H), 7.23(s, 1H), 6.98 (d, J=7.2, 2H), 7.24-7.35(m, 5H), 5.1-5.22(q, J=12.8, 
2H), 3.48-3.59(t, J=7.69,1H), 2.06-2.2(m, 1H), 1.79-1.89(m,1H), 0.87-0.98(t, J = 
7.33,3H).13C NMR (400 MHz, CDCl3); δ 12.38, 26.76, 53.7, 65.9, 124.1, 126.7, 127.5, 
128.2, 128.7, 128.8, 131.6, 131.9, 134.7, 136.2, 139.1, 167.4, 174.1 ppm. 
4-(1,3-dioxoisoindolin-2-yl)-3-methoxybenzyl2-(tert-butoxycarbonylamino)acetate 
(6p): 
The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl) 3-methoxy phenyl)isoindoline-1,3-dione PG2 (3.46 g, 10 m.mol) and 
BOC-Glycine (1.75 g, 10 m.mol) to yield 3.56 g (79%) and 4.01 g (87%) respectively. 1H 
NMR (400 MHz, CDCl3); δ 7.85-7.89 (m, 2H), 7.68-7.71 (m, 2H), 7.58 (d, J=7.2, 2H), 
7.23(s, 1H), 6.98 (d, J=7.2, 2H), 5.21(s, 2H), 5.1(s, br, 1H), 4.02-4.06 (d, J=5.4, 2H), 
1.3-1.5(d, J=, 9H). 13C NMR (400 MHz, CDCl3); δ 28.5, 42.7, 66.6, 80.3, 124.1, 126.9, 
129.3, 131.9, 131.9, 134.8, 135.4, 155.9, 167.4, 170.5 ppm.  
4-(1,3-dioxoisoindolin-2-yl)-3-methoxybenzyl2-(benzyloxycarbonylamino)acetate 
(6q): 
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The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl) 3-methoxy phenyl)isoindoline-1,3-dione PG2 (3.46 g, 10 m.mol) and 
Z-glycine (2.1 g, 10 m.mol) to yield 3.74 g (88%) and 4.12 g (95%) respectively. 1H 
NMR (400 MHz, CDCl3); δ δ 7.85-7.89 (m, 2H), 7.68-7.71 (m, 2H), 7.58 (d, J=7.2, 2H), 
7.23(s, 1H), 6.98 (d, J=7.2, 2H), 7.3-7.38(m, 5H), 5.25 (s,br,1H), 5.22(s,2H), 5.14 
(s,2H), 4.02-4.06 (d, J=5.4, 2H).13C NMR (400 MHz, CDCl3); δ 43.1, 66.7, 67.4, 124.1, 
126.9, 128.4, 128.5, 128.8, 129.4, 131.9, 132.1, 134.8, 135.3, 136.5, 156.6, 167.4, 
170.1 ppm.  
4-(1,3-dioxoisoindolin-2-yl)-3-methoxybenzyl benzoate (6r):  
The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl)3-methoxyphenyl)isoindoline-1,3-dione PG2 (3.46 g, 10 m.mol) and 
sodium benzoate (1.44 g, 10 m.mol) to yield 3.41 g (84%) and 3.68 g (88%) 
respectively. 1H NMR (400 MHz, CDCl3); δ 8δ 7.85-7.89 (m, 2H), 7.68-7.71 (m, 2H), 
7.58 (d, J=7.2, 2H), 7.23(s, 1H), 7.55-7.58  (td, J1=7.42 J2=1.46, 1H), 7.43-7.47 (dd, 
J1=7.42, J2=1.12, 2H), 6.98 (d, J=7.2, 2H),  5.41 (s,2H). 13C NMR (400 MHz, CDCl3); δ 
65.9, 123.7, 126.6, 128.3, 128.8, 129.6, 129.9, 131.5, 131.6, 133.1, 134.4, 135.9, 166.3, 
167.1 ppm.  
4-(1, 3-dioxoisoindolin-2-yl)-3-methoxybenzyl picolinate (6s):  
The titled compound was prepared according to the general methods A and B from 2-
(4-(bromomethyl) 3-methoxy phenyl)isoindoline-1,3-dione PG2 (3.46 g, 10 m.mol) and 
picolinic acid (1.23 g, 10 m.mol) to yield 3.25 g (83%) and 3.42 g (86%) respectively. 1H 
NMR (400 MHz, CDCl3);  δ 8.75-8.78 (d, J=4.61, 1H), 8.11-8.19 (d,J=7.69,1H), 6.98 (d, 
J=7.2, 2H), 7.44-7.50 (m,3H), 5.49 (s,2H).13C NMR (400 MHz, CDCl3); δ 67.1, 124.1, 
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125.6, 126.9, 127.3, 129.6, 131.9, 131.9, 134.7, 135.7, 137.3, 148.1, 150.2, 165.2, 
167.4 ppm.  
4-(1,3-dioxoisoindolin-2-yl)-3-methoxybenzyl 4-(1,3-dioxoisoindolin-2-yl) benzoate 
(6t): The titled compound was prepared according to the general methods A and B from 
2-(4-(bromomethyl) 3-methoxy phenyl)isoindoline-1,3-dione PG2 (3.46 g, 10 m.mol) and 
4-(1,3-dioxoisoindolin-2-yl)benzoic acid (2.67 g, 10 m.mol) to yield 4.94 g (93%) and 
5.10 g (96%) respectively. 1H NMR (400 MHz, CDCl3); δ 8.22-8.26(d, J=8.4, 2H), 7.94-
8.0(m, 4H), 7.78-7.86(m, 4H), 7.62-7.64(d, J=4.8, 2H), 7.58-7.61 (d, J=4.8, 2H), 7.48-
7.52 (d, J =8.4, 2H), 5.44 (s, 2H). 13C NMR (400 MHz, CDCl3); δ 66.5, 124.1, 124.2, 
126.2, 126.9, 129.1, 129.3, 130.8, 131.7, 131.8, 131.9, 134.7, 134.9, 136, 136.3, 165.8, 
167, 167.4 ppm. 
4-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)benzyl 3-oxobutanoate (6u): 
The titled compound was prepared according to the general method C from 2-(4-
(bromomethyl)phenyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione PG3 (3.65 g, 10 m.mol) 
and potassium mono ethyl malonate (1.7 g, 10 m.mol) to yield 3.13 g (91%). 1H NMR 
(400 MHz, CDCl3) δ 8.65 (d, J = 7.3 Hz, 2H), 8.27 (d, J = 8.3 Hz, 2H), 7.79 (t, J = 7.8 
Hz, 2H), 7.36 (d, J = 8.1 Hz, 2H), 7.21 (d, J = 8.1 Hz, 2H), 5.22(s, 2H), 4.15-4.24 (q, 
J=6.9, 2H), 3.42(s, 2H), 1.20-1.28(t, J =6.9, 3H). 13C NMR (400MHz, CDCl3) δ 164.6, 
139.6, 135.6, 134.5, 131.9, 131.7, 129.8, 129.5, 129.4, 128.7, 127.3, 125.8, 123.1, 77.8, 
64.5, 59.7, 39.6, 12.1 ppm. 
4-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)benzyl acetate (6v):  
The titled compound was prepared according to the general method C from 2-(4-
(bromomethyl)phenyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione PG3 (3.65 g, 10 m.mol) 
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and sodium acetate (0.8 g, 10 m.mol) to yield 2.95 g (88%). 1H NMR (400 MHz, CDCl3) 
δ 8.65 (d, J = 7.3 Hz, 2H), 8.27 (d, J = 8.3 Hz, 2H), 7.79 (t, J = 7.8 Hz, 2H), 7.36 (d, J = 
8.1 Hz, 2H), 7.21 (d, J = 8.1 Hz, 2H), 5.26(s, 2H), 2.25 (s, 3H). 13C NMR (400MHz, 
CDCl3) δ 164.6, 139.6, 135.6, 134.5, 131.9, 131.7, 129.8, 129.5, 129.4, 128.7, 127.3, 
125.8, 123.1, 77.8, 21.6 ppm. 
4-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)benzyl benzoate (6w): 
The titled compound was prepared according to the general method C from 2-(4-
(bromomethyl)phenyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione PG3 (3.65 g, 10 m.mol) 
and sodium benzoate (1.44 g, 10 m.mol) to yield 3.41 g (84%) and 3.68 g (88%) 
respectively.1H NMR (400 MHz, CDCl3) δ 8.65 (d, J = 7.3 Hz, 2H), 8.27 (d, J = 8.3 Hz, 
2H), 7.79 (t, J = 7.8 Hz, 2H), 7.36 (d, J = 8.1 Hz, 2H), 7.16(m, 5H), 7.21 (d, J = 8.1 Hz, 
2H), 5.26(s, 2H), 2.25 (s, 3H). 13C NMR (400MHz, CDCl3) δ 164.6, 139.6, 135.6, 134.5, 
131.9, 131.7, 130.8, 129.8, 129.5, 129.4, 127.3, 124.3, 128.7, 126.5, 127.3, 125.8, 
123.1, 77.8 ppm. 
General Methods of Deprotection: 
Method D-1: To a suspension of 1 gm of ester in 15 ml of Methanol was added 400mg 
of 10% Pd/C and the solution was kept in the par shaker at a pressure of 65 atm for 5-6 
hrs until completion of the reduction. The solvent was then evaporated and the residue 
was taken in sodium bicarbonate solution. This solution was washed with 
dichloromethane to collect the byproducts and acidified using 10% HCl to yield the acid 
as a crystalline compound or oil that is obtained upon extraction with ethyl acetate. 
Method D-2: To a suspension of 1 gm of ester in 15 ml of Methanol were added 177 
mg of HCOONH4 and 300mg of 10% Pd/C. The suspension was then heated at 50 deg 
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c for 2-3 hrs until completion of the reduction. The solvent was then evaporated and the 
residue was taken in sodium bicarbonate solution. This solution was washed with 
dichloromethane to collect the byproducts and acidified using 10% HCl to yield the acid 
as a crystalline compound or oil that is obtained upon extraction with ethyl acetate. 
Method D-3: A solution of 1 gm of ester in 15 ml of ethyl acetate was purged with 
excess of HCl (using MeOH and SOCl2). 2-3 hours after passing HCl the solvent was 
evaporated and the residue was taken in sodium bicarbonate solution. This solution was 
washed with dichloromethane to collect the byproducts and acidified to yield the acid as 
a crystalline compound or oil that is obtained upon extraction with ethyl acetate. 
Method D-4: To a suspension of 1 gm of ester in 15 ml of 1:1 MeOH, Dichloromethane 
was added powdered NaOH (112mg, 2.8m.mol) at 0 deg C and the reaction mixture 
was stirred for about 2 hrs and the methanol was evaporated. The residue was taken 
into Sodium bicarbonate solution, washed with DCM to collect the byproducts and 
acidified to yield the acid as a crystalline compound or oil that can be obtained upon 
extraction using ethyl acetate.  
Method D-5: To a suspension of 1 gm ester in 10 ml of MeOH was added 2-3 eqs of 
Hydrazine hydrate. As the reaction proceeds a gradual increase in precipitation of 
pthalhydrazide is observed. After completion of reaction in about 5-6 hrs, the 
pthalhydrazide was separated by filtering it out and the filtrate was evaporated under 
vacuum. The residue thus obtained upon concentration is diluted in 5 ml of DCM; 1 
equivalent of TFA was added and allowed the mixture to stir for 15 minutes. The mixture 
was further diluted with 15 ml of DCM and washed with 10% HCl solution followed by 
water, dried with Na2SO4 and concentrated to give the acid. 
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General method of preparation of the β- keto esters (E): 
To a solution of the esters 6a-6w (10 m.mol, 1 eq) in 25 ml of dry acetonitrile or DCM 
was added MgCl2 (0.9g, 10 m.mol, 1eq), triethyl amine (2g, 20 m.mol, 2eq) and the 
mixture was stirred under nitrogen. After 2 hrs of stirring, the acid chloride (10 m.mol, 
1eq) was added drop wise at 0°C. The mixture was stirred for additional 2 hrs. After the 
completion of reaction was confirmed by TLC, solvent was evaporated under vacuum 
and the products 8a-8g can be crystallized in a mixture of hexane and DCM 
1-(4-(1,3-dioxoisoindolin-2-yl)benzyl) 3-ethyl 2-benzoylmalonate (8a):  
The title compound is prepared by general procedure E from 6a (3.67g, 10 m.mol) and 
benzoyl chloride (1.4g, 10 m.mol) in 82% yield (3.8 g). 1H NMR 13.39 (s), 7.98-7.95 (m, 
2H), 7.78-7.81 (m, 2H), 7.48-7.51(d, J=8.42, 2H), 7.43-7.47(d, J=8.42 Hz, 2H), 7.49 –
7.42 (m, 5H), 5.28 (br, s), 5.16 (s, 2H), 4.23 (q, J=7.13, 2H), 1.23 (t, J=7.13, 3H); 13C 
NMR (CDCl3) 189.4, 165.3, 165.2, 164.4, 135.8, 134.4, 133.2, 132.6, 129.1, 128.7, 
127.1, 124.7,121.8, 64.5, 62.7, 61.9, 14.4, 14.1 ppm. 
1-(4-(1,3-dioxoisoindolin-2-yl)benzyl) 3-ethyl 2-(2,4,6-trimethoxybenzoyl)malonate 
(8b): The title compound is prepared by general procedure E from 6a (3.67g, 10 m.mol) 
and trimethoxy benzoyl chloride (2.3 g, 10 m.mol) in 85% yield (4.78 g). 1H NMR 13.39 
(s), 7.98-7.95(m, 2H), 7.78-7.81 (m, 2H), 7.48-7.51(d, J=8.42, 2H), 7.43-7.47(d, J=8.42 
Hz, 2H), 7.44 (s, 2H), 5.28 (br, s), 5.16 (s, 2H), 4.62(s, 9H), 4.23 (q, J=7.13, 2H), 1.23 (t, 
J=7.13, 3H); 13C NMR (CDCl3) 189.4, 165.3,164.4, 135.8, 134.4, 133.2,132.6, 128.8, 
127.1, 124.6,121.8, 64.5, 62.7, 61.9, 14.4, 14.1 ppm. 
1-(4-(1,3-dioxoisoindolin-2-yl)benzyl) 3-ethyl 2-(3-nitrobenzoyl)malonate (8c): 
The title compound is prepared by general procedure E from 6a (3.67g, 10 m.mol) and 
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3-nitro benzoyl chloride (1.85 g, 10 m.mol) in 69% yield (3.56 g). 1H NMR 13.28 (s), 
7.98-7.95(m, 2H), 7.78-7.81 (m, 2H), 7.48-7.51(d, J=8.42, 2H), 7.43-7.47(d, J=8.42 Hz, 
2H), 7.63–8.92 (m, 4H), 5.28 (br, s), 5.16 (s, 2H), 4.23 (q, J=7.13, 2H), 1.23 (t, J=7.13, 
3H); 13C NMR (CDCl3) 189.4, 165.3, 165.2, 164.4, 135.8, 134.4, 133.2, 132.6, 129.1, 
128.7, 127.1, 124.6,121.8, 64.5, 63.7, 51.2, 61.9, 14.4, 14.1 ppm. 
1-(4-(1,3-dioxoisoindolin-2-yl)benzyl) 3-ethyl 2-acetylmalonate (8d): 
The title compound is prepared by general procedure E from 6a (3.67g, 10 m.mol) and 
acetyl chloride (0.8 g, 10 m.mol) in 74% yield (3.02 g). 1H NMR 13.45, 7.98-7.95(m, 
2H), 7.78-7.81 (m, 2H), 7.48-7.51(d, J=8.42, 2H), 7.43-7.47(d, J=8.42 Hz, 2H), 5.18 (s, 
2H), 4.38 (br, s), 4.23 (q, J=7.13 Hz, 2H), 2.27 & 2.13 (s, s, total 3H), 1.23 (t, J=7.13 Hz, 
3H); 13CNMR (CDCl3) 197.1, 165.3, 165.2, 164.4, 133.2, 132.6, 128.7, 127.1, 124.7, 
100.2, 64.5, 62.2, 61.4, 21.1, 14.4, 14.3 ppm. 
1-(4-(1,3-dioxoisoindolin-2-yl)benzyl) 3-ethyl 2-hexanoylmalonate (8e): 
The title compound is prepared by general procedure E from 6a (3.67g, 10 m.mol) and 
hexanoyl chloride (1.34 g, 10 m.mol) in 67% yield (3.11 g). 1H NMR 13.31, 4.37 (br s, br 
s, total 1H), 7.98-7.95(m, 2H), 7.78-7.81 (m, 2H), 7.48-7.51(d, J=8.42 Hz, 2H), 7.43-
7.47(d, J=8.42 Hz, 2H), 5.16 (s, 2H), 4.26 (q, J=6.87 Hz, 2H), 2.59 (t, J=7.29 Hz, 1H), 
2.41 (t, J=7.29, 1H), 1.64–1.57 (m, 2H), 1.21–1.15 (m, 8H), 1.08 (t, J=7.13,1.5H), 0.98 
(t, J.7.13, 1.5 H); 13CNMR (CDCl3) 199.8, 171.5, 164.9, 164.4, 165.1, 134.4, 133.2, 
132.6, 99.5, 64.2, 62.5, 61.3, 27.6, 14.3, 14.2, 7.8 ppm. 
1-(4-(1,3-dioxoisoindolin-2-yl)benzyl) 3-ethyl 2-octanoylmalonate (8f): 
The title compound is prepared by general procedure E from 6a (3.67g, 10 m.mol) and 
octanoyl chloride (1.58 g, 10 m.mol) in 64% yield (3.15 g). 1H NMR 13.36, 4.43 (br s, br 
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s, total 1H), 7.98-7.95(m, 2H), 7.78-7.81 (m, 2H), 7.48-7.51(d, J=8.42 Hz, 2H), 7.43-
7.47(d, J=8.42 Hz, 2H), 5.16 (s, 2H), 4.26 (q, J=6.87 Hz, 2H), 2.59 (t, J=7.29 Hz, 1H), 
1.64–1.57 (m, 2H), 1.31–1.21 (m, 10H), 0.86 (t, J=6.87 Hz, 3H); 13C NMR 199.4, 171.6, 
165.3, 165.1, 134.4, 133.2, 132.6, 129.1, 128.7, 100.1, 64.1, 62.6, 61.5, 34.2, 32.2, 
29.8, 29.6, 27.2, 25.4, 23.8, 23.1, 14.6, 14.5, 14.4 ppm. 
1-(4-(1,3-dioxoisoindolin-2-yl)benzyl) 3-ethyl 2-dodecanoylmalonate (8g): 
The title compound is prepared by general procedure E from 6a (3.67g, 10 m.mol) and 
dodecanoyl chloride (1.86 g, 10 m.mol) in 68% yield (3.54 g). 1H NMR 13.39, 4.48 (br s, 
br s, total 1H), 7.98-7.95(m, 2H), 7.78-7.81 (m, 2H), 7.48-7.51(d, J=8.42 Hz, 2H), 7.43-
7.47 (d, J=8.42 Hz, 2H), 5.16 (s, 2H), 4.26 (q, J=6.87 Hz, 2H), 2.59 (t, J=7.29 Hz, 1H), 
2.41 (t, J=7.29, 1H), 1.64–1.57 (m, 2H), 1.31–1.21 (m, 10H), 0.86 (t, J=6.87 Hz, 3H); 
13C NMR 199.39, 171.58, 165.26, 165.17, 164.42, 165.05, 134.41, 133.21, 132.56, 
129.07, 128.69, 100.08, 62.61, 61.5, 34.2, 32.2, 29.8, 29.6, 27.2, 25.4, 23.8, 23, 14.6, 
14.4, 14.3 ppm. 
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Chapter IV 
Synthesis of α-β  unsaturated amino acids 
4.1 Introduction: 
α-β Unsaturated amino acids also known as α-dehydroaminoacids (DHA’s) are very 
important intermediates in biological epimerization1 of L-α-amino acid into the enatiomer 
by the process of dehydrogenation-hydrogenation1. Also there are many peptide 
antibiotics2-5, which are prepared from these compounds. Some of these compounds 
with antibiotic activity also exhibited phytotoxic activity6-8. Dehhydro peptides, another 
important class of biological compounds can be derived only from DHAs making them 
even more powerful class of compounds. A vast number of reports wee found on 
correlating the structure and biological activity of dehydro oligopeptides containing one 
or more DHA moieities9-11. For example, Berninamycin A, an antibiotic is a 
cyclodehydropeptide with two DHP sequences and about seven DHA residues and has 
been isolated from a culture of Streptomyces bernensis5. The syntheses of DHPs are 
well established and have been known for quite sometime. Elimination of peptides with 
a leaving group12-15, by direct coupling of DHAs with amino acids16,17, ring cleavage of 
unsaturated azalactones18-21, are few of the most common methods used to synthesize 
these compounds. Although there are many methods of synthesis available for DHPs, 
DHAs one of the main components for preparation of DHPs are not very well 
established in synthesis and only few methods are reported for these compounds22. 
One of the methods involves reduction of 2-azido alkenoates in to corresponding 2-
amino alkenoates in presence of Al-Hg23 and the other reports preparation of methyl 2-
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α-amino-2-α-alkenoates by elimination24 of methanol from corresponding methoxy-
amino acids. But both these methods report a very low yield, involve complex 
purification methods and also were found hard to reproduce. Dehydrochlorination of α-
chloro amino acids25 is one another method reported, however the procedures to make 
α- chloro amino acids only are not well established and using these as starting materials 
would not be a wise proposal. Therefore, a good method of synthesis for DHAs is on 
demand and also the method to be developed should applied in general to any type of 
compounds along with good yield and easy purification methods. 
4.3 Results and Discussion:  
The synthesis of α-β unsaturated amino acids is not very well established and there are 
only a few methods available for synthesis of these compounds and hence a great deal 
of interest is put into these compounds. Our research started off with oxazolones as 
starting materials for these compounds, later extended to attempts with a tag molecule 
and azide approach, which will further be discussed in the rest of the chapter. 
4.3.1. The oxazolone approach: 
In one of the previous attempts as part of synthesizing a class of oxazolones26, a 
method has been stabilized in our research group where in oxazolone with common 
structure as shown in scheme 1 is produced. These oxazolones were used as starting 
materials in synthesis of α-β unsaturated amino acids. Since the oxazolone ring can be 
opened up in acidic conditions, it was expected that the acidic hydrolysis could both 
open up the ring and also yield α-β unsaturated amino acids which can further be 
transformed into the corresponding esters. 
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Scheme 4.1: Synthesis of N-acyl α-β unsaturated amino acids. 
 
When the proposed synthesis was attempted, it was realized that the opening of the 
oxazolone ring was possible but the further hydrolysis to obtain an α-β unsaturated 
amino acid was unsuccessful. With milder conditions of acidic hydrolysis since the 
oxazolone produced N-acyl α-β unsaturated amino ester and conditions harsher than 
that decomposed the products, various acidic conditions were explored based on their 
reactivity. These reactions were applied two sets of compounds 1a with acetyl 
protection of N-glycine and 1b with benzoyl protection of N-glycine to obtain the 
oxazolones 3a and 3b and upon hydrolysis produced 5a and 5b but not 4a and 4b as 
shown in scheme 4.2.  
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Scheme. 4.2: Synthesis of α-β unsaturated amino acids using acetyl and benzoyl 
protection on N-Glycine. 
 
The results remained unaltered even after trying various acidic conditions for hydrolysis 
and so it was proposed that changing the acyl substitution on the compound from an 
amidic linkage to a carbamate linkage would make it more labile to acidic hydrolysis. In 
scheme 4.2 the oxazolones were made from N-acyl glycines and to make the protection 
on N more labile, acyl protection has been altered to ethoxy carbonyl and carboxy 
benzyl protections as in scheme 4.3.  
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Scheme 4.3 Synthesis of ethoxy and benzoxy oxazolones. 
 
4.3.2 The TAG molecule approach: 
By changing the N- protection on glycine, the reactivity of glycines as N-acyl glycines 
was different from these and so the oxazolones and the following condensation reaction 
did not occur in the same conditions using Sodium acetate and had to be altered to 
oxalyl chloride in DCM after trying other reagents like DCC.  Although the oxazolones 
were prepared the synthesis of α-β unsaturated amino esters was not successful even 
after. The hydrolysis would have been easier in this case as compared to the previous 
case but the stability and existence of these oxazolones was by itself a problem, the 
ethoxy oxazolone was completely lost during the evaporation of solvent under nitrogen 
and the benzoxy oxazolone was lost during work up, probably due to their very low 
volatility. So since the loss of compound during work up is greatly dependent on the 
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physical nature of the compound rather than its chemical behavior, the tag molecule 
was introduced as it is done in case of α-β keto esters. However in case of β keto 
esters, the pthalimide based tag molecule was used as a bromo derivative but the 
naphthalimide based tag molecule is used as a hydroxy derivative in this case27. The 
tag molecule has been prepared in few steps starting from naphthalimide and is 
obtained as its hydroxy derivative in a very good yield. The reason for changing the tag 
molecule from phthalyl to naphthyl is that the naphthyl based protection group is of 
higher molecular weight as compared to the phthalyl and also hydroxy derivative was 
necessary for reactivity with the substrates in this sequence. The scheme 4.4 below 
explains the step-by-step procedure for preparing the naphthalimide based tag 
molecule. 
 
Scheme. 4.4 Synthesis of the tag molecule. 
The tag molecule thus synthesized was incorporated into the synthesis of α-β 
unsaturated amino acids and the scheme 4.5 explains the proposed synthesis using the 
naphthalimide based protection group. The reaction of the protection group with phenyl 
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chloroformate yields the corresponding carbonate in a good yield with pyridine as 
solvent. Pyridine itself acts as a base also in this reaction. 
 
Scheme 4.4 Proposed synthesis of α,β-unsaturated amino acid with protection group. 
 
However, the reaction with glycine was not successful because of the solubility issues 
associated with glycine.  With this reaction not proceeding further, glycine was replaced 
with ethanolamine to react with the carbonate followed by an oxidation reaction and this 
yielded the desired product as shown in scheme 4.5. The oxidation was performed in 
Jones oxidation conditions in chromic acid and was produced in a very good yield28. But 
the following reaction, which involves formation of oxazolone and condensation with 
aldehyde in sodium acetate and acetic anhydride, was not successful under these 
conditions, like it was possible with the simple alkyl substituted oxazolones. The glycine 
protected with naphthalimide-based protection group was resistant to these conditions 
and so this reaction needs to be explored further. 
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Scheme 4.5 Synthesis of α,β-unsaturated amino acid with ethanolamine 
 
Initially, it was felt that the reaction did not proceed due to the solubility issues 
associated with naphthalimide-protected glycine and so the solvent conditions had to be 
explored.  After trying several solvents, DMF, DMSO and pyridine were the best 
solvents for any of these reactions. DBU, DCC, TFA, pyridine, H2SO4 and NaHCO3 are 
few of the coupling reagents29-35 tried as shown in scheme 4.6 and table 1. DBU, TFA, 
pyridine and acetic anhydride in DMSO or DMF did not yield the product, H2SO4 
resulted in sulfonification on the ring of the aromatic aldehyde and no reaction with 
aliphatic aldehydes, but acetic anhydride in pyridine and NaHCO3 in pyridine conditions 
resulted in oxazolone formation but the following condensation reaction was not 
successful.  
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Scheme. 4.6 Intermediates and byproducts in oxazolone synthesis with tag molecule. 
Table 4.1. Various coupling reagents used for oxazolone synthesis: 
Entry Reagent Solvent Product 
1 NaOAc Acetic anhydride NR 
2 Lead Acetate Acetic anhydride NR 
3 Triphosgene Ethyl Acetate NR 
4 DCC DCM, DMF, DMSO, Pyridine NR 
5 (COCl)2, AgCN DCM,  NR 
6 DBU Pyridine 17 
7 Acetic Anhydride Pyridine 17 
8 H2SO4 H2SO4 18 
9 TFA DCM NR 
NR- No Reaction 
N O
O
O
R2
N
O
O
HCl MeOH
-Cl+H3N OH
OR2
O
O
N
O
O
HN
OH
O
14
15 a,b
6a-e
N O
O
O
N
O
O
17
AC2O
Pyrdine
Several
Conditions
H2SO4
O
O
O
O
H
HO3S
HO3S
O
O
O
O
H
17
18
 133	  
So the oxazolone was isolated from the reaction mixture by precipitating it in 10% HCl 
and was further investigated for reaction with aldehyde. The oxazolone formed with the 
protection group attached is resistant to condensation reaction even when tried with 
various bases. The table below shows all the bases tried and the results obtained in the 
process. With increase in basicity, instead of the condensation reaction, the protection 
group was completely hydrolyzed, leaving glycine as the product. After a series of trials 
it was realized that the protection group is very labile to basic conditions and hence 
could not sustain the reaction conditions. Although the protection group solved the 
problem associated with low volatility, it was not successful in synthesizing α-β 
unsaturated amino acids. Hence alternative methods of synthesis were desirable and 
needed to be explored. 
Table. 4.2 Various bases tried in condensation of aldehydes with oxazolones.      
Entry Reagent Solvent Result 
1 NaOAc/Ac2O Various Solvents No Reaction 
2 Acetic Anhydride DCM, DMF No Reaction 
3 TFA DCM No Reaction 
4 KHCO3 Acetic Anhydride No product 
5 H2SO4 Acetic Anhydride No product 
6 LDA THF Mixed Products 
7 n-BuLi THF Hydrolysis 
8 Li(trimethylsilyl) amide Ether No Product 
9 HMDS Ether Hydrolysis 
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4.3.3. The azide approach: 
As the oxazolone approach and the tag molecule approach failed in synthesizing the α-
β unsaturated amino acids, the azide approach was used to synthesize α-β unsaturated 
amino esters. The reaction sequence is as shown in the scheme 4.7 below and is 
started from ethyl bromo acetate, a commercially available compound which is 
transformed into the corresponding azide. The azide is than condensed with the 
aldehyde and the azide is reduced to the corresponding amino group to obtain the 
desired product.  
 
Scheme 4.7 Proposed scheme of synthesis of α-β unsaturated amino esters. 
 
The first step of the reaction in which a bromide is transformed into the azide, the 
reaction was successful and the product was obtained in a 100% yield. The second step 
where the aldehyde condensation takes place, it was not successful with all the 
aldehydes especially with small chain aldehydes. For aromatic and long chain 
aldehydes it gave a moderate yield and is good for this type of condensation reactions. 
The table 3 explains the results obtained based on various aldehydes tried out. 
The final step where azide has to be reduced into an amine, the reduction reaction was 
not successful even after trying out several conditions as shown in table 4. Shin et. al 
earlier reported the reduction of these types of azides, but reproduction of the same 
procedure did not result in any reaction36. And as the azide was resistant to the various 
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other reducing agents like phosphine, boron trifloride ethereate Zn and Fe37-42, the 
method was not very useful and applicable in this case and so an alternative has to be 
looked for. 
 
Table 4.3. Various condensed aldehydes produced and their yields. 
Entry Aldehyde Product Yield(%) 
21a Acetaldehyde 
 
6 
21b Hexanal 
 
54 
21c Octanal 
 
52 
21d Benzaldehyde 
 
82 
21e TrimethoxyBenzaldehyde 
 
78 
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Table 4.4. Various reduction methods tried for reducing azides:  
Entry Substrate Reducing agent Result 
1 
 
Al-Hg Mixed Products 
2 
 
PPh3, THF:H2O(1:1) Imino Phosphorane 
3 
 
PPh3, Toluene-HCl, (5%) Imino Phosphorane 
4 
 
BF3(OEt) 2 Decomposed 
5 
 
NaBH4 No Reduction 
6 
 
Zn/NH4Cl Mixed products 
7 
 
Fe/NH4Cl No Reduction 
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4.4 Conclusion: 
α-β Unsaturated amino esters and acids are very important intermediates for 
synthesizing Magnesidin and many other biologically active compounds, their structural 
behavior and existence makes them tough to synthesize. Although many attempts have 
been made to synthesize these compounds due to their complexity, they were not 
synthesized. The oxazolone approach had problems with condensation reaction and in 
those cases where the condensation was successful; the intermediates were lost during 
the work up or evaporation of solvents. Changing the protection on N of glycine from 
acyl to ethoxy carbonyl or benzoxy carbonyl did not improve the results of the reaction. 
The tag molecule was then introduced as a protection on the N, but this however did not 
improve the results of synthesis. The oxazolone formation was achieved and was 
isolated as pure product but the condensation reaction to be done further was not 
accomplished. So the introduction of the tag molecule did not contribute to the synthesis 
of unsaturated amino acids. So the concentration was diverted from making unsaturated 
amino acids to unsaturated amino esters. The azide approach was used for this class of 
compounds and this method not successful either as the condensation reaction was a 
problem in the sequence. Only aromatic and long chain aliphatic aldehyde 
condensations were possible in low to moderate yields but the next step of reduction 
was unsuccessful even after attempting with various reducing agents. Since DHAs were 
not synthesized, DHPs the analogues of DHAs were used as part of synthesis of 
magnesidin and these compounds are discussed in the next chapter. 
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4.5 Experimental and spectral data: 
4-ethylidene-2-phenyloxazol-5(4H)-one (3a): 
A suspension of N-benzoyl glycine (1.8 g, 10 m.mol), sodium acetate (540 mg, 10 
m.mol), and acetic anhydride (10 ml) was stirred at 0°C for 30 minutes. Into the white 
suspension, acetaldehyde (0.6 g; 15 m.mol) was added. The resulting suspension was 
stirred at room temperature for 1 h and then at 60°C for 5 h. The reaction mixture 
became a brown solution that upon cooling to room temperature again became a 
suspension. This suspension was mixed with water (300 ml) and stirred at room 
temperature for a half an hour. The insoluble material was separated by filtration, 
washed with water (3 x 20 ml), and recrystallized from methanol (50 ml). Product 
obtained as yellow needles in 95% yield.  MP: 148-150°C; 1H NMR (CDCl3, 300 MHz) δ  
7.32-8.20 (5H, m), 7.16 (1H, s), 2.45 (3H, s); 13C NMR (CDCl3, 100MHz) δ  166.1,  
137.3,135.1,133.3,129.0,128.2, 125.8, 14.8 ppm. 
4-Benzylidene-2-methyl-4H-oxazol-5-one (3b): 
A suspension of N-acetylglycine (1.6 g, 10 m.mol), sodium acetate (540 mg, 10 m.mol), 
and acetic anhydride (10 ml) was stirred at room temperature for 30 minutes. Into the 
white suspension, benzaldehyde (1.1 g; 10 m.mol) was added. The resulting 
suspension was stirred at room temperature for 1 h and then at 60°C for 5 h. The 
reaction mixture became a brown solution that upon cooling to room temperature again 
became a suspension. This suspension was mixed with water (300 ml) and stirred at 
room temperature for a half an hour. The insoluble material was separated by filtration, 
washed with water (3 x 20 mL) and recrystallized from methanol (50 mL). 90% product 
was obtained as off white amorphous solid.   MP:  148-150°C.  1H NMR (400 MHz, 
 139	  
CDCl3) δ 7.32-8.20(5H, m), 7.16(1H, s), 2.45 (3H, s); 13C NMR (100 MHz, CDCl3) δ 
133.3, 132.4, 131.7, 131.3, 129.1, 55.9, 15.8 ppm. 
2-benzamidobut-2-enoic acid (5a): 
A 30% aqueous HCl solution was added a methanol solution of 4-ethylidene-2-phenyl-
4H-oxazol-5-one (1.8 g; 10 m.mol). The reaction mixture was stirred at room 
temperature for 30 minutes, followed by methanol evaporation at reduced pressure. The 
remaining clear water solution was basified with NaHCO3 solution to pH 3 and left at 
room temperature overnight. The formed crystalline product was separated by filtration, 
washed with cold water (3 x 50 mL) and dried at 110°C for 30 min to afford pure 
product. It was isolated in 91% yield, white amorphous solid.  MP: 135.5-137.5°C; 1H 
NMR (400 MHz, DMSO-d6) δ 9.54(1H, s), 8.21(2H, d, J =8.4 Hz), 7.98-7.44 (3H, m), 
6.68(1H, q, J =6.8 Hz), 1.72(3H, d, J =6.8 Hz).  13C NMR (100 MHz, DMSO-d6) δ 171.9, 
165.7, 133.9, 133.8, 133.0, 131.6, 131.5, 128.3, 127.7, 127.6, 13.6 ppm. 
2-acetamido-3-phenylacrylic acid (5b): 
A 30% aqueous HCl solution was added a methanol solution of 4-benzylidene-2-methyl-
4H-oxazol-5-one (18.7g; 0.1 mol). The reaction mixture was stirred at room temperature 
for 30 minutes, followed by methanol evaporation at reduced pressure. The remaining 
clear water solution was basified with NaHCO3 solution to pH 3 and left at room 
temperature overnight. The formed crystalline product was separated by filtration, 
washed with cold water (3 x 50 mL) and dried at 110°C for 30 min to afford pure 
product. It was obtained in 93% yield and product was obtained as white amorphous 
solid. MP: 190°C. 1H NMR (DMSO-d6, 300MHz) d 9.5 (1H, s, NH), 7.62 (2H, d, J = 7.2 
Hz), 7.41 (2H, t, J = 6.0 Hz), 7.35 (1H, t, J = 7.2 Hz). 7.24 (1H, s), and 1.91 (3H, s); 13C 
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NMR (DMSO-d6, 100 MHz) d 169.4, 166.5, 133.8, 131.2, 129.8, 129.2,128.6, 127.5, 
and 22.6 ppm. Anal. calcd. for C11H11NO3 (MW 205.21): C, 64.38; H, 5.40; N, 6.83. 
Found: C, 64.26; H, 5.49; N, 6.89. 
Ethoxycarbonylamino-acetic acid (7a) 
To a stirred solution of glycine (0.75 g, 10 m.mol) in 2 M NaOH (1.0 equiv.) at 0°C were 
added simultaneously ethyl chloroformate (1.08 g, 10 m.mol) and 2 M NaOH (1.0 
equiv.) drop wise. The mixture was stirred at 0°C for 3 h then washed with ether (3x 
20ml). The aqueous phase was acidified with 2 M HCl and extracted with ethyl acetate 
(3 × 30 ml). The combined organic phase was dried and the solvent evaporated to 
obtain the product as colorless solid in 70% yield.  M.P. 67-69°C. 1H-NMR (400 MHz, 
DMSO-d6) 7.34(1H, t, J =6 Hz), 4.05-3.97(2H, m), 3.62(2H, d, J =6.4 Hz), 1.15(3H, t, J 
=6.8 Hz); 13C-NMR (100 MHz, DMSO-d6) d 174.4, 173.7, 157.2, 43.2, 42.6, 62.4, 61.8, 
14.6 ppm. 
Ethoxycarbonylamino-acetic acid (7a) 
To a stirred solution of glycine (0.75 g, 10 m.mol) in 2 M NaOH (1.0 equiv.) at 0°C were 
added simultaneously benzyl chloroformate (1.95 g, 10 m.mol) and 2 M NaOH (1.0 
equiv.) drop wise. The mixture was stirred at 0°C for 3 h then washed with ether (3x 
20ml). The aqueous phase was acidified with 2 M HCl and extracted with ethyl acetate 
(3 × 30 ml). The combined organic phase was dried and the solvent evaporated to 
obtain the product as colorless solid in 70% yield.  M.P. 67-69°C. 1H NMR (400 MHz, 
DMSO-d6) 7.53(m, 5H), 7.34(1H, t, J =6 Hz), 4.05-3.97(2H, m), 13C NMR (100 MHz, 
DMSO-d6) d 174.4, 173.7, 157.2, 43.2, 42.6, 62.4, 61.8, 14.6 ppm. 
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2-p-tolyl-1H-benzo[de]isoquinoline-1,3(2H)-dione (9): 
A suspension of benzo[de]isochromene-1,3-dione (1.98 g, 10 mmol) and p-amino 
toluene (1.07 g, 10 m.mol) in 25 ml of pyridine was heated at 70°C for about 20 hours. 
Increasing the temperature to reflux and setting up a collector to collect the solvent 
distilled off the excess solvent, the solvent was collected until enough solvent remained 
for recrystallization.  The compound was obtained as white needles upon bringing the 
reaction mixture to room temperature in 80% yield.  MP:  311°C. 1H NMR (400 MHz, 
CDCl3) d 8.64 (2H, dd, J=1.2, 1.2 Hz), 8.26 (2H, dd, J=1.2, 1.2 Hz), 7.79 (2H, dd, 
J=7.80, 7.80 Hz), 7.36 (2H, d, J=8 Hz), 7.20 (2H, d, J=8 Hz), 2.44 (3H, s); 13C NMR 
(400 MHz, CDCl3) d 164.7, 138.8, 134.5, 132.9, 131.9, 131.8, 130.4, 128.8, 128.5, 
127.2, 123.1, 55.9, 21.6 ppm. 
2-(4-(bromomethyl)phenyl)-1H-benzo[de]isoquinoline-1,3 (2H) -dione (10): 
To a solution of 2-p-Tolyl-benzo[de]isoquinoline-1,3-dione (2.8g, 10m.mol) 9 in 75ml of 
chloroform was added N-bromo-succinimide (3.63g, 20 m.mol) and catalytic amount of 
benzoyl peroxide (15mg) at 0°C. The solution was stirred under a flashlight for the 
reaction to occur. TLC monitored the reaction for completion. After completion of the 
reaction the solvent was removed under vacuum and the residue was subjected to 
column chromatography. The compound was isolated in 65% dichloromethane and 35% 
hexane mixture. Alternatively the product can be recrystallized from dichloromethane. 
Yield of the obtained product was observed to be 85%.  MP:  Starts decomposing 
before melting at 249.1°C. 1H NMR (400 MHz, CDCl3) d 8.66 (2H, dd, J=1.2, 1.2 Hz), 
8.29 (2H, dd, J=0.8, 0.8 Hz), 7.81 (4H, t, J=7.6 Hz), 7.59 (2H, d, J= 8.4 Hz), 3.31(2H, d, 
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J = 8.4 Hz); 13C NMR (400 MHz, CDCl3) d 164.5, 138.3, 135.6, 134.6, 131.9, 130.3, 
129.3, 127.3, 122.9, 32.8 ppm.  
4-(1,3-dioxoisoindolin-2-yl) benzyl acetate (11): 
A suspension of 2-(4-Bromomethyl-phenyl)-benzo[de]isoquinoline-1,3-dione 10 (3.5 g, 
10 mmol)  and sodium acetate (1g, 12mmol)  in 10 ml of dimethyl sulfoxide was 
sonicated for 4 hours. The reaction mixture was poured on to ice and left for 1 hour. The 
product precipitated out as a white solid.  The solid was washed with a 100 mL water (x 
3) to give the crude product. The product was recrystallized from methanol to give pure 
product in 95% yield.  MP:  Does not melt till 400°C. 1H NMR(400 MHz, CDCl3) 
d 8.65(2H, d, J = 6.4 Hz), 8.27(2H, d, J =7.6 Hz), 7.79(4H, t, J=8 Hz), 7.54(2H, d, J =8 
Hz), 7.32(2H, d, 8 Hz), 5.19(2H, s), 2.16(3H, s). 13C NMR (400 MHz, CDCl3) d 163.3, 
142.6, 134.5, 131.5, 130.8, 128.8, 127.9, 127.3, 126.9, 122.7, 75.2, 62.7, 55.3, 21.6 
ppm. 
2-(4-(hydroxymethyl) phenyl)-1H-benzo[de] isoquinoline-1,3(2H)-dione (12): 
To a solution of acetic acid 4-(1,3-dioxo-1H,3H-benzo[de]isoquinolin-2-yl)-benzyl ester 
(3.5g, 10 m.mol) 11 in a 15 ml of 1:1 methanol and dichloromethane was added 
powdered NaOH (400 mg, 10 m.mol) at 0°C and the reaction mixture was stirred for 2 
hours and the methanol was evaporated.  The residue was taken into 1N sodium 
bicarbonate solution and the product was extracted into dichloromethane, which is dried 
under MgSO4.  The solvent is evaporated under vacuum to yield a yellowish solid. MP:  
282°C. 1H NMR (400 MHz, CDCl3) d 8.66 (2H, dd, J=0.8, 0.8 Hz), 8.29 (2H, dd, J=1.2, 
1.2 Hz), 7.81 (4H, dd, J=7.6 Hz), 7.57(2H, d, J=8.4 Hz), 7.33(2H, d, J=8.4 Hz), 4.81(2H, 
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d, J=6 Hz); 13C NMR (400 MHz, CDCl3) 163.3, 142.6, 134.5, 131.5, 130.8, 128.8, 127.9, 
127.3, 126.9, 122.7, 75.2, 62.7, 55.3, 48.6 ppm. 
 4-(1,3-dioxoisoindolin-2-yl) benzyl phenyl carbonate (13): 
To a solution of 2-(4-(hydroxymethyl)phenyl)-1H-benzo[de] isoquinoline-1,3 (2H)-dione 
(3.03 g, 10 m.mol) 12 in pyridine was added phenyl chloroformate (1.56 g, 10 m.mol) 
drop wise. As the addition is complete a solid appears on the solution and when the 
reaction is left to stir longer the precipitate slowly disappears back into the solution. The 
solution was then stirred for an additional 1 hr and was poured in to 100ml of 10% HCl. 
The solid obtained was then filtered to obtain the product and was directly used in the 
next step. 1H NMR (400 MHz, CDCl3); 8.66 (2H, dd, J=1.2, 1.2 Hz), 8.29 (2H, dd, J=0.8, 
0.8 Hz), 7.81 (4H, t, J=7.6 Hz), 7.59 (2H, d, J= 8.4 Hz), 7.34-7.39 (m, 5H).  13C NMR 
(400 MHz, CDCl3) d 164.5, 138.3, 135.6, 134.6, 132.1, 131.2, 131.9, 130.3, 128.6, 
129.3, 127.3, 122.9, 32.8 ppm.  
2-((4-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)benzyloxy)carbonylamino)acetic 
acid (14 ):  
To a solution of 4-(1,3-dioxo-1H-benzo[de]isoquinolin-2 (3H)-yl)benzyl-2-hydroxy ethyl 
carbamate 16 (3.9 g, 10 m.mol) in acetone was added 2ml of  sulphuric acid and 2ml of 
chromic acid. The reaction mixture was stirred at room temperature for 3 hrs and 
acetone was evaporated under vacuum and quenched with NaHCO3 to obtain the 
product as white solid in 84% yield. 1H NMR (400 MHz, CDCl3);  8.48-8.5(m, 2H), 7.89 
(t, 2H), 7.49(t, 1H), 7.37(t, 2H), 7.47 (d, 2H), 5.09 (s, 2H), 3.68 (d, 2H). 13C NMR 163.3, 
142.6, 134.5, 131.5, 130.8, 128.7, 127.9, 127.3, 126.9, 122.7, 75.2, 62.6, 55.3, 28.6 
ppm. 
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4-(1,3-dioxo-1H-benzo [de] isoquinolin-2(3H)-yl) benzyl 2-hydroxy ethyl carbamate 
(16): To a solution of 4-(1,3-dioxoisoindolin-2-yl) benzyl phenyl carbonate (3.7g, 10 
m.mol) 13 in DCM was added ethanol amine (0.6 g, 10 m.mol) drop wise. The solution 
is left to stir for about 3-4 hrs and the reaction completion was monitored by TLC. After 
the completion of reaction, DCM was evaporated under vacuum to obtain the pure 
product and was directly used in the next step. 
2-(4-((5-oxo-4,5-dihydrooxazol-2-yloxy)methyl) phenyl)-1H-benzo[de] isoquinoline-
1,3(2H)-dione (17): To a solution of 2-((4-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-
yl)benzyloxy) carbonyl amino) acetic acid (4g, 10 m.mol) 14 in 40 ml of pyridine and 
acetic anhydride (1 ml) was added to the solution. The reaction mixture was refluxed for 
3-4 hrs and was poured on to 10% HCl Solution. The white precipitate thus formed is 
the product, which was filtered and dried and used for next step directly. 1H NMR (400 
MHz, CDCl3); 8.6 (d, 2H), 8.28(d, 2H), 7.8(t, 2H), 7.42(t, 2H), 7.28(d, 2H), 5.38 (s, 2H), 
4.48 (s, 2H). 13C NMR 163.3, 142.6, 134.5, 131.5, 130.8, 128.8, 127.9, 127.3, 126.9, 
122.7, 75.2, 62.7, 55.3, 38.2 ppm. 
Ethyl 2-azidoacetate (20): 
 To a stirred solution of ethyl bromo acetate (1.65 g, 10 m.mol) 19 in 15 ml water and 
acetone mixture (1:4) was added NaN3 (0.65 g, 8.9mmol). The resulting suspension 
was stirred at room temperature for 2 hours. DCM was added to the mixture and the 
organic layer was separated. The aqueous layer was extracted with 2 x 10 ml DCM and 
the combined organic layers were dried over Na2SO4. Solvent was removed under 
reduced pressure, and the azide was directly used without purification. 1H NMR (400 
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MHz, CDCl3); δ 4.13 (q, J=6.2 Hz, 2H), 3.82 (s, 2H), 1.18 (t, J= 6.2 Hz, 3H). ) 13C NMR 
(400, CDCl3) 162.6, 46.5, 38.2, 13.4 ppm. 
Ethyl 2-azidobut-2-enoate (21a):  
To a well stirred solution containing potassium methoxide (0.7 g, 10 mmol) in dry 
methanol (20 ml), a solution of ethyl azidoacetate 20 (1.29 g, 10 mmol) and 
acetaldehyde (0.4 g, 10 mmol) in dry methanol (20 ml) was added drop wise at -10°C 
under nitrogen. The reaction mixture was stirred at this temperature for 4h and it was 
poured into aqueous 30% ammonium chloride (100ml). The aqueous layer is then 
extracted with ethyl acetate (3x20 ml), the organic layer is dried with sodium sulfate, 
and the solvent was evaporated under vacuum to give the corresponding vinyl azide 
21a, yield 93 mg (6%). 1H NMR (400 MHz, CDCl3) δ 6.29 (q, 1H), 4.22 (q, J=6.2 Hz, 
2H), 2.05(t, 3H), 1.29 (t, J=6.2 Hz, 3H). 13C NMR (400 MHz, CDCl3) δ 167.9, 141.5, 
136.5, 61.2, 14.2, 9.5 ppm. 
Ethyl 2-azidooct-2-enoate (21b):  
To a well stirred solution containing potassium methoxide (0.7 g, 10 mmol) in dry 
methanol (20 ml), a solution of ethyl azidoacetate 20 (1.29 g, 10 mmol) and 
hexanaldehyde (1 g, 10 mmol) in dry methanol (20 ml) was added drop wise at -10°C 
under nitrogen. The reaction mixture was stirred at -10°C for 4h and it was poured into 
aqueous 30% ammonium chloride (100ml). The aqueous layer is then extracted with 
ethyl acetate (3x20 ml), the organic layer is dried with sodium sulfate, and the solvent 
was evaporated under vacuum to give the corresponding vinyl azide 21b, yield 1.13g 
(52%). 1H NMR (400 MHz, CDCl3) δ 6.49 (q, 1H), 4.14 (q, J=6.2 Hz, 2H), 2.16 (q, 2H), 
1.29 (m, 2H) 1.24 (t, J=6.2 Hz, 3H), 0.9 (t, 3H). 13C NMR (400 MHz, CDCl3) δ 167.8,  
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149.4, 135, 132.9, 61.9, 31.9, 29.7, 29.6, 29.3, 24.2, 22.7, 14.8, 14.2 ppm. 
Ethyl 2-azidodec-2-enoate (21c): 
 To a well stirred solution containing potassium methoxide (0.7 g, 10 mmol) in dry 
methanol (20 ml), a solution of ethyl azidoacetate 20 (1.29 g, 10 mmol) and 
octanaldehyde (1.28 g, 10 mmol) in dry methanol (20 ml) was added drop wise at -10°C 
under nitrogen. The reaction mixture was stirred at -10°C for 4h and it was poured into 
aqueous 30% ammonium chloride (100ml). The aqueous layer is then extracted with 
ethyl acetate (3x20 ml), the organic layer is dried with sodium sulfate, and the solvent 
was evaporated under vacuum to give the corresponding vinyl azide 21c, yield 1.29g 
(54%). 1H NMR (400 MHz, CDCl3) δ 6.09 (q, 1H), 4.18 (q, J=6.2 Hz, 2H), 2.18(q, 2H), 
1.31 (m, 14H) 1.24 (t, J=6.2 Hz, 3H), 0.88(t, 3H). 13C NMR (400 MHz, CDCl3) δ 167.8,  
149.4, 135, 132.9, 61.9, 31.9, 29.7, 29.6, 29.3, 24.2, 22.7, 14.8, 14.2 ppm. 
Ethyl 2-azido-3-phenylacrylate (21d):  
To a well stirred solution containing sodium (0.23 g, 10 mmol) in dry ethanol (30 ml), a 
solution of ethyl azidoacetate 20 (1.29 g, 10 mmol) and benzaldehyde (0.53 g, 5 mmol) 
in dry ethanol (10 ml) was added drop wise at -10°C under nitrogen. The reaction 
mixture was stirred at 0°C for 4 h and it was poured into aqueous 30% ammonium 
chloride (100ml) and the formed solid was separated by filtration, washed with water (30 
ml) and dried to give vinyl azide 21d, yield 1.8 g (82%). 1H NMR (400 MHz, CDCl3); δ 
7.91 (s, 1H), 7.60 (d, 2H), 7.4(d, 2H), 7.33(t, 1H), 4.24 (q, J=6.2 Hz, 2H), 1.24 (t, J=6.2 
Hz, 3H). 13C NMR (400 MHz, CDCl3) δ 167.1, 135.2, 128.6, 128.5, 127.9, 132.9, 118.8, 
61.8, 14.8 ppm. 
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Ethyl 2-azido-3-(2,4,6-trimethoxyphenyl)acrylate (21e):  
To a well-stirred solution containing sodium (0.23 g, 10 mmol) in dry ethanol (30 ml), a 
solution of ethyl azidoacetate 20 (1.29 g, 10 mmol) and trimethoxy benzaldehyde (0.98 
g, 5 mmol) in dry ethanol (30 ml) was added drop wise at -10°C under nitrogen. The 
reaction mixture was stirred at 0°C for 4 h and it was poured into aqueous 30% 
ammonium chloride (100ml) and the formed solid was separated by filtration, washed 
with water (30 ml) and dried to give vinyl azide 21e, yield 2.39 g (78%). 1H NMR (400 
MHz, CDCl3);  δ 8.19 (s, 1H), 6.09 (s, 2H), 4.2 (q, J=6.2 Hz, 2H), 3.83 (s, 9H), 1.29 (t, 
J=6.2 Hz, 3H). 13C NMR (400 MHz, CDCl3) δ 167.4, 160.6, 159.6, 132.9, 118.8, 101.7, 
90.9, 61.4, 56.2, 55.8, 14.2 ppm. 
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Chapter V 
Synthetic approaches towards Magnesidin: 
5.1 Abstract: 
Magnesidin is a tetramic acid isolated from nature, responsible for the formation of 
dental plaque. In spite of its biological activity, the complexity of its structure makes its 
synthesis complex. The intermediates like β- keto acids synthesized in previous 
chapters and few other intermediates like 1,3-benzodioxoles, α-β unsaturated amides 
synthesized in this chapter would be used towards synthesizing magnesidin.  
5.2 Introduction: 
5.2.1 Magnesidin:  
Magnesidin, a magnesium salt of tetramic acid isolated from pseudomonas 
magnesiorubra demonstrates strong antibiotic activity against bacteria (mainly 
streptococcus and anaerobes) responsible for the formation of dental plaque. There are 
only two literature reports outlining the synthetic preparation of magnesidin, these 
reported procedures are very difficult to reproduce and apply to the large-scale 
preparation1. The viability of this strategy was investigated by Jones and coworkers2. 
Therefore, for the commercialization of magnesidin and/or its analogs a new reliable 
and large-scale applicable synthetic procedure must be developed. In many literature 
reported attempts to reproduce this procedure, intermediates were lost during 
purification. These problems explain why there is no manufacturing procedure for the 
preparation of such an important antibiotic. It is even more important that there are no 
reliable synthetic procedures for many other tetramic acid derivatives, considering that 
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they show a remarkable diversity in terms of biogenetic descent as well as structural 
variations.  The high polarity of these compounds and the fact that they can exist in 
various tautomeric forms (2,4-diketo form prevails in solution) renders them difficult to 
handle and their spectra difficult to interpret tetramic acid. In designing a successful 
synthesis of tetramic acid, it was felt that it would be wise to explore the way in which 
nature assembles the tetramic acid. The retro synthetic analysis and synthesis is 
discussed in results and discussion section.  
5.2.2 .1,3-benzoxodioles: 
In many instances, protection groups that are commonly used in synthetic organic 
chemistry are also present in nature for completely different purposes3. This is certainly 
the case with 1,3-benzodioxoles4-7. Probably the most commonly known and widely 
used natural products with 1,3-benzodioxole moieties are safrole8, myristicin,9,10 and 
piperin11. Derivatives of these natural products are used as inhibitors of mono-
oxygenase enzymes,12 pesticides or pesticide intermediates,13 herbicides,14 
antioxidants,15 antimicrobials,16 and medicines.17-19  And in the similar way 1,3-
benzodioxoles are also important intermediates in synthesizing magnesidin derivatives. 
β- keto esters an important intermediate in derivative in synthesis of magnesidin needs 
to be protected during he reaction process and protection of these compounds with 
catechol would result in 1,3-benzodioxole derivatives. And as there is such an 
importance for these compounds it should not be a surprise that there is a substantial 
demand for simple and very effective method for preparation of wide variety of the 1,3-
benzodioxole derivatives. 
 
 153	  
5.2.3 α-β  Unsaturated amides: 
α-β unsaturated amides also known as α-dehydropeptides (DHPs) are also another 
type of intermediates necessary for synthesizing magnesidin. Dehydro amino acids 
(DHAs) were actually necessary intermediates for the synthesis but since their 
synthesis was complicated and unaccomplishable; dehhydro peptides were targeted for 
synthesis. Going beyond magnesidin, DHPs are also an important class of biological 
compounds can be derived only from DHAs making them even more powerful class of 
compounds. A vast number of reports wee found on correlating the structure and 
biological activity of dehydro oligopeptides containing one or more DHA moieities20-22. 
For example, Berninamycin A, an antibiotic is a cyclodehydropeptide with two DHP 
sequences and about seven DHA residues and has been isolated from a culture of 
Streptomyces bernensis23. The syntheses of DHPs are well established and have been 
known for quite sometime. Elimination of peptides with a leaving group24-27, by direct 
coupling of DHAs with amino acids28,29, ring cleavage of unsaturated azalactones30-33, 
are few of the most common methods used to synthesize these compounds. Although 
there are many methods of synthesis available for DHPs, DHAs one of the main 
components for preparation of DHPs are not very well established in synthesis and only 
few methods are reported for these compounds34,35. 
5.3 Results and discussion: 
5.3.1 Retro synthesis based on biosynthesis of magnesidin: 
In synthesizing magnesidin, the structure of synthetic equivalent of magnesidin has 
been studied and it can be classified into the following important synthetic fragments. 
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The retro analysis of magnesidin is shown in scheme 5.1.  The retro synthetic pathway 
involves synthesizing magnesidin from fragments like β-keto acids and α-β unsaturated 
amino acids, both these further prepared from smaller molecules as starting materials. 
Of these fragments β-keto acids have been synthesized successfully and their synthesis 
has been described in chapter III.  But synthesis of α-β unsaturated amino acids was 
not very successful and hence this failure has to be addressed in designing the total 
synthesis of magnesidin. The synthesis has been addressed with various approaches 
and each of these approaches is described in detail in the following section as the 
oxazolone approach, the tag molecule approach and the azide approach.  
 
Scheme 5.1 Retro synthetic analysis of Magnesidin. 
5.3.2 The oxazolone approach:  
 This was one of the first approaches towards the synthesis of magnesidin wherein a 
methodology has been developed to synthesize various oxazolones, which were initially 
proposed to be used for the synthesis of α-β unsaturated amino acids. As the 
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oxazolones were unsuccessful to be used as starting materials for α-β unsaturated 
amino acids, they were directly applied in the synthesis of magnesidin as shown in 
scheme 5.2.  Few oxazolones were picked, all starting from N-protected aryl glycines 
and aromatic aldehydes and are coupled with aryl β-keto esters i.e. all R1, R2 and R3 
are aromatic. The aryl-substituted oxazolone is treated with aryl β-keto esters in 
presence of TFA and sodium sulphate to produce tetramic acids. Aromatic analogues 
are chosen because aromatic compounds would be easier to follow on NMR. 
 
Scheme 5.2 Direct oxazolone condensation with β-keto esters. 
 
A particular oxazolone was used which was synthesized using N-benzoyl glycine and 
trimethoxy benzaldehyde in presence of sodium acetate and acetic anhydride. This 
oxazolone 1 was reacted with benzoyl ethyl acetate 2 to obtain the tetramic acid 3. The 
tetramic acid differs form magnesidin with its substituents in the ring. The 1H NMR in 
the figure 5.1 also clearly shows the formation of the tetramic acid obtained in this 
reaction. 
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Fig. 5.1 1H-NMR of tetramic acid prepared from oxazolone and β-keto esters. 
 
 Based on the preliminary results it was hypothesized that the synthesis of magnesidin 
would be possible when appropriate oxazolones are made and treated with β-keto 
esters.  However the oxazolone required to synthesize magnesidin would need an 
oxazolone with a low molecular weight and synthesizing and isolating low molecular 
weight oxazolones was a synthetic challenge as reported in earlier chapter. So the tag 
molecule used in previous cases is considered to be used even in these syntheses. 
5.3.3. The TAG molecule approach: 
The tag molecule can PG 3 was used in analyzing the retro synthetic pathway for 
magnesidin, the tag molecule can be prepared in few steps starting from 1,8- naphthalic 
anhydride and p-toluidene. The tag molecule would react with phenyl chloroformate to 
produce the corresponding carbamate, which further can be reacted with glycine. The 
obtained product is transformed into the corresponding oxazolone, which would further 
be condensed with acetaldehyde. Opening the oxazolone ring with the active carbon of 
β - keto acids followed by a ring closure yields the tetramic acid, protected on N-1 by the 
tag molecule. Hydrolysis cleaves the protection group and an acylation reaction that 
follows would produce the desired tetramic acid Magnesidin and the retro synthetic 
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analysis to produce magnesidin with the use of tag molecule would be as shown in 
scheme 5.3. 
 
Scheme 5.3 Retro synthetic analysis of Magnesidin using the tag molecule PG 3. 
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After identifying the retro synthetic analogues a design for the synthesis is necessary 
and using the retro analysis the synthesis of magnesidin is proposed as shown in 
scheme 5.4.  
 
Scheme 5.4 Attempt for synthesis of magnesidin using the tag molecule. 
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However, the total synthesis was not accomplished and could not produce magnesidin. 
The method could not be generalized and it was not possible to produce tetramic acids 
other than 3 in fig 5.1. From the step, which produces 11 in the above reaction scheme 
5.4, the reactions did not work out well. The product was obtained in very few cases, 
especially when trimethoxy benzaldehyde has been replaced with acetaldehyde and 
other aliphatic aldehydes. Even in case of aromatic aldehydes it was not possible to 
synthesize with simple unsubstituted aldehydes like benzaldehyde. So the oxazolone 
approach favored the formation of few selected tetramic acids where the aromatic 
aldehydes were condensed. However it was not successful in producing the desired 
tetramic acid magnesidin, which requires condensation with acetaldehyde.  
 
5.3.4. The azide approach: 
The azide approach is another approach that was attempted to be used in synthesizing 
α-β unsaturated amino acids and was unsuccessful in synthesizing these compounds. 
The idea behind synthesizing α-β unsaturated amino acids is to couple the N-terminal 
with the β-keto acids to obtain the corresponding α-β unsaturated peptides. There are 
few methods of synthesis available for these compounds but the methods of synthesis 
are not very effective in terms of yield and feasibility with synthesis. So a method of 
synthesis is on demand for these compounds. 
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Scheme 5.5 Proposed synthesis of α-β unsaturated amino acids 
 
While synthesizing α-β unsaturated amino acids, the scheme involved synthesis of 
azides of α-β unsaturated esters 16 condensed with aldehydes to produce compounds 
like 17, which further had to be reduced to α-β unsaturated amino acids 18 as shown in 
scheme 5.5. Various reducing agents are tried for reduction and triphenyl phosphine is 
one of them. Triphenyl phosphine in presence of THF and water reduces azide to amine 
in general cases but the azides 17 a-m that have been tried did not undergo reduction 
but formed the corresponding iminophosphoranes 19 a-m in 50% yield. Changing the 
solvent system from THF-Water to DCM has increased the yield of iminophosphoranes 
from 50% to 94%. Since the iminophosphoranes did not undergo any further reduction, 
they were explored at this stage to react directly with the corresponding acids or acid 
chloride to obtain the corresponding dehydro amides as shown in scheme 5.6. The 
reaction between the salt of an acid and the iminophosphorane was not successful as 
anticipated so the salt of an acid was replaced with acid chloride to obtain the desired 
products 20a-e. 
 
Scheme 5.6 Proposed synthesis of α-β unsaturated amides. 
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5.3.5 Synthesis of α-β  unsaturated amides: 
 The affinity between oxygen and phosphorous has been known for quite some time a 
lot of chemistry has been developed based on their affinity36-43. Wittig reaction is one of 
the famous and most used reaction amongst these. Based on the mechanism of Wittig 
reaction, a mechanism has been proposed as shown in scheme 5.7. Although the 
mechanism has been proposed and several type of acid salts have been used for 
synthesis, the reaction did not proceed under these conditions. To further extend the 
studies on these reactions the salt of the acid has been replaced by an acid chloride. 
When the iminophsophorane reacted with the acid chloride the acid chloride and the 
iminophsophorane were both consumed but there wasn’t any trace of the product on 1H 
NMR when the crude was analyzed. But later when the reaction mixture was worked up 
using, NaHCO3 or NaOH solution there was some product observed however the yield 
were a little low. To solve this problem various other reagents were tried to substitute 
the use of base and silica was found to be very useful. After the reaction is complete 
stirring the reaction mixture 
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Scheme 5.7 Proposed mechanism of reaction between salt of an acid and 
iminophosphoranes. 
 
in silica gave a better yield of the product than it did in NaHCO3. Although the product 
was confirmed on 1H NMR and 13C NMR, since the product was not formed obviously, 
the product 20b obtained from the reaction between benzoyl chloride and the 
corresponding iminophsophorane (scheme 5.8) was analyzed using crystallography as 
shown in figure 5.2. The x-ray crystallographic structure obtained confirms the product 
and also shows that the double bond exists in z- configuration or the trans configuration 
as desired because the structure elucidation of magnesidin1 shows that the methyl (in 
this case phenyl) group exists trans to the carbonyl on the ring (in this case, the 
carbonyl of ethyl ester.  
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Figure 5.2 X-ray Crystallographic structure of the product. 
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Scheme 5.8 Synthesis of the product 20b. 
 
While investigating the mechanism of the reaction between acid chloride and the 
iminophosphorane, various phosphorane reactions like Wittig and Wittig related 
reactions which are very close to the current reaction are studied and the mechanism 
can be proposed to happen in two ways; the N attack as shown in scheme 5.8 and the 
O attack as shown in scheme 5.9.  In both these mechanisms the release of phosphine 
oxide has been predicted and was also observed to form during the reactions. The need 
a base or a nucleophile in order to yield the product was a necessary condition, 
otherwise the product would not be observed either on TLC or NMR. In scheme 5.9 
where the N- attack was proposed, after the nitrogen ylide is formed nucleophilic N 
attacks the carbonyl of the acid and the chlorine group leaves forming the counter anion 
for the adduct thus formed. The adduct then forms a 4-membered ring like in any other 
Wittig reaction and elimination of phosphine oxide produces the desired candidate. 
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Scheme 5.9 Mechanism proposed to occur by N-attack. 
 
In scheme 5.10 where the attack was proposed to be an O- attack, the oxygen in the 
carbonyl of the acid is the active species and the phosphorous in phosphine is prone to 
attack by the oxygen, followed by 4-membered ring formation and release of phosphine 
oxide to yield the product.  
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Scheme 5.10 Mechanism proposed to occur by O-attack. 
As this method of preparation of α-β unsaturated amides from the azides is not well 
explored, and also because the analogues of these compounds are essential 
intermediates for not only synthesizing the derivatives of tetramic acids but also many 
other natural products, the method has been applied to prepare a various other α-β 
unsaturated amides with different substituents. Three aldehydes benzaldehyde, 
trimethoxy benzaldehyde, hexanal and octanal are used for condensation and acetyl 
chloride, benzoyl, hexanoyl and octanoyl chlorides have been tried as other acid 
sources. The results were not very impressive with acetaldehyde. Derivatives prepared 
are shown in the figure 5.3.  
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Figure 5.3: Various α-β unsaturated amides synthesized: 
Since the method was successful in synthesizing the α-β unsaturated amides the 
synthesis is applied in the synthesis of magnesidin. With the application of the above-
developed methodology, the retro synthetic analysis for Magnesidin has been proposed 
as shown in scheme 5.11. 
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Scheme 5.11 Retro synthetic analysis of magnesidin using α-β unsaturated amides 
 
In the proposed retro synthetic analysis, one of the step involves protection of β-keto 
ester and after a couple of protections are analyzed it was concluded that protection 
with catechol would be the best one, considering the fact that the protection group must 
survive the following reaction conditions in the scheme. There are few methods of 
synthesis reported, which involve protection of these compounds and keto group 
protected with catechol produce compounds called benzodioxoles.  
5.3.6 Synthesis of 1,3 benzodioxoles: 
There are several synthetic approaches for preparation of these important compounds. 
One of the most common approaches is through condensation of carbonyl compounds 
with catechol in the presence of an acid catalyst.44 The applicability of this synthetic 
approach strongly depends on the efficiency of the acidic catalyst.45 In particular 1,3- 
benzodioxoles have been prepared from corresponding carbonyl compounds and 
catechol with catalysts such as p-toluenesulfunic acid,46 copper p-toluenesulfonate,47 
pyridinium p-toluene sulfonate,48 and KSF or K-1049 to name a few.  There are also 
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methods that utilize aggressive Lewis acid catalysts, such as phosphorus pentoxide50 or 
phosphorus trichloride.51 clearly there is a demand for simple and highly efficient 
synthetic procedures for the preparation of these valuable compounds. 
Recently, we designed a microwave organic synthetic reactor52 that allows the synthetic 
organic chemist to carry out organic reactions together with magnetic stirring, stable 
microwave power control, temperature control, and solvent refluxing.53 This reactor 
design adds an advantage in performing a number of very efficient reactions over 
conventional synthetic methods.54-56 Microwave assisted reactions are particularly 
effective when small polar molecules are part of the reaction transformation.57-59  One 
can also speculate that microwave heating should be especially effective for chemical 
transformations in which water is one of the reaction products.  In conventional 
approaches, to drive the reaction to completion, the addition of water-consuming and 
aggressive reagents, such as phosphorus pentoxide and phosphorus trichloride, are 
used.  We believe that the combination of simple and safe catalysts, such as acidic 
polymers (dowex), acidic clay (K10), and p-toluenesulphonic acid, in microwave will be 
a prevailing alternative approach for 1,3-benzodioxole derivatives. 
 
Figure 5. 4.  Structures of 1,3- benzodioxoles used for optimizing reaction conditions 
 
To test the validity of this assumption, we subsequently selected four different carbonyl 
compounds (both aliphatic and aromatic ketones and aldehydes) that have the 
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capability of producing four different derivatives of 1,3-benzodioxoles presented in figure 
5.2. Three acid catalysts (amberlite, clay K-10, and p-toluenesulfonic acid) and three 
solvents (benzene, toluene, and xylene) were selected for a comparison of the 
differences in conventional and microwave-assisted preparation of the 1,3- 
benzodioxoles. Overall, 72 reactions were performed and the isolated yields of the 
corresponding 1,3-benzodioxoles are presented in Table 5.1. Microwave magnetron 
power was adjusted to generate vigorous solvent refluxing (400W for benzene, 500W 
for toluene, and 560W for xylene). There are substantial differences regarding the 
nature of substrate, solvent, acid catalyst, and above all conventional vs. microwave 
assisted reactions. There is a clear improvement in using microwave over conventional 
heating in all of the substrates. The reaction time for microwave-assisted reactions is up 
to twenty times shorter than for comparable reactions under conventional heating. 
When the reaction time was shortened, thermal decomposition was also minimized, 
resulting in higher isolated yields and more simplified product purification. The choice of 
the acid catalyst was also important.  p-Toluenesulfonic acid (PTSA) continuously gave 
the best results in comparison to amberlite and clay K-10 (Table 5.1). In many 
instances, the solvent of choice was benzene, although xylene as a solvent somewhat 
shortened reaction times, the amount of thermal decomposition byproducts increased. 
Isolated yields were good to excellent for the aromatic and aliphatic ketones as well as 
aromatic aldehydes.  Isolated yields seem to be slightly lower for aliphatic aldehydes.  
Under both conventional and microwave heating, a considerable amount (10-30%) of 
the aldol condensation product was formed. However, separation of the aldol byproduct 
from the corresponding 1,3-benzodioxole was simple and involved filtration through a 
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short column of silica gel.  Nevertheless, the microwave-assisted preparation of 1,3-
benzodioxole from aliphatic aldehydes can be optimized to about 80-85% conversion 
with more than 75% isolated yield. 
Now that the advantage of the microwave versus conventional heating was 
demonstrated (Table 5.1), we would also like to show the NMR reaction following the 
preparation of (1f) from benzaldehyde and catechol in benzene with PTSA as an acid 
catalyst (Figure 5.5).60  This reaction is a perfect demonstration of the efficiency and 
selectivity of the microwave assisted preparation of 1,3-benzodioxoles.  There is no 
formation of byproducts and according to 1H-NMR, the conversion is almost 
quantitative. The isolated yield reflects loss during isolation and purification.  If xylene is 
used instead of benzene as reaction media, the reaction time has shortened to 90 
minutes (benzaldenhyde is consumed) and a small amount of decomposition byproduct 
is formed, reflecting slightly lower isolated yield (Table 5.1). 
The efficiency of the microwave-assisted preparation of 1,3-benzodioxole from both 
aliphatic and aromatic aldehydes was demonstrated in Table 5.2.  All reactions were 
performed in benzene as a reaction media, p-tolunebenzoic acid (PTSA) as the acid 
catalyst, and the microwave heating with magnetron power of 400W. For aromatic 
aldehydes, the reactions are very clean but for aliphatic aldehydes the reaction should 
be carefully monitored because the aldol byproducts are formed. 
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Table 5.1.Comparison of microwave and conventional carbonyl protection with catechol. 
 Conventional Microwave  
Product 
 
 
Solvent 
 
Catalyst Time 
(min.) 
Yield 
(%) 
Time 
(min.) 
Yield 
(%) 
A 300 71 120 78 
B 1440 68 120 96 
 
S1 
C 162 93 105 84 
A 270 77 105 72 
B 14401 87 105 89 
 
S2 
C 160 85 90 78 
A 220 58 90 66 
B 1200 72 90 74 
 
 
28-IIg 
 
 
S3 
C 150 74 90 62 
A 3600 68 240 63 
B 7440 58 240 59 
 
S1 
C 2400 69 210 66 
A 3240 72 120 71 
B 7440 71 120 91 
 
S2 
C 1440 73 120 82 
A 3000 63 90 73 
B 7200 76 90 79 
 
 
 
28-IIj 
 
S3 
C 1200 69 90 84 
A 1080 48 120 62 
B 4200 58 120 87 
 
S1 
C 900 58 120 69 
A 900 54 120 62 
B 2880 80 120 84 
 
S2 
C 510 65 120 74 
A 720 53 90 59 
B 2400 68 90 72 
 
 
 
28-IIf 
 
S3 
C 450 61 90 71 
A 900 34 90 28 
B 1200 42 90 53 
 
S1 
C 900 29 90 39 
A 780 31 90 33 
B 1080 60 90 72 
 
S2 
C 840 26 90 41 
A 690 22 75 25 
B 900 38 75 49 
 
 
 
28-IIc 
 
 
S3 
C 600 18 75 33 
S1 = Benzene, S2 = toluene, S3 = Xylene, A = Dowex, B = PTSA, C = Clay K-10, a-
conventional, b-microwave. 
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Figure 5.5.  The 1H NMR microwave assisted reaction following for preparation of 28-If 
 
Considering these problems, benzene is better solvent choice when using aliphatic 
aldehydes because benzene as a solvent presents lower amounts of the aldol product 
formation when compared to xylene. For aliphatic aldehydes, the optimal reaction time 
seems to be between 90-120 minutes.  The formation of the aldol product with aliphatic 
aldehydes appears to not be a problem for 1,3-benzodioxole purification (filtration 
through short silica gel column) resulting that their isolated yields of in general ~10% 
lower than for aromatic aldehydes (Table 5.2).  However, aliphatic 1,3- benzodioxoles 
can be prepared with this method in 70-80% making it a method of choice for the 
preparation of these valuable compounds. 
 174	  
 
Table 5.2. Microwave assisted preparation of 1,3-benzodioxole from 
aldehydes 
 
Time 
(Minutes) 
Yield 
(%) 
28-I a: R = n-C3H7 120 79 
28-I b: R = n-C4H9 120 73 
28-I c: R = n-C7H15 90 72 
28-I d: R = n-C9H19 90 72 
28-I e: R = n-C11H23 90 70 
28-I f: R = C6H5 120 87 
28-I g: 2-CH3OC6H4 90 91 
28-I h: 3-CH3OC6H5 90 89 
28-I i: 3-NO2C6H4 150 79 
 
Ketones are ideal starting materials for the preparation of 1,3- benzodioxoles.  They are 
more reactive and therefore the required microwave heating is shorter than in 
comparison with aldehydes.  Contrary to the problem with aldol condensation products 
forming as a byproduct in reaction with aliphatic aldehydes, with aromatic aldehydes the 
condensation is not present at all or the formed amount is negligible (1-2% at the most).   
The reaction with both aliphatic and aromatic ketones with one aliphatic group is 
practically quantitative.  The lower isolated yields result from the loss of product during 
isolation and the acid catalyst removal (Table 5.3). However, we were not able to 
prepare 2,2-diphenyl-1,3-benzodioxole from benzophenone and catechol.  This was the 
case with several other diaromatic ketones. Aromatic substituents such as nitro, 
methoxy, hydroxyl, dimethylamino, and amino do not interfere with the reaction; 
O
O
R 28-I
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however, they can either facilitate (electron donating group) or retard (electron 
withdrawinggroup) the reaction.  This reaction is very simple and is applicable to large-
scale preparation of 1,3- benzodioxoles.  Hundred gram quantities of these compounds 
can be prepared in research laboratories in a matter of hours.  For instance, 104 g of 2-
methyl-2-phenyl-1,3-benzodioxole was prepared from acetophenone and catechol in 
less than three hours. 
Table 5.3.  Microwave assisted preparation of 1,3-benzodioxole from ketones 
 
 
Time 
(Minutes) 
Yield 
(%) 
28-II a: R1 = R2 = CH3 120 82 
28-II b: R1 = CH3; R2 = C(CH3)3 60 98 
28-II c: R1 = CH3, R2 = CH2CH3 120 96 
28-II d: R1 = R2 = CH2CH3 90 93 
28-II e: R1 = CH3; R2 = n-C6H13 60 92 
28 II f: R1-R2 = -(CH2)4- 60 91 
28 II g: R1-R2 = -(CH2)5- 120 96 
28-II h: R1 = CH3; R2 = CH2COCH3 75 86 
28-II i: R1 = CH3; R2 = CH2CH2COCH3 75 89 
28-II j: R1 = CH3; R2 = C6H5 120 96 
28-II k: R1 = CH3; R2 = 4-ClC6H4 120 87 
28-II l: R1 = CH3; R2 = 3,5-(CH3)2C6H4 120 97 
28-II m: R1 = CH3; R2 = CH2CO2C2H5 120 89 
 
O
O
28-IIR2
R1
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5.3.7 Attempts towards total synthesis of magnesidin: 
Once a stable and efficient method has been developed for preparation of 
benzodioxoles, it was incorporated back into the synthesis of magnesidin and the total 
synthesis of Magnesidin goes as shown in scheme 5.12. In the scheme 5.12 where 
acetaldehyde has to be condensed with the corresponding azide 16, to produce 17a the 
yield is very low and isolation of that compound would not be possible. This is 
accounted towards the low volatility of this compound and also to the fact that 
acetaldehyde readily undergoes polymerization, there by making the reaction 
complicated. Even to obtain a 3% product in this reaction various bases were tried for 
condensation. Usually in a typical condensation like this, NaOEt or NaOMe are ideal 
bases to be used but they both did not yield good results with acetaldehyde. After trying 
several bases it was observed a small amount of product formation was possible with 
KOMe, MeOH conditions. Since reaction has too many complications along with the 
negligible amount of product formed, the possibility of the entire scheme, acetaldehyde 
has been replaced with benzaldehyde and the same reactions applied to prepare the 
corresponding phenyl derivative of tetramic acid and the synthesis of this compound 
can be performed in several steps as shown in scheme 5.13. In this sequence however 
the reactions proceeded a little farther than in scheme 5.12. With benzaldehyde it was 
possible to do the condensation reaction in NaOEt, EtOH and the product 17b was 
isolated in 78% yield, which was further reacted with catechol protected acid 28-In 
chloride to give the corresponding amide 30b. 1H and 13C NMR spectra confirmed the 
product formation and hence was taken forth in the reaction scheme. 
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Scheme 5.12 Partially accomplished total synthesis of magnesidin. 
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Scheme 5.13 Partially accomplished total synthesis of phenyl derivative of Magnesidin. 
 
However, the deprotection of catechol in acidic conditions to produce 31b were 
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abstraction to obtain 32b was performed prior to the deprotection of catechol to check 
the possibility of the reaction and even after trying one of the mildest and strongest 
bases, the reaction did not proceed. The highest concentration of HCl used for 
deprotection of catechol was 12M solution. Any concentration beyond this would lead to 
a complicated spectrum of the mixture, indicating a decomposition of the tetramic acid. 
Same was the case when tried to abstract the base, when a slightly stronger base is 
tried it would decompose. And this can be explained from the fact that the tetramic acid 
is pH sensitive. It is stable only at a certain pH in the actual form and attaining that pH 
would be difficult to attain artificially.  
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5.4. Conclusion: 
To summarize, the synthesis of Magnesidin was not achieved in the course of research 
but good progress has been made towards its synthesis. Various intermediates were 
synthesized using the tag molecule approach. The tag molecule itself was not well 
explored in terms of reaction yield and conditions. Using the microwave provided a 
stable, efficient, less time consuming, very selective and environmentally safe 
procedure for mono and di bromination of toluidenes. The microwave conditions that 
assisted in preparation of 1,3-benzodioxole derivatives from aldehydes and ketones is 
superior to currently existing preparation methods. The isolated yields are generally 
higher and the required reaction time is significantly (up to 20 times) shorter in 
comparison with conventional heating. Aromatic aldehydes, aromatic-aliphatic ketones, 
and aliphatic ketones are excellent starting materials; however reaction with aliphatic 
aldehydes must be carefully monitored to maximize the isolated yield of the product due 
to formation aldol byproduct.  Even in this case isolated yield of corresponding 1,3- 
benzodioxole is higher than 70%. Due to its simplicity the method is applicable to large-
scale preparation of benzodioxoles. The microwave prepared tag molecule was used in 
synthesizing another essential class of compounds called β-keto acids. All β-keto acids 
were produced in good to excellent yields. The tag molecule was not successful in 
synthesizing the α-β unsaturated amino acids, but the oxazolones that were intended to 
be used for their synthesis were made using the tag molecules. These oxazolones were 
not otherwise produced due to their very weak structures and their readiness to undergo 
side reactions. The change in the approach and the idea to use azide has made it 
possible to synthesize the α-β unsaturated amides which are precursors of α-β 
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unsaturated amino acids. In this case, all of the aldehydes were condensed with the 
corresponding esters of the azide except for acetaldehyde. It underwent polymerization 
which prevented it from reacting in the desired or expected ways. After all the 
intermediates were synthesized and incorporated to form magnesidin, the synthesis 
was still not successful. This can be attributed to the complex structure and improper 
chemical behavior of the compound. In the azide approach, the synthesis was almost 
accomplished when the aldehyde used was a benzaldehyde. The product formation 
was observed in this case but isolation was a problem. The product decomposed during 
the deprotection of catechol or proton abstraction. Since the desired product was 
observed, future synthetic attempts should focus on the isolation of the product as a 
metal salt instead of attempting conventional purification such as column 
chromatography. As the synthesis has almost been accomplished through this thesis, 
all that remains to be found is a stable and simple isolation method for magnesidin 
production. 
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5.5. Experimental and spectral data: 
2-p-tolyl-1H-benzo[de]isoquinoline-1,3(2H)-dione (3): 
A suspension of benzo[de]isochromene-1,3-dione (1.98 g, 10 mmol) and p-amino 
toluene (1.07 g, 10 m.mol) in 25 ml of pyridine was heated at 70°C for about 20 hours. 
Increasing the temperature to reflux and setting up a collector to collect the solvent 
distilled off the excess solvent, the solvent was collected until enough solvent remained 
for recrystallization.  The compound was obtained as white needles upon bringing the 
reaction mixture to room temperature in 80% yield. MP:  311°C. 1H NMR (400 MHz, 
CDCl3) d 8.64 (2H, dd, J=1.2, 1.2 Hz), 8.26 (2H, dd, J=1.2, 1.2 Hz), 7.79 (2H, dd, 
J=7.80, 7.80 Hz), 7.36 (2H, d, J=8 Hz), 7.20 (2H, d, J=8 Hz), 2.44 (3H, s); 13C NMR 
(100 MHz, CDCl3) d 164.72, 138.85, 134.47, 132.94, 131.96, 131.83, 130.39, 128.76, 
128.49, 127.24, 123.09, 55.91, 21.57. 
2-(4-(bromomethyl)phenyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (4): To a 
solution of 2-p-Tolyl-benzo[de]isoquinoline-1,3-dione (2.8g, 10m.mol) 9 in 75ml of 
chloroform was added N-bromo-succinimide (3.63g, 20 m.mol) and catalytic amount of 
benzoyl peroxide (15mg) at 0°C. The solution was stirred under a flashlight for the 
reaction to occur. TLC monitored the reaction for completion. After completion of the 
reaction the solvent was removed under vacuum and the residue was subjected to 
column chromatography. The compound was isolated in 65% dichloromethane and 35% 
hexane mixture. Alternatively the product can be recrystallized from dichloromethane. 
Yield of the obtained product was observed to be 85%.  MP: Starts decomposing before 
melting at 249.1°C. 1H NMR (400 MHz, CDCl3) d 8.66 (2H, dd, J=1.2, 1.2 Hz), 8.29 (2H, 
dd, J=0.8, 0.8 Hz), 7.81 (4H, t, J=7.6 Hz), 7.59 (2H, d, J= 8.4 Hz), 3.31(2H, d, J = 8.4 
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Hz); 13C NMR (100 MHz, CDCl3) d 164.5, 138.3, 135.6, 134.6, 131.9, 130.3, 129.3, 
127.3, 122.9, 32.8 ppm.  
4-(1,3-dioxoisoindolin-2-yl) benzyl acetate (5): 
A suspension of 2-(4-Bromomethyl-phenyl)-benzo[de]isoquinoline-1,3-dione 10 (3.5 g, 
10 mmol)  and sodium acetate (1g, 12mmol)  in 10 ml of dimethyl sulfoxide was 
sonicated for 4 hours. The reaction mixture was poured on to ice and left for 1 hour. The 
product precipitated out as a white solid.  The solid was washed with a 100 ml water (x 
3) to give the crude product. The product was recrystallized from methanol to give pure 
product in 95% yield.  MP:  Does not melt till 400°C. 1H-NMR(400 MHz, CDCl3) 
d 8.65(2H, d, J = 6.4 Hz), 8.27(2H, d, J =7.6 Hz), 7.79(4H, t, J=8 Hz), 7.54(2H, d, J =8 
Hz), 7.32(2H, d, 8 Hz), 5.19(2H, s), 2.16(3H, s).  
2-(4-(hydroxymethyl)phenyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione(6):             
To a solution of acetic acid 4-(1,3-dioxo-1H,3H-benzo[de]isoquinolin-2-yl)-benzyl ester 
(3.5g, 10 m.mol) 11 in a 15 ml of 1:1 methanol and dichloromethane was added 
powdered NaOH (400 mg, 10 m.mol) at 0°C and the reaction mixture was stirred for 2 
hours and the methanol was evaporated.  The residue was taken into 1N sodium 
bicarbonate solution and the product was extracted into dichloromethane, which is dried 
under MgSO4.  The solvent is evaporated under vacuum to yield a yellowish solid. MP:  
282°C. 1H NMR (400 MHz, CDCl3) d 8.66 (2H, dd, J=0.8, 0.8 Hz), 8.29 (2H, dd, J=1.2, 
1.2 Hz), 7.81 (4H, dd, J=7.6, 7.6 Hz), 7.57(2H, d, J=8.4 Hz), 7.33(2H, d, J=8.4 Hz), 
4.81(2H, d, J=6 Hz); 13C NMR (100 MHz, CDCl3) d 163.3, 142.6, 134.5, 131.5, 130.8, 
128.8, 127.9, 127.3, 126.9, 122.7, 75.2, 62.7, 55.3, 48.6 ppm. 
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4-(1,3-dioxoisoindolin-2-yl)benzylphenyl carbonate (7): 
To a solution of 2-(4-(hydroxymethyl)phenyl)-1H-benzo[de] isoquinoline-1,3 (2H)-dione 
(3.03 g, 10 m.mol) 12 in pyridine was added phenyl chloroformate (1.56 g, 10 m.mol) 
drop wise. As the addition is complete a solid appears on the solution and when the 
reaction is left to stir longer the precipitate slowly disappears back into the solution. The 
solution was then stirred for an additional 1 hr and was poured in to 100ml of 10% HCl. 
The solid obtained was then filtered to obtain the product and was directly used in the 
next step. 1H NMR (400 MHz, CDCl3); δ 8.66 (2H, dd, J=1.2, 1.2 Hz), 8.29 (2H, dd, 
J=0.8, 0.8 Hz), 7.81 (4H, t, J=7.6 Hz), 7.59 (2H, d, J= 8.4 Hz), 7.34-7.39 (m, 5H). 13C 
NMR (400 MHz, CDCl3) δ 164.5, 138.3, 135.6, 134.6, 132.1, 131.1, 131.9, 130.3, 128.6, 
129.3, 127.3, 122.9, 32.8 ppm.  
4-(1,3-dioxo-1H-benzo[de] isoquinolin-2 (3H)-yl) benzyl 2-hydroxy ethyl carbamate 
(8): To a solution of 4-(1,3-dioxoisoindolin-2-yl) benzyl phenyl carbonate (3.7g, 10 
m.mol) 13 in DCM was added ethanolamine (0.6 g, 10 m.mol) drop wise. The solution is 
left to stir for about 3-4 hrs and the reaction completion was monitored by TLC. After the 
completion of reaction, DCM was evaporated under vacuum to obtain the pure product 
and was directly used in the next step. 
2-((4-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)yl)benzyloxy)carbonylamino) acetic 
acid (9): To a solution of 4-(1,3-dioxo-1H-benzo[de]isoquinolin-2 (3H)-yl)benzyl-2-
hydroxy ethyl carbamate 16(3.9 g, 10 m.mol) in acetone was added 2ml of  sulphuric 
acid and 2ml of chromic acid. The reaction mixture was stirred at room temperature for 
3 hrs and acetone was evaporated under vacuum and quenched with NaHCO3 to obtain 
the product as white solid in 84% yield. 1H NMR (400 MHz, CDCl3); 8.48-8.5(m, 2H), 
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7.89 (t, 2H), 7.49(t, 1H), 7.37(t, 2H), 7.47 (d, 2H), 5.09 (s, 2H), 3.68 (d, 2H). 13C NMR 
163.3, 142.6, 134.5, 131.5, 130.8, 128.8, 127.9, 127.3, 126.9, 122.7, 75.2, 62.7, 55.3, 
28.6 ppm. 
2-(4-((5-oxo-4,5-dihydrooxazol-2-yloxy)methyl) phenyl)-1H-benzo[de] isoquinoline-
1,3(2H)-dione (10): 
2-((4-(1,3-dioxo-1H-benzo[de]isoquinolin-2-3Hyl)benzyloxy)carbonylamino) acetic acid 
(4g, 10 m.mol) 14 was dissolved in 40 ml of pyridine and acetic anhydride (1 ml) was 
added to the solution. The reaction mixture was refluxed for 3-4 hrs and was poured on 
to 10% HCl Solution. The white precipitate thus formed is the product, which was 
filtered and dried and used for next step directly. 1H NMR (400 MHz, CDCl3); 8.6 (d, 
2H), 8.28(d, 2H), 7.8(t, 2H), 7.42(t, 2H), 7.28(d, 2H), 5.38 (s, 2H), 4.48 (s, 2H). 13C 
NMR 163.25, 142.63, 134.49, 131.52, 130.81, 128.76, 127.90, 127.31, 126.90, 122.68, 
75.15, 62.65, 55.25, 38.24. 
Ethyl 2-azidoacetate (16): 
 To a stirred solution of ethyl bromo acetate (1.65 g, 10 m.mol) 19 in 15 ml water and 
acetone mixture (1:4) was added NaN3 (0.65 g, 8.9mmol). The resulting suspension 
was stirred at room temperature for 2 hours. DCM was added to the mixture and the 
organic layer was separated. The aqueous layer was extracted with 2 x 10 ml aliquots 
of DCM and the combined organic layers were dried over Na2SO4. Solvent was 
removed under reduced pressure, and the azide was good for use without further 
purification. 1H NMR (400, CDCl3) δ 4.13 (q, J=6.2 Hz, 2H), 3.82 (s, 2H), 1.18 (t, J= 6.2 
Hz, 3H). ) 13C NMR (400, CDCl3) δ 162.5, 46.5, 38.2, 13.4 ppm. 
(Z)-Ethyl 2-azidobut-2-enoate (17a):  
 186	  
To a well stirred solution containing potassium methoxide (0.7 g, 10 mmol) in dry 
methanol (20 ml), a solution of ethyl azidoacetate 16 (1.29 g, 10 mmol) and 
acetaldehyde (0.4 g, 10 mmol) in dry methanol (20 ml) was added drop wise at -10°C 
under nitrogen. The reaction mixture was stirred at -10°C for 4h and it was poured into 
aqueous 30% ammonium chloride (100ml). The aqueous layer is then extracted with 
ethyl acetate (3x20 ml), the organic layer is dried with sodium sulfate, and the solvent 
was evaporated under vacuum to give the corresponding vinyl azide 21a, yield 93 mg 
(6%). 1H NMR (400 MHz, CDCl3) δ 6.29 (q, 1H), 4.22 (q, J=6.2 Hz, 2H), 2.05(t, 3H), 
1.29 (t, J=6.2 Hz, 3H). 13C NMR (400 MHz, CDCl3) δ 167.9, 141.5, 136.5, 61.2, 14.2, 
9.5 ppm. 
(Z)-Ethyl 2-azidooct-2-enoate (17b):  
To a well stirred solution containing potassium methoxide (0.7 g, 10 mmol) in dry 
methanol (20 ml), a solution of ethyl azidoacetate 16 (1.29 g, 10 mmol) and 
hexanaldehyde (1 g, 10 mmol) in dry methanol (20 ml) was added drop wise at -10°C 
under nitrogen. The reaction mixture was stirred at -10°C for 4h and it was poured into 
aqueous 30% ammonium chloride (100ml). The aqueous layer is then extracted with 
ethyl acetate (3x20 ml), the organic layer is dried with sodium sulfate, and the solvent 
was evaporated under vacuum to give the corresponding vinyl azide 21b, yield 1.13g 
(52%). 1H NMR (400 MHz, CDCl3) δ 6.49 (q, 1H), 4.14 (q, J=6.2 Hz, 2H), 2.16 (q, 2H), 
1.29 (m, 2H) 1.24 (t, J=6.2 Hz, 3H), 0.9 (t, 3H). 13C NMR (400 MHz, CDCl3) δ 167.8, 
149.4, 135, 132.9, 61.9, 31.9, 29.7, 29.6, 29.3, 24.2, 22.7, 14.8, 14.2 ppm. 
(Z)-Ethyl 2-azidodec-2-enoate (17c): 
 To a well stirred solution containing potassium methoxide (0.7 g, 10 mmol) in dry 
 187	  
methanol (20 ml), a solution of ethyl azidoacetate 16 (1.29 g, 10 mmol) and 
octanaldehyde (1.28 g, 10 mmol) in dry methanol (20 ml) was added drop wise at -10°C 
under nitrogen. The reaction mixture was stirred at -10°C for 4h and it was poured into 
aqueous 30% ammonium chloride (100ml). The aqueous layer is then extracted with 
ethyl acetate (3x20 ml), the organic layer is dried with sodium sulfate, and the solvent 
was evaporated under vacuum to give the corresponding vinyl azide 21c, yield 1.29g 
(54%). 1H NMR (400 MHz, CDCl3) δ 6.09 (q, 1H), 4.18 (q, J=6.2 Hz, 2H), 2.18(q, 2H), 
1.31 (m, 14H) 1.24 (t, J=6.2 Hz, 3H), 0.88(t, 3H). 13C NMR (400 MHz, CDCl3) δ 167.8, 
149.4, 135, 132.9, 61.9, 31.9, 29.7, 29.6, 29.3, 24.2, 22.7, 14.8, 14.2 ppm. 
 
(Z)-Ethyl 2-azido-3-phenylacrylate (17d):  
To a well stirred solution containing sodium (0.23 g, 10 mmol) in dry ethanol (30 ml), a 
solution of ethyl azidoacetate 16 (1.29 g, 10 mmol) and benzaldehyde (0.53 g, 5 mmol) 
in dry ethanol (10 ml) was added drop wise at -10°C under nitrogen. The reaction 
mixture was stirred at 0°C for 4 h and it was poured into aqueous 30% ammonium 
chloride (100ml) and the formed solid was separated by filtration, washed with water (30 
ml) and dried to give vinyl azide 21d, yield 1.8 g (82%). 1H NMR (400 MHz, CDCl3) δ 
7.91 (s, 1H), 7.60 (d, 2H), 7.4(d, 2H), 7.33(t, 1H), 4.24 (q, J=6.2 Hz, 2H), 1.24 (t, J=6.2 
Hz, 3H). 13C NMR (400 MHz, CDCl3) δ 167.1, 135.2, 128.6, 128.5, 127.9, 132.9, 118.8, 
61.8, 14.8 ppm. 
 
(Z)-Ethyl 2-azido-3-(2,4,6-trimethoxyphenyl)acrylate (17e):  
To a well-stirred solution containing sodium (0.23 g, 10 mmol) in dry ethanol (30 ml), a 
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solution of ethyl azidoacetate 16 (1.29 g, 10 mmol) and trimethoxy benzaldehyde (0.98 
g, 5 mmol) in dry ethanol (30 ml) was added drop wise at -10°C under nitrogen. The 
reaction mixture was stirred at 0°C for 4 h and it was poured into aqueous 30% 
ammonium chloride (100ml) and the formed solid was separated by filtration, washed 
with water (30 ml) and dried to give vinyl azide 21e, yield 2.39 g (78%). 1H NMR (400 
MHz, CDCl3);  δ 8.19 (s, 1H), 6.09 (s, 2H), 4.2 (q, J=6.2 Hz, 2H), 3.83 (s, 9H), 1.29 (t, 
J=6.2 Hz, 3H). 13C NMR (400 MHz, CDCl3) δ 167.4, 160.6, 159.6, 132.9, 118.8, 101.7, 
90.9, 61.4, 56.2, 55.8, 14.2 ppm. 
(Z)-ethyl 2-acetamido-3-phenylacrylate (20a) 
To a solution of (Z)-ethyl 2-azido-3-phenylacrylate 17d (2.17 g, 10 m.mol) in DCM was 
added triphenyl phosphine (2.62 g, 10 m.mol) and the mixture was stirred at room 
temperature. After it was stirred for 2 hrs, triethyl amine (2.01 g, 20 m.mol) was added 
to it at 0°C. To this cooled solution was added a solution of acetyl chloride (0.78g, 10 
m.mol) in DCM at 0°C, drop wise. After reaction mixture was stirred for 6 hrs, 100 mg of 
silica was added into the solution and stirred for another 30 minutes. After evaporating 
the solvent under vacuum, the desired product is obtained and for further purification it 
was subject to column chromatography. The pure product was obtained in 54% yield 
(1.27 g). 1H NMR (400 MHz, CDCl3); δ 8.0 (s, br, 1H), 7.60 (d, 2H), 7.40 (d, 2H), 7.33 (t, 
1H), 6.55 (s, 1H), 4.24 (q, 2H), 1.86 (s, 3H), 1.29 (t, 3H). 13C NMR (400 MHz, CDCl3) δ 
170.4, 161.7, 134.2, 128.6, 128.5, 127.9, 123.6, 61.4, 23.4, 14.2 ppm. 
 
  
(Z)-ethyl 2-benzamido-3-phenylacrylate (20b) 
 189	  
To a solution of (Z)-ethyl 2-azido-3-phenylacrylate 17d (2.17 g, 10 m.mol) in DCM was 
added triphenyl phosphine (2.62 g, 10 m.mol) and the mixture was stirred at room 
temperature. After it was stirred for 2 hrs, triethyl amine (2.01 g, 2 m.mol) was added to 
it at 0°c. To this cooled solution was added a solution of benzoyl chloride (1.48g, 10 
m.mol) in DCM at 0°C, drop wise. After reaction mixture was stirred for 6 hrs, 100 mg of 
silica was added into the solution and stirred for another 30 minutes. After evaporating 
the solvent under vacuum, the desired product is obtained and for further purification it 
was subject to column chromatography. The pure product was obtained in 58% yield 
(1.71 g). 1H NMR (400 MHz, CDCl3); δ 8.4 (s, br, 1H), 8.03(d, 1H), 7.62-7.78 (m, 5H), 
7.31-7.48 (m, 3H), 4.28 (q, 2H), 1.22 (t, 3H). 13C NMR (400 MHz, CDCl3) δ 166.2, 
161.4, 134.6, 133.2, 132.1, 128.8, 128.6, 128.5, 127.9, 123.6, 121.7, 14.2 ppm. 
(Z)-ethyl 2-hexanamido-3-phenylacrylate (20c) 
To a solution of (Z)-ethyl 2-azido-3-phenylacrylate 17d (2.17 g, 10 m.mol) in DCM was 
added triphenyl phosphine (2.62 g, 10 m.mol) and the mixture was stirred at room 
temperature. After it was stirred for 2 hrs, triethyl amine (2.01 g, 2 m.mol) was added to 
it at 0°c. To this cooled solution was added a solution of hexanoyl chloride (1.34 g, 10 
m.mol) in DCM at 0°C, drop wise. After reaction mixture was stirred for 6 hrs, 100 mg of 
silica was added into the solution and stirred for another 30 minutes. After evaporating 
the solvent under vacuum, the desired product is obtained and for further purification it 
was subject to column chromatography. The pure product was obtained in 52% yield 
(1.28 g). 1H NMR (400 MHz, CDCl3); δ 8.4 (s, br, 1H), 8.03(d, 1H), 7.62-7.78 (m, 5H), 
7.31-7.48 (m, 3H), 4.28 (q, 2H), 1.22 (t, 3H). 13C NMR (400 MHz, CDCl3) δ 166.2, 
161.4, 134.6, 133.2, 132.1, 128.8, 128.6, 128.5, 127.9, 123.6, 121.7, 14.2 ppm. 
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(Z)-ethyl 2-acetamido-3-(2,4,6-trimethoxyphenyl)acrylate (20d) 
To a solution of (Z)-Ethyl 2-azido-3-(2,4,6-trimethoxyphenyl)acrylate 17e (3.07 g, 10 
m.mol) in DCM was added triphenyl phosphine (2.62 g, 10 m.mol) and the mixture was 
stirred at room temperature. After it was stirred for 2 hrs, triethyl amine (2.01 g, 2 m.mol) 
was added to it at 0°c. To this cooled solution was added a solution of acetyl chloride 
(0.78g, 10 m.mol) in DCM at 0°C, drop wise. After reaction mixture was stirred for 6 hrs, 
100 mg of silica was added into the solution and stirred for another 30 minutes. After 
evaporating the solvent under vacuum, the desired product is obtained and for further 
purification it was subject to column chromatography. The pure product was obtained in 
58% yield (1.87 g). 1H NMR (400 MHz, CDCl3) δ 8.12 (s, br, 1H), 7.52(d, 2H), 7.49-7.36 
(m, 3H), 4.28 (q, 2H), 2.28(q, 2H), 1.8(m, 6H), 1.21 (t, 3H), 1.02(t, 2H). 13C NMR (400 
MHz, CDCl3) δ 170.5, 161.9, 134.2, 128.8, 128.6, 128.5, 127.9, 123.8, 121.4,14.6, 10.1 
ppm. 
(Z)-ethyl 2-benzamido-3-(2,4,6-trimethoxyphenyl)acrylate (20e) 
To a solution of (Z)-Ethyl 2-azido-3-(2,4,6-trimethoxyphenyl)acrylate 17e (3.07 g, 10 
m.mol) in DCM was added triphenyl phosphine (2.62 g, 10 m.mol) and the mixture was 
stirred at room temperature. After it was stirred for 2 hrs, triethyl amine (2.01 g, 2 m.mol) 
was added to it at 0°c. To this cooled solution was added a solution of benzoyl chloride 
(1.48g, 10 m.mol) in DCM at 0°C, drop wise. After reaction mixture was stirred for 6 hrs, 
100 mg of silica was added into the solution and stirred for another 30 minutes. After 
evaporating the solvent under vacuum, the desired product is obtained and for further 
purification it was subject to column chromatography. The pure product was obtained in 
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61% yield (2.35 g). 1H NMR (400 MHz, CDCl3) δ 8.12 (s, br, 1H), 8.03 (d, 2H), 7.52(d, 
2H), 7.49-7.36 (m, 3H), 4.28 (q, 2H), 3.58(s, 9H), 2.28(q, 2H), 1.8(m, 6H), 1.21 (t, 3H), 
1.02(t, 2H). 13C NMR (400 MHz, CDCl3) δ 166.2, 161.7, 160.6, 159.6, 133.2, 132.1, 
128.8, 128.6, 128.5, 127.9, 123.8, 121.4, 101.7, 90.9, 61.4, 56.2, 55.8, 14.6 ppm. 
 (Z)-ethyl 2-hexanamido-3-(2,4,6-trimethoxyphenyl)acrylate (20f)  
To a solution of (Z)-Ethyl 2-azido-3-(2,4,6-trimethoxyphenyl)acrylate 17e (3.07 g, 10 
m.mol) in DCM was added triphenyl phosphine (2.62 g, 10 m.mol) and the mixture was 
stirred at room temperature. After it was stirred for 2 hrs, triethyl amine (2.01 g, 2 m.mol) 
was added to it at 0°c. To this cooled solution was added a solution of hexanoyl chloride 
(1.34 g, 10 m.mol) in DCM at 0°C, drop wise. After reaction mixture was stirred for 6 
hrs, 100 mg of silica was added into the solution and stirred for another 30 minutes. 
After evaporating the solvent under vacuum, the desired product is obtained and for 
further purification it was subject to column chromatography. The pure product was 
obtained in 57% yield (1.92 g). 1H NMR (400 MHz, CDCl3) δ 8.12 (s, br, 1H), 6.55 (q, 
1H), 4.28 (q, 2H), 2.28(q, 2H), 1.86(s, 3H), 1.81(m, 6H), 1.21 (t, 3H), 1.02 (t, 2H). 13C 
NMR (400 MHz, CDCl3) δ 170.4, 170.1,127.9, 115.7, 101.7, 61.4, 23.4, 21.2, 20.8, 16.8, 
14.6, 14.1,10.2 ppm.  
 (Z)-ethyl 2-acetamidonon-2-enoate (20g) 
To a solution of (Z)-ethyl 2-hexanamido-3-phenylacrylate 20c (2.11 g, 10 m.mol) in 
DCM was added triphenyl phosphine (2.62 g, 10 m.mol) and the mixture was stirred at 
room temperature. After it was stirred for 2 hrs, triethyl amine (2.01 g, 2 m.mol) was 
added to it at 0°C. To this cooled solution was added a solution of acetyl chloride 
(0.78g, 10 m.mol) in DCM at 0°C, drop wise. After reaction mixture was stirred for 6 hrs, 
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100 mg of silica was added into the solution and stirred for another 30 minutes. After 
evaporating the solvent under vacuum, the desired product is obtained and for further 
purification it was subject to column chromatography. The pure product was obtained in 
43% yield (0.8 g). 1H NMR (400 MHz, CDCl3) δ 8.12 (s, br, 1H), 6.55 (q, 1H), 4.28 (q, 
2H), 2.28(q, 2H), 1.86(s, 3H), 1.81(m, 6H), 1.21 (t, 3H), 1.02 (t, 2H). 13C NMR (400 
MHz, CDCl3) δ 170.4, 170.1,127.9, 115.7, 101.7, 61.4, 23.4, 21.2, 20.8, 16.8, 14.6, 
14.1, 10.2 ppm. 
 (Z)-ethyl 2-benzamidooct-2-enoate (20h) 
To a solution of (Z)-ethyl 2-hexanamido-3-phenylacrylate 17c (2.11 g, 10 m.mol) in 
DCM was added triphenyl phosphine (2.62 g, 10 m.mol) and the mixture was stirred at 
room temperature. After it was stirred for 2 hrs, triethyl amine (2.01 g, 2 m.mol) was 
added to it at 0°c. To this cooled solution was added a solution of benzoyl chloride (1.48 
g, 10 m.mol) in DCM at 0°C, drop wise. After reaction mixture was stirred for 6 hrs, 100 
mg of silica was added into the solution and stirred for another 30 minutes. After 
evaporating the solvent under vacuum, the desired product is obtained and for further 
purification it was subject to column chromatography. The pure product was obtained in 
47% yield (1.16 g). 1H NMR (400 MHz, CDCl3) δ 8.12 (s, br, 1H), 6.55 (q, 1H), 4.28 (q, 
2H), 2.28(q, 2H), 1.86(s, 3H), 1.81(m, 6H), 1.21 (t, 3H), 1.02 (t, 2H). 13C NMR (400 
MHz, CDCl3) δ 170.4, 170.1,127.9, 115.7, 101.7, 61.4, 23.4, 21.2, 20.8, 16.8, 14.6, 
14.1, 10.2 ppm. 
(Z)-ethyl 2-hexanamidooct-2-enoate (20i) 
To a solution of (Z)-ethyl 2-hexanamido-3-phenylacrylate 17c (2.11 g, 10 m.mol) in 
DCM was added triphenyl phosphine (2.62 g, 10 m.mol) and the mixture was stirred at 
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room temperature. After it was stirred for 2 hrs, triethyl amine (2.01 g, 2 m.mol) was 
added to it at 0°c. To this cooled solution was added a solution of hexanoyl chloride 
(1.34 g, 10 m.mol) in DCM at 0°C, drop wise. After reaction mixture was stirred for 6 
hrs, 100 mg of silica was added into the solution and stirred for another 30 minutes. 
After evaporating the solvent under vacuum, the desired product is obtained and for 
further purification it was subject to column chromatography. The pure product was 
obtained in 41% yield (0.82 g). 1H NMR (400 MHz, CDCl3) δ 8.12 (s, br, 1H), 6.55 (q, 
1H), 4.28 (q, 2H), 2.28(q, 2H), 1.86(s, 3H), 1.81(m, 6H), 1.21 (t, 3H), 1.02 (t, 2H). 13C 
NMR (400 MHz, CDCl3) δ 170.4, 170.1,127.9, 115.7, 101.7, 61.4, 23.4, 21.2, 20.8, 16.8, 
14.6, 14.1, 10.2 ppm.  
(Z)-ethyl 2-acetamidoundec-2-enoate (20j) 
To a solution of (Z)-Ethyl 2-azidooct-2-enoate 17b (2.39 g, 10 m.mol) in DCM was 
added triphenyl phosphine (2.62 g, 10 m.mol) and the mixture was stirred at room 
temperature. After it was stirred for 2 hrs, triethyl amine (2.01 g, 2 m.mol) was added to 
it at 0°c. To this cooled solution was added a solution of acetyl chloride (0.78g, 10 
m.mol) in DCM at 0°C, drop wise. After reaction mixture was stirred for 6 hrs, 100 mg of 
silica was added into the solution and stirred for another 30 minutes. After evaporating 
the solvent under vacuum, the desired product is obtained and for further purification it 
was subject to column chromatography. The pure product was obtained in 46% yield 
(0.85 g). 1H NMR (400 MHz, CDCl3) δ 8.12 (s, br, 1H), 6.55 (q, 1H), 4.28 (q, 2H), 2.28(q, 
2H), 1.86(s, 3H), 1.81(m, 6H), 1.21 (t, 3H), 1.02 (t, 2H). 13C NMR (400 MHz, CDCl3) δ 
170.4, 170.1,127.9, 115.7, 101.7, 61.4, 23.4, 21.2, 20.8, 16.8, 14.6, 14.1, 10.2 ppm.  
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(Z)-ethyl 2-benzamidodec-2-enoate (20k) 
To a solution of (Z)-Ethyl 2-azidooct-2-enoate 17b (2.39 g, 10 m.mol) in DCM was 
added triphenyl phosphine (2.62 g, 10 m.mol) and the mixture was stirred at room 
temperature. After it was stirred for 2 hrs, triethyl amine (2.01 g, 2 m.mol) was added to 
it at 0°c. To this cooled solution was added a solution of benzoyl chloride (1.48 g, 10 
m.mol) in DCM at 0°C, drop wise. After reaction mixture was stirred for 6 hrs, 100 mg of 
silica was added into the solution and stirred for another 30 minutes. After evaporating 
the solvent under vacuum, the desired product is obtained and for further purification it 
was subject to column chromatography. The pure product was obtained in 48% yield 
(1.19 g). 1H NMR (400 MHz, CDCl3) δ 8.12 (s, br, 1H), 6.55 (q, 1H), 4.28 (q, 2H), 2.28(q, 
2H), 1.86(s, 3H), 1.81(m, 6H), 1.21 (t, 3H), 1.02 (t, 2H). 13C NMR (400 MHz, CDCl3) δ 
170.4, 170.1,127.9, 115.7, 101.7, 61.4, 23.4, 21.2, 20.8, 16.8, 14.6, 14.1, 10.2 ppm.  
 (Z)-ethyl 2-hexanamidodec-2-enoate (20l) 
To a solution of (Z)-Ethyl 2-azidooct-2-enoate 17b (2.39 g, 10 m.mol) in DCM was 
added triphenyl phosphine (2.62 g, 10 m.mol) and the mixture was stirred at room 
temperature. After it was stirred for 2 hrs, triethyl amine (2.01 g, 2 m.mol) was added to 
it at 0°c. To this cooled solution was added a solution of hexanoyl chloride (1.34g, 10 
m.mol) in DCM at 0°C, drop wise. After reaction mixture was stirred for 6 hrs, 100 mg of 
silica was added into the solution and stirred for another 30 minutes. After evaporating 
the solvent under vacuum, the desired product is obtained and for further purification it 
was subject to column chromatography. The pure product was obtained in 42% yield 
(0.83 g). 1H NMR (400 MHz, CDCl3) δ 8.02 (s, br, 1H), 6.16 (q, 1H), 4.28 (q, 2H), 2.28(q, 
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2H), 1.86 (3, 8H), 1.81(m, 6H), 1.21 (t, 3H), 1.02 (t, 2H). 13C NMR (400 MHz, CDCl3) δ 
170.4, 170.1,127.9, 115.7, 101.7, 61.4, 23.4, 21.2, 20.8, 16.8, 14.6, 14.1,10.2 ppm.  
Potassium 3-ethoxy-3-oxopropanoate (22) 
To a solution of diethyl malonate (1.75 g, 10 m.mol) in acetone, add potassium 
hydroxide (0.56g, 10 m.mol) in portions and a precipitation occurs as the reaction 
proceeds. After stirring the suspension for 12 hrs, it was filtered to obtain the pure 
product as white amorphous solid with 90% yield (1.55 g). 1H NMR (400 MHz, CDCl3) δ 
4.13 (q, 2H), 3.19(s, 2H), 1.29(t, 3H). 1H NMR (400 MHz, CDCl3) δ 175.4, 166.8, 61.12, 
43.28, 14.12 ppm. 
2-(4-(bromomethyl)phenyl)isoindoline-1,3-dione (23):Titled compound is prepared 
according to the general procedure E from 2-p-tolylisoindoline-1,3-dione (2.37g, 
10m.mol), N-bromo succinimide(3.2g,1.8m.mol) and benzoyl peroxide (5 mg; 0.02 
mmol, 0.34 mol %) in 25 ml of ethyl acetate or 20 ml of diethyl carbonate. The product 
was obtained in 90% yield (2.83g) in ethyl acetate and 95% yield (2.99g) in diethyl 
carbonate. 1H NMR (400 MHz, CDCl3);  δ 7.94-7.97 (m, 2H), 7.78-7.81 (m, 2H), 7.53 (d, 
J = 8.42 Hz, 2H), 7.45 (d, J = 8.42 Hz, 2H), 4.52 (s, 2H) ppm. 13C NMR δ 167.35, 
137.72, 134.78, 131.89, 130.07, 126.92, 124.09 and 32.82 ppm. 
 4-(1,3-dioxoisoindolin-2-yl) benzyl ethyl malonate (24): 
A suspension of potassium 3-ethoxy-3-oxopropanoate 22 (1.7 g, 10 m.mol) and 2-(4-
(bromomethyl)phenyl)isoindoline-1,3-dione 23 (3.1 g, 10 m.mol) in 25 ml of DMSO was 
sonicated for 4 hrs to obtain a clear solution. Once the reaction completion is confirmed 
by TLC, the solution is poured onto cool ice to get a white amorphous solid (3.55 g, 96% 
) which  is dried and used for next step directly. 1H NMR (400 MHz, CDCl3); δ 7.95-7.98 
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(m, 2H), 7.78-7.82 (m, 2H), 7.48-7.51  (d, J=8.42, 2H), 7.43-7.47 (d, J=8.42, 2H), 
5.22(s, 2H), 4.15-4.24 (q, J=6.9, 2H), 3.42(s, 2H), 1.20-1.28(t, J =6.9, 3H). 13C NMR 
(400 MHz, CDCl3); δ 12.1, 39.6, 59.7, 64.5, 121.9, 124.7, 127.1, 129.7, 129.8, 132.6, 
133.2, 164.4, 165.2 ppm.  
General Method of preparation of benzodioxoles (28-I): Benzene (10 ml) suspension 
of carbonyl compound (10 mmol), catechol (1.1 g; 1mmol), and p-toluenesulfonic acid (5 
mg) were refluxed with Dean Stark trap and microwave power of 400W for time 
indicated in Tables 2 and 3. Solvent was evaporated at reduced pressure. The solid 
residue was dissolved in hot dichloromethane-hexane (1:9; 3 ml) place on short (2x2 
inches) silica gel column. Silica gel was washed with dichloromethane-hexane (1:9; 
3x20 ml). The filtrates were combined and the solvent was evaporated to yield pure 
product. 
2-propylbenzo[d][1,3]dioxole (28-Ia):  
The titled compound has been prepared in 120 minutes using the above general 
method from buteraldehyde (0.72 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 79% 
yield (1.29g). 1H NMR (400 MHz, CDCl3) δ 7.66(d, 2H), 7.49(m, 3H), 6.96 (s, 1H), 
6.94(m, 4H). 13C NMR (400 MHz, CDCl3) δ 145.7,127.6, 124.56,120.9, 118.12, 115.12, 
65.8 ppm. 
2-butylbenzo[d][1,3]dioxole (28-Ib): 
The titled compound has been prepared in 120 minutes using the above general 
method from pentanal (0.86 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 73% yield 
(1.29g). 1H NMR (400 MHz, CDCl3) δ 7.66(d, 2H), 7.49(m, 3H), 6.96 (s, 1H), 6.94(m, 
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4H). 13C NMR (400 MHz, CDCl3) δ 145.7,127.6, 124.56,120.9, 118.12, 115.12, 65.8 
ppm. 
2-heptylbenzo[d][1,3]dioxole (28-Ic): 
The titled compound has been prepared in 90 minutes using the above general method 
from octanal (1.28 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 72% yield (1.58 g). 1H 
NMR (400 MHz, CDCl3) δ 7.66(d, 2H), 7.49(m, 3H), 6.96 (s, 1H), 6.94(m, 4H). 13C NMR 
(400 MHz, CDCl3) δ 145.7,127.6, 124.56,120.9, 118.12, 115.12, 65.8 ppm. 
2-nonylbenzo[d][1,3]dioxole (28-Id): 
The titled compound has been prepared in 90 minutes using the above general method 
from decanal (1.56 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 72% yield (1.78 g). 
1H NMR (400 MHz, CDCl3) δ 7.66(d, 2H), 7.49(m, 3H), 6.96 (s, 1H), 6.94(m, 4H). 13C 
NMR (400 MHz, CDCl3) δ 145.7,127.6, 124.56,120.9, 118.12, 115.12, 65.8. 
2-undecylbenzo[d][1,3]dioxole (28-Ie): 
The titled compound has been prepared in 90 minutes using the above general method 
from dodecanal (1.84 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 70% yield (1.73 g). 
1H NMR (400 MHz, CDCl3) δ 7.66(d, 2H), 7.49(m, 3H), 6.96 (s, 1H), 6.94(m, 4H). 13C 
NMR (400 MHz, CDCl3) δ 145.7,127.6, 124.56,120.9, 118.12, 115.12, 65.8. 
2-phenylbenzo[d][1,3]dioxole (28-If): 
The titled compound has been prepared in 120 minutes using the above general 
method from benzaldehyde (1.06 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 87% 
yield (1.72 g). 1H NMR (400 MHz, CDCl3) δ 7.66(d, 2H), 7.49(m, 3H), 6.96 (s, 1H), 
6.94(m, 4H). 13C NMR (400 MHz, CDCl3) δ 145.7,127.6, 123.4, 124.56,120.9, 118.12, 
115.54.56,  65.8. 
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2-(2-methoxyphenyl)benzo[d][1,3]dioxole (28-Ig): 
The titled compound has been prepared in 90 minutes using the above general method 
from 2-methoxy benzaldehyde (1.36 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 91% 
yield (2.07 g). 1H NMR (400 MHz, CDCl3) δ 7.66(d, 2H), 7.49(m, 3H), 6.96 (s, 1H), 
6.94(m, 4H). 13C NMR (400 MHz, CDCl3) δ 145.7,127.6, 124.56,120.9, 118.12, 115.12, 
67.74, 58.67. 
2-(3-methoxyphenyl)benzo[d][1,3]dioxole (28-Ih): 
The titled compound has been prepared in 90 minutes using the above general method 
from 3-methoxy benzaldehyde (1.51 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 89% 
yield (2.02 g). 1H NMR (400 MHz, CDCl3) δ 7.66(d, 2H), 7.49(m, 3H), 6.96 (s, 1H), 
6.94(m, 4H). 13C NMR (400 MHz, CDCl3) δ 145.7,127.6, 124.6,120.9, 118.1, 115.1, 
56.8 ppm  
2-(3-nitrophenyl)benzo[d][1,3]dioxole (28-Ii): 
The titled compound has been prepared in 150 minutes using the above general 
method from 3-nitro benzaldehyde (0.72 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 
79% yield (1.91g). 1H NMR (400 MHz, CDCl3) δ 7.66(d, 2H), 7.49(m, 3H), 6.96 (s, 1H), 
6.94(m, 4H). 13C NMR (400 MHz, CDCl3) δ 145.7,127.6, 124.6,120.9, 118.1, 115.1 
ppm.  
2,2-dimethylbenzo[d][1,3]dioxole (28-IIa): 
The titled compound has been prepared in 120 minutes using the above general 
method from acetone (1.04 g, 20 m.mol) and catechol (1.1 g, 10 m.mol) in 82% (1.23 g). 
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yield. 1H NMR (400 MHz, CDCl3) δ 6.88(m, 4H), 1.71(s, 6H). 13C NMR (400 MHz, 
CDCl3) δ 145.7,127.6, 120.9, 115.1, 25.8 ppm. 
 
2-tert-butyl-2-methylbenzo[d][1,3]dioxole (28-IIb): 
The titled compound has been prepared in 60 minutes using the above general method 
from pinacolone (1 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 98% yield (1.88 g).  
1H NMR (400 MHz, CDCl3) δ 6.88(m, 4H), 1.76(s, 3H), 0.94(s, 9H). 13C NMR (400 
MHz, CDCl3) δ 145.6,126.4, 120.9, 115.2, 44.7, 24.9, 20.8 ppm. 
2-ethyl-2-methylbenzo[d][1,3]dioxole (28-IIc): 
The titled compound has been prepared in 120 minutes using the above general 
method from 2-butanone (0.72 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 96% yield 
(1.57 g). 1H NMR (400 MHz, CDCl3) δ 6.88(m, 4H), 2.02(t, 2H), 0.90 (s, 3H). 13C NMR 
(400 MHz, CDCl3) δ 145.6,126.4, 120.9, 115.2, 44.7, 24.9, 20.8 ppm. 
2,2-diethylbenzo[d][1,3]dioxole (28-IId): 
The titled compound has been prepared in 90 minutes using the above general method 
from 3-pentanone (0.86 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 93% yield (2.04 
g). 1H NMR (400 MHz, CDCl3) δ 6.82(s, 4H), 2.02(q, 2H), 1.09 (t, 3H). 13C NMR (400 
MHz, CDCl3) δ 148.59,121.06, 108.12, 30.60, 7.32 ppm. 
2-hexyl-2-methylbenzo[d][1,3]dioxole (28-IIe): 
The titled compound has been prepared in 60 minutes using the above general method 
from octanone (1.28 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 92% yield (2.02 g). 
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1H NMR (400 MHz, CDCl3) δ 6.77(s, 4H), 1.92(q, 2H), 1.62(t, 2H), 1.58(s, 3H), 1.32 (m, 
8H), 0.89 (t, 3H). 13C NMR (400 MHz, CDCl3) δ 147.9, 121.2, 119.3, 108.5, 39.5, 31.9, 
29.6, 24.5, 23.4, 22.8, 14.3 ppm.  
 
spiro[benzo[d][1,3]dioxole-2,1'-cyclopentane] (28-IIf): 
The titled compound has been prepared in 120 minutes using the above general 
method from cyclopentanone (0.84 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 91% 
yield (1.60 g). 1H NMR (400 MHz, CDCl3) δ 6.81(m, 4H), 2.14(t, 4H), 1.87 (t, 4H). 13C 
NMR (400 MHz, CDCl3) δ 147.6,121.1, 118.4, 108.7, 35.4, 24.8, 23.4 ppm. 
spiro[benzo[d][1,3]dioxole-2,1'-cyclohexane] (28-IIg): 
The titled compound has been prepared in 120 minutes using the above general 
method from cyclohexanone (0.98 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 96% 
yield (1.82 g). 1H NMR (400 MHz, CDCl3) δ 6.81(m, 4H), 2.14(t, 4H), 1.92(t, 2H), 1.87 (t, 
4H). 13C NMR (400 MHz, CDCl3) δ 147.6, 121.1, 118.4, 108.7, 35.4, 25.6, 24.8, 23.4 
ppm. 
1-(2-methylbenzo[d][1,3]dioxol-2-yl)propan-2-one (28-IIh): 
The titled compound has been prepared in 75 minutes using the above general method 
from 2,4-petanedione (1 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 86% yield (1.65 
g). 1H NMR (400 MHz, CDCl3) δ 6.79(m, 4H), 3.05 (s, 2H), 2.21(s, 2H), 1.75 (s, 3H). 
13C NMR (400 MHz, CDCl3) δ 204.27, 147.01,129.97, 121.78, 121.54, 116.05, 109.06, 
51.98, 46.52, 31.78, 24.56 ppm.  
4-(2-methylbenzo[d][1,3]dioxol-2-yl)butan-2-one (28-IIi): 
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The titled compound has been prepared in 75 minutes using the above general method 
from 2,5-hexanedione (1.14 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 89% yield 
(1.83 g). 1H NMR (400 MHz, CDCl3) δ 6.72(m, 4H), 2.57 (t, 2H), 2.21(t, 2H), 2.06 (s, 
3H), 1.57 (s, 3H). 13C NMR (400 MHz, CDCl3) δ 207.3, 147.6,121.4, 121.3, 118.2, 
108.6, 37.1, 33.1, 32.9, 30.1, 24.8 ppm.   
2-methyl-2-phenylbenzo[d][1,3]dioxole (28-IIj): 
The titled compound has been prepared in 120 minutes using the above general 
method from acetophenone (1.2 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 96% 
yield (2.03 g). 1H NMR (400 MHz, CDCl3) δ 7.69(m, 2H), 7.42(m, 3H), 6.88(m, 4H), 2.06 
(s, 3H), 1.57 (s, 3H). 13C NMR (400 MHz, CDCl3) δ 147.8, 141.8, 129.4, 128.8, 125.5, 
121.9, 117.1, 109.2, 22.5 ppm. 
2-(4-chlorophenyl)-2-methylbenzo[d][1,3]dioxole (28-IIk): 
The titled compound has been prepared in 120 minutes using the above general 
method from 4-chloro acetophenone (1.54 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) 
in 87% yield (2.14 g). 1H NMR (400 MHz, CDCl3) δ 7.69(m, 2H), 7.42(m, 3H), 6.88(m, 
4H), 2.06 (s, 3H), 1.57 (s, 3H). 13C NMR (400 MHz, CDCl3) δ 147.8, 141.8, 129.4, 
128.8, 125.5, 121.9, 117.1, 109.2, 22.5 ppm. 
2-(3,5-dimethylphenyl)-2-methylbenzo[d][1,3]dioxole (28-IIl): 
The titled compound has been prepared in 120 minutes using the above general 
method from 3,5-dimethyl acetophenone (1.48 g, 10 m.mol) and catechol (1.1 g, 10 
m.mol) in 97% yield (1.32 g). 1H NMR (400 MHz, CDCl3) δ 7.27(s, 3H), 6.88(m, 4H), 
2.18(s, 6H), 2.06 (s, 3H). 13C NMR (400 MHz, CDCl3) δ 147.8, 141.8, 129.4, 128.9, 
125.5, 121.9, 117.1, 109.2, 22.5 ppm. 
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ethyl 2-(2-methylbenzo[d][1,3]dioxol-2-yl)acetate (28-IIm): 
The titled compound has been prepared in 120 minutes using the above general 
method from ethyl acetoacetate (1.3 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 89% 
yield (1.98 g). 1H NMR (400 MHz, CDCl3) δ 6.72(m, 4H), 4.13(q, 2H), 2.94(s, 2H), 
1,81(s, 2H), 1.19(t, 3H). 13C NMR (400 MHz, CDCl3) δ 147.8, 141.8, 129.4, 128.9, 
125.5, 121.9, 117.1, 109.2, 22.5 ppm. 
2-(2-methylbenzo[d][1,3]dioxol-2-yl)acetic acid (28-IIn): 
The titled compound has been prepared in 120 minutes using the above general 
method from ethyl 3-oxooctanoate (1.3 g, 10 m.mol) and catechol (1.1 g, 10 m.mol) in 
89% yield (1.98 g). 1H NMR (400 MHz, CDCl3) δ 6.72(m, 4H), 4.13(q, 2H), 2.94(s, 2H), 
1,81(s, 2H), 1.19(t, 3H). 13C NMR (400 MHz, CDCl3) δ 147.8, 141.8, 129.4, 128.9, 
125.5, 121.9, 117.1, 109.2, 22.5 ppm. 
  2-(2-methylbenzo[d][1,3]dioxol-2-yl)acetyl chloride (29): 
To a solution of ethyl 2-(2-methylbenzo[d][1,3]dioxol-2-yl)acetate 28-IIm (2.2g, 10 
m.mol) in 20 ml of 1:1 water and methanol, was added NaOH (0.4g, 10 m.mol) in 
portions at 0°C.  The solution was stirred at 0°C for 30 minutes and then brought to 
room temperature. After TLC confirms the reaction completion, methanol is evaporated 
under vacuum, and the aqueous layer is extracted by dichloromethane. The aqueous 
layer is then acidified with 10% HCl to obtain the desired product as precipitate from the 
solution. The precipitate thus obtained is dissolved in DCM to which oxalyl chloride (10 
m.mol, 1 eq) and a drop of DMF are added at 0°c and the desired product is obtained 
after 30 min of stirring from 0°C to room temperature and is used directly in the next 
step. 
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(Z)-ethyl 2-(2-(2-butylbenzo[d][1,3]dioxol-2-yl)acetamido)-3- phenyl acrylate (30b):  
To a solution of (Z)-ethyl 2-azido-3-phenylacrylate (0.217 g, 1 m.mol) in DCM was 
added triphenyl phosphine (0.262 g, 1 m.mol) and the mixture was stirred at room 
temperature. After it was stirred for 2 hrs, triethyl amine (0.2g, 2 m.mol) was added to it 
at 0°c. To this cooled solution was added a solution of 2-(2-methylbenzo [d][1,3] dioxol-
2-yl) acetyl chloride 29 in DCM at 0°c, drop wise. After reaction mixture was stirred for 6 
hrs, 100 mgs of silica was added into the solution and stirred for another 30 minutes. 
After evaporating the solvent under vacuum, the desired product is obtained and for 
further purification it was subject to column chromatography. The pure product was 
obtained in 78% yield. 
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